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The innate immune response has evolved to detect DNA from viruses and intracellular 
bacteria and differentiate this from our almost identical self-DNA. DNA detected in the 
cytoplasm is thought to be identified as foreign due to its location, and bacterial DNA in 
endosomes in recognised by its hypomethylated motifs. However, it is not clear how foreign 
DNA in the nucleus is differentiated from self-DNA, or what happens when the appearance of 
self-DNA is altered as it is in the case of DNA damage, a regular cellular occurrence. DNA 
damage has been shown to induce an immune response in tissues exposed to chemical 
mutagens – this has implications in the clearance of cancer cells after chemotherapy-induced 
DNA damage, with evidence that the immune response mounted by patients may determine 
chemotherapy responsiveness. To investigate the immune events following DNA damage, we 
analysed human keratinocytes, fibroblasts, and monocytes, and found that Etoposide, an 
inducer of double strand breaks, induced an early innate immune response, characterised by 
Type-I interferon and inflammatory cytokine production. This innate immune response to DNA 
damage was particularly potent in keratinocytes. This response required components of the 
cytoplasmic DNA sensing pathway, the predominantly nuclear sensor IFI16 and the 
cytoplasmic adaptor protein STING, but was independent of the enzyme cGAS, which is 
essential for the immune response to cytosolic DNA. The transcriptional and signalling profiles 
of the Etoposide-induced response differ from those of the classical pathogen sensing 
pathway, indicating that these two stimuli have overlapping but distinct pathways. This cell-
intrinsic innate immune response also involved DNA damage response factors ATM and p53, 
suggesting that DDR components may interact with immune components to alert the cell to 
damage. The innate immune response that we observe may play a role in the inflammatory 
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Chapter 1: Introduction 
1.1 The DNA Damage Response 
1.1.1 Introduction to DNA repair 
The maintenance and faithful replication of DNA in cells is essential for genomic stability and 
the successful inheritance of genomic material to daughter cells. If our DNA becomes 
damaged this can lead to changes in our DNA which, if passed on to daughter cells, may 
cause genetic instability and the development of cancer (Ciccia & Elledge, 2010). For this 
reason, the DNA damage response (DDR) has evolved to repair DNA lesions quickly and 
efficiently, or to promote cell death when the damage is too extensive. It has been estimated 
that every cell could experience up to 105 spontaneous lesions in DNA per day 
(Hoeijmakers, 2009). These DNA lesions come from many different sources. Cellular 
metabolic processes produce reactive oxygen species (ROS) which can cause oxidative 
damage. Ionising radiation (IR) and Ultraviolet (UV) light from the atmosphere can also 
damage our DNA. Everyday exposure to chemicals is another potentially genotoxic factor.  
There are many different types of DNA lesion which are repaired by specialised mechanisms 
(Table 1.1) (Ciccia & Elledge, 2010). To effectively repair DNA lesions without passing 
possibly deleterious mutations onto daughter cells, the DDR has to coordinate a halt in the 
cell cycle, recruit the correct repair proteins to resolve the particular type of damage, and 
potentially coordinate cellular apoptosis. The DDR is primarily mediated by sensor proteins 
of the PI3K (Phosphoinositide 3-Kinase)-like protein kinase family (PIKKs) (Savitsky, 1995), 
and by members of the poly(ADP-ribose) polymerase (PARP) family (Amé, 2004). PIKKs 
include the kinases ATM (Ataxia Telangiectasia Mutated), ATR (Ataxia Telangiectasia and 
Rad3-related) and DNA-PK (DNA-dependent Protein Kinase). Following recognition of DNA 
lesions, these primary DDR mediators coordinate a wide range of cellular activities after 
DNA damage, including DNA repair, cell-cycle checkpoint control, apoptosis, and 
transcription. Defects in any of these processes can result in genomic instability after DNA 
damage. DDR sensors work by post-translational modification of their downstream targets,  
15 
 
Type of Damage Source Repair mechanism 
Mismatched DNA bases Replication errors Mismatch repair 
Modification of bases IR, Oxidation, ROS, 
alkylating drugs 
Base excision repair (BER) 
Pyrimidine dimers UV light Nucleotide excision repair (NER) 
Intrastrand crosslinks Crosslinking agents NER 
Interstrand crosslinks 
(ICLs) 
Crosslinking agents ICL repair 




Single strand break repair 










Single-strand annealing (SSA) 
Table 1.1: Different types of DNA damage, their potential sources and their repair 
mechanisms 
 
leading to recruitment of proteins to the site of damage to amplify the DDR response. ATM, 
ATR, and DNA-PK have many common targets.  
1.1.2 DSBs and Topoisomerases 
Certain genotoxic agents such as IR, ROS, and topoisomerase inhibitors can lead to a break 
in both strands of DNA, known as a double strand break (DSB). DNA breaks can also be 
induced transiently to facilitate DNA repair and avoid replication fork stalls. Topoisomerase 
(TOP) enzymes relax torsional strain in DNA molecules partially by mediating DNA breaks in 
this way (Wang, 1996). There are two types of topoisomerase enzymes. Type I 
topoisomerases relax DNA by breaking only one strand of DNA, whereas type II 
topoisomerases break both strands of DNA. TOP2 binds to DNA, and facilitates a transient 
DSB of the DNA phosphodiester backbone, creating an intermediate known as the cleavage 
16 
 
complex. During this time, coiled DNA strands are free to rotate to around each other to 
remove torsional strain (Champoux, 2001). Two topoisomerase subunits covalently bind to 
the 5’-terminus of the DSB by phosphodiester bonds between the 5’ phosphate and the 
active-site tyrosine. There is then rapid intact second strand passage, re-ligation of the 
cleaved DNA strand, and enzyme turnover (Burden, 1998). Topoisomerase II is a target for 
several chemotherapeutic agents used in the treatment of cancer. Anti-cancer drugs, such 
as etoposide and doxorubicin that target this enzyme stabilise the cleavage complex, 
forming ternary complexes with the DNA and the enzyme, preventing religation, leading to a 
cleavable complex which leads to DNA strand breaks with blocked 5’ ends (Burden, 1996).  
1.1.3 Double Strand Break Repair 
DSBs are very cytotoxic lesions – even a single DSB can lead to cell death (Huang, 1996). 
DSB repair can be mediated by four independent pathways: Homologous Recombination 
(HR), Non-Homologous End Joining (NHEJ), alternative-NHEJ, and single-strand annealing 
(SSA) (Ciccia & Elledge, 2010). The choice of pathway can be mediated by the extent of 
DNA end processing. DNA end resection is a process that generates a long 3’ single strand 
DNA by degradation of the 5’ ending strand (White, 1990). This 3’ ssDNA strand then 
invades the homologous DNA template (Sun, 1991). Classical NHEJ does not require DNA 
end resection, the ends are directly ligated, whereas alt-NHEJ, HR, and SSA are dependent 
on DSB resection (Hartlerode, 2009).  
In the NHEJ pathways, DSBs are bound by the Ku heterodimer (Ku70 and Ku80) within 
seconds. Ku70/80 have a loop structure which DNA ends can go through (Walker, 2001). 
They then load and activate DNA-PKcs, the catalytic subunit of DNA-PK, initiating NHEJ 
(Gottlieb, 1993). During NHEJ, DNA-PKcs functions to stabilise DSB ends and prevent end 
resection by phosphorylating its targets. DNA-PKcs autophosphorylation allows the enzyme 
access to DNA ends and then prevents excessive end processing (Reddy, 2004). DNA-PKcs 
loading leads to XRCC4 (X-Ray Repair Cross Complementing 4)/DNA ligase IV recruitment, 
promoting the religation of the broken ends (Grawunder, 1997) (Diagram 1.1). DNA termini 





Diagram 1.1: DSB repair mechanisms in mammalian cells – Non-Homologous End Joining 
(NHEJ) or Homologous Recombination (HR). Figure adapted from The DNA Damage 
Response: Making It Safe to Play with Knives (Ciccia & Elledge, 2010). NHEJ (left) involves 
the recruitment of Ku subunits to DSBs, these then recruit DNA-PKcs (the catalytic subunit of 
DNA-PK) molecules to the DNA break. The main target for phosphorylation by DNA-PKcs is 
itself, this allows the recruitment and action of ARTEMIS, involved in DNA end processing. 
DNA-PKcs can then initiate DNA end protection which allows DNA ligation to occur. In 
alternative NHEJ (middle), CtIP and MRN in G1 results in alternative NHEJ. 
HR (right) is initiated by PARP, in competition with Ku, binding to DNA breaks. PARP recruits 
the MRN complex, which initiates DSB resection together with CtIP and BRCA1, and recruits 
ATM. ATM then phosphorylates many of the HR components. DSBs are then further 
resectioned and ssDNA ends coated in RPA molecules. BRCA2 displaces RPA from ssDNA 
ends and assembles RAD51 filaments, leading to strand invasion into homologous DNA 
sequences and Holliday junction formation and resolution. After end resection, homologous 
ssDNA ends can be directly annealed by Single Strand Annealing, dependent on RAD52. 




Cellular DSBs are also sensed by the MRE11-RAD50-NBS1 (Meiotic Recombination 11 
Homolog-RAD50 Double Strand Break Repair Protein-Nijmegen breakage syndrome 1 
(MRN)) complex. This complex senses chromatin perturbations in DNA very quickly after 
damage and recruits and activates the DDR kinase, ATM, triggering ATM 
autophosphorylation at Ser1981 and preparing DNA for HR (Diagram 1.1) (Uziel, 2003; Lee, 
2004; Lee, 2005). The MRN complex is essential for cell viability (Xiao, 1997; Luo, 1999; 
Zhu, 2001). RAD50 contains ATPase domains that interact with MRE11 and associates with 
the DNA ends of the DSB (Hopfner, 2002). In addition to stabilizing DNA ends, MRE11 has 
endonuclease and exonuclease activities important for the initial steps of DNA end resection 
that is essential for HR (Paull, 1998). NBS1 interacts with MRE11 and ATM, which promotes 
the recruitment of ATM to DSBs, where ATM is activated by the MRN complex (Lee, 2005; 
Williams, 2008). The MRN complex has been shown to be essential for DNA end resection, 
the ssDNA product of which stimulates ATM activity (Jazayeri, 2008). ATM then activates 
CtIP (CtBP (carboxy-terminal binding protein) interacting protein) in the S and G2 phases of 
the cell cycle, when sister chromatids can be used for HR (Chen, 2008). CtIP associates with 
MRN and BRCA1 (Breast Cancer 1), which ubiquitinates CtIP and facilitates its association 
with damage sites (Ouchi, 2006; Chen, 2008). RPA (Replication Protein A) is a ssDNA 
binding protein that facilitates end resection by facilitating the function of downstream 
helicases and endonucleases (Cejka, 2010). The invading single strand of DNA produced by 
end resection. in complex with Rad51, is then paired with the homologous DNA template, 
creating an intermediate known as the Holliday junction (Holliday, 1964). The Holliday 
junction is then resolved to give recombined DNA. 53BP1 inhibits DSB resection promoted 
by CtIP and ATM, and instead promotes NHEJ (Bunting, 2010). Loss of 53BP1 partially 
rescues the HR defect of BRCA1 mutant cells, suggesting that BRCA1 overcomes 53BP1 
function at DSBs to promote DSB resection (Bouwman, 2010; Bunting, 2010). 
1.1.4 ATM and γH2AX 
The protein kinase ATM has been shown to be kept in an inactive dimer or high-order 
multimer, with the kinase domain bound to a region surrounding serine 1981, in unirradiated 
cells (Bakkenist, 2003). Upon cellular irradiation, rapid autophosphorylation of serine 1981 
occurs, causing dimer dissociation, and initiating ATM kinase activity (Bakkenist, 2003). This 
19 
 
phosphorylation of ATM on serine 1981 is essential for its function (Bakkenist, 2003). Most 
ATM molecules in the cell are rapidly phosphorylated on this site after even low doses of 
radiation or the induction of a single double strand break (Bakkenist, 2003). This activation is 
not dependent upon direct binding to DNA strand breaks, but from changes in chromatin 
(Bakkenist, 2003). ATM then triggers a cascade of phosphorylation of several key targets 
implicated in cell cycle control, DNA repair or stress responses (Shiloh, 2003). The order and 
timing of recruitment is dependent on a series of posttranslational modifications induced by 
the activation of the DDR (Bergink, 2009; Harper and Elledge, 2007; Misteli, 2009). ATM 
kinase activity is required for arrests in G1, S and G2 phases of the cell cycle. Cells with 
kinase dead or S1981A mutant ATM fail to prevent mitosis upon DNA damage (Bakkenist, 
2003). 
Ataxia telangiectasia (AT) is an autosomal recessive syndrome caused by loss of function 
mutations in ATM. It is characterised by progressive cerebellar ataxia, immunodeficiency, 
radiosensitivity, hypogonadism, increased cancer incidence, and inflammatory syndromes 
(Ammann, 1971; Nowak-Wegrzyn, 2004; Westbrook, 2010). AT cells are hypersensitive to 
ionizing radiation and have defects in cell cycle checkpoint activation in response to DNA 
damage (Kastan, 1992; Beamish, 1994). AT cells show a small defect in DSB repair rate, 
with approximately 10% of breaks induced by X-rays or ionising radiation (IR) being 
unresolved (Riballo, 2004). These correspond to breaks occurring on heterochromatin, 
where ATM is required to open the chromatin structure, allowing access of the repair 
machinery. ATM is also involved in specialised DSB-repair mechanisms when DSB ends are 
blocked (Álvarez-Quilón, 2014). AT cells have a higher rate of error-prone recombination 
than Wild Type (WT) cells (Luo, 1996). The inability to repair even a single DSB can lead to 
cell death or genome rearrangements. Therefore, while ATM affects a minority of DNA 
lesions, its loss can lead to profound chromosomal instability in AT patients and ATM 
deficient cells.  
One key target of DDR kinases is the histone H2AX, which is phosphorylated on Ser139 
upon DNA damage, at this point becoming gamma-H2AX (γH2AX) (Rogakou, 1998). This 
activation is globally amplified across megabases of chromatin and by MDC1 (Mediator of 
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DNA damage checkpoint protein 1). MDC1 binds directly to phosphorylated H2AX (Stucki, 
2005) and to ATM to amplify H2AX phosphorylation and a cascade of monoubiquitination 
and K63-linked polyubiquitination at sites of DNA damage (Lou, 2006; Sobhian, 2007). 
γH2AX foci are conserved from yeast to humans, and are important in inducing the global 
phosphorylation of DDR substrates, including p53 and 53BP1 (p53-Binding Protein 1), that 
elicit cell-cycle arrest, repair, senescence, or apoptosis (Polo, 2011). γH2AX foci recruit 
chromatin modifying enzymes, DDR kinases, and DDR effector proteins into nuclear foci 
around the DSB (Rogakou, 1999; Celeste, 2002). Chromatin modifying enzymes regulate 
post-translational modifications (PTMs) of DNA and DDR factors, maintaining these DDR 
factors at H2AX scaffolds (Lee, 2010; van Attikum, 2009). H2AX is also ubiquitinated upon 
DNA damage (Huen, 2007). These ubiquitin chains stimulate further ubiquitination and the 
recruitment of more DDR proteins (Doil, 2009; Stewart, 2009; Wang, 2007). This is one 
example of the complex layers of PTMs that regulate all stages of the DDR. Many such 
modifiers are simultaneously recruited to sites of damage and alter the function of 
surrounding proteins while being themselves altered. This process is dynamic, with the type 
of damage defining how the repair proceeds. However, H2AX and MDC1 knockout mice 
have only partial defects in DSB repair (Celeste, 2002; Lou, 2006). While this process of 
signal amplification is not essential for cell viability, it may be an important warning system in 
the cell against mutations that could lead to cancer. 
1.1.5 P53 
An important downstream target of ATM is p53, which is often referred to as the guardian of 
the genome due to its mutation in many cancers. P53 is positively regulated through a 
succession of PTMs in response to DNA damage (Hupp, 1992; Rodriguez, 1999). Cellular 
levels of p53 are maintained at low levels and p53 turnover is tightly regulated by 
ubiquitination and proteasome-mediated degradation. ATM phosphorylates p53 on serine-15 
(Banin, 1998; Canman, 1998). This phosphorylation has been shown to be important in 
p53’s ability to overcome negative regulation by MDM2 (Murine double minute-2) and to 
arrest cell growth (Shieh, 1997; Meek, 1998). MDM2 is a RING (Really Interesting New 
Gene) finger ubiquitin E3 ligase that binds to the N-terminus of p53, preventing its 
transcriptional activity, and mediates the proteasomal degradation of p53 through 
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ubiquitination (Honda, 1997; Fuchs, 1998; Rodgriguez, 2000). After DNA damage, the 
amount of p53 in cells increases through attenuated proteolysis, and its transcriptional 
activity is enhanced to up-regulate its target genes. to induce cell-cycle arrest, apoptosis, or 
senescence through transcriptional regulation. The main effector of p53-mediated cell cycle 
arrest is the p53 target gene, p21 (Meek, 1998). p21 is an inhibitor of cyclin-dependent 
kinases, key regulators of the cell cycle. p53 activates p21 transcriptionally, which facilitates 
p53 inhibition of cell proliferation (El-Deiry, 1993). P53 regulates many other proteins 
including pro-apoptosis factors Bax (BCL2-associated X protein) and p53 upregulated 
modulator of apoptosis (PUMA) proteins (Espinosa, 2001; Ashcroft, 1999; Riley, 2008). p53 
can also directly activate repair pathways such as NER through regulation of the NER 
factors including XPC (xeroderma pigmentosum group C) (Adimoolam, 2002). Mutation of 
the p53 gene can promote oncogenic transformation, tumour progression, and resistance to 
chemotherapeutic agents by reducing the potential of cells to undergo apoptosis and cell 
growth arrest.  
1.1.6 PARP-1 
Poly(ADP-ribose) polymerase-1 (PARP-1) is an enzyme which, upon sensing DNA breaks 
with its N-terminal zinc-finger domain, synthesizes poly(ADP-ribose) (PAR). PARP-1 
synthesizes PAR from donor nicotinamide adenine dinucleotide (NAD+) attached to itself or 
other acceptor proteins such as histones and transcription-regulating factors (Pleschke, 
2000; Kim, 2004). Poly(ADP-ribosyl)ation is a posttranslational modification of nuclear 
proteins that facilitates DNA repair responses, contributing to the survival of injured 
proliferating cells (D'Amours, 1999). PARPs are a family of 18 proteins, encoded by different 
genes and displaying a conserved catalytic domain, in which PARP-1 and PARP-2 are the 
only enzymes whose catalytic activity is immediately stimulated by DNA strand-breaks (Amé, 
2004). Both PARP-1 and PARP-2 are activated by SSBs and DSBs and catalyse the 
addition of PAR chains on proteins that act as platforms to recruit factors to chromatin to 
promote repair breaks (Ménissier de Murcia, 2003). PARP-1 and PARP-2 have been shown 
to respond to DNA lesions with different kinetics, with PARP-1 responding first and PARP-2 
being recruited with other repair factors (Mortusewicz, 2007). The occurrence of a break 
leads to posttranslational modifications of histones and chromatin structure relaxation and 
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therefore to increased DNA accessibility (Poirier, 1982). As an amplified DNA damage 
signal, auto-poly(ADP-ribosyl)ation of PARP-1 triggers the recruitment of XRCC1, which 
coordinates and stimulates the repair process, to the DNA damage sites in less than 15 
seconds in living cells (Okano, 2003). PARP-1 has been shown to mediate the initial 
accumulation of the MRN complex to DSBs in a γH2AX- and MDC1-independent manner 
(Haince, 2008). Recruitment of ATM by MRN and PARP-1 then enhances activation of the 
γH2AX cascade and stabilisation of DDR factors at sites of damage (Haince, 2007). In the 
absence of PARP-1, ATM substrate activation is delayed (Haince, 2007).  
1.1.7 DNA Damage and Cancer 
Cancer is a term used to define a collection of evolutionary diseases characterised by 
unregulated cell proliferation and genomic instability (Hanahan, 2000; Negrini, 2010). 
Cancerous cells and tissues share certain hallmarks – genome instability and mutation; 
resistance to apoptosis signals and anti-growth signals; self-sufficiency in growth signals 
providing limitless replicative potential; tissue invasion and metastasis; sustained 
angiogenesis and tumour-promoting inflammation; immune cell evasion (Hanahan, 2000; 
Hanahan, 2011).  
Many chemical agents have been classified as carcinogens due to a correlation between 
exposure to these agents and cancer development (Pleasance, 2010). Carcinogens were 
found to cause DNA damage. This damage and its repair can introduce errors and mutations 
into the DNA sequence. Some mutations are deleterious to the cell and lead to cell death. 
Other mutations can lead to the transformation of cells into cancerous cells. The genomic 
instability displayed by cancer cells is characterised by alterations of chromosomal numbers 
or structure, accumulation of DNA base mutations and accumulation of short DNA repeats 
indicative of failed DNA repair (Negrini, 2010). With each genomic mutation, there may be a 
mutation which is beneficial to cell survival, conferring a selective advantage to the cancer 
cell in its environment. Genes that when mutated can lead to cancer are either oncogenes or 
tumour suppressor genes (Croce, 2008; Sherr, 2004). Oncogenes, when mutated, become 
activated and in turn activate cellular processes that lead to a cancer cell phenotype, 
whereas tumour suppressor genes, when mutated, become inactivated, and are unable to 
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stop the development of cancer. The majority of cancer-causing mutations are acquired, by 
the accumulation of mutations due to DNA damage events, a minority are inherited.  
DDR activation can prevent the development of cancer by preventing damaged-cell 
replication, and inducing cellular senescence or apoptosis early in tumour cell development 
(Bartkova, 2006; Di Micco, 2006). Deficiency of DDR components, therefore, is often 
associated with the development of cancer. People carrying mutations in HR genes ATM, 
Checkpoint Kinase 2 (CHK2), BRCA1/2, NBS1, and RAD50 have a greatly increased risk of 
developing breast, ovarian, and prostate cancer (Fackenthal, 2007; Moynahan, 2010; Walsh, 
2007). Patients with deficiencies in NER factors fail to repair UV lesions after sun exposure, 
leading to Xeroderma Pigmentosa, a syndrome known to greatly increase the risk of skin 
cancer and melanoma (Hoeijmakers, 2009). However, the majority of cancers are caused by 
acquired mutations, and are not inherited. Inactivation of p53 allows cells to enter the cell 
cycle despite DNA breaks, facilitating the inheritance of gene mutations in daughter cells 
(Kastan, 1991). More than 50% of human cancers have acquired P53 mutations, a further 
15% carry mutations in ATM (Ding, 2008).  
Despite their role in causing cancer, DNA damaging agents are also used in the treatment of 
cancer, this treatment is known as chemotherapy or radiotherapy. Due to their high 
proliferative rate, cancer cells are very sensitive to DNA damage-induced cell death. In the 
example of Etoposide, a topoisomerase II inhibitor, Etoposide stabilises the cleavage 
complex of DNA topoisomerase II, resulting in a DSB upon replication. Etoposide showed 
cytotoxic effect in vitro and in vivo, making it a good drug target for rapidly proliferating cells 
(Chen, 1984). However, tumour cells can become resistant to chemotherapy, it requires only 
one cell to survive for the resurgence of a new, resistant strain of cancer (Sawicka, 2004). 
Chemotherapy agents also have a wide range of off target effects. Non-cancerous but 
rapidly dividing cells such as gut epithelium, immune cells, and hair follicles are all sensitive 
to chemotherapy-induced cell death (Gudkov, 2010). Chemotherapy can also alter the 
tumour cell microenvironment to promote cancer cell survival and drug resistance (Gilbert, 




1.2 The Innate Immune Response 
1.2.1 The function of the innate immune system 
Living organisms, from plants to humans, have evolved a mechanism to detect and eliminate 
invading pathogens – the immune system. In mammals, the immune system is composed of 
two branches - the innate immune system, and the adaptive immune system. The adaptive 
immune system is composed of a large variety of T and B lymphocytes, all with distinct 
receptors specific to one antigen. Once the specific antigen has been detected, there is 
clonal expansion of the lymphocyte with a receptor specific for that antigen, making any 
future responses much faster and much stronger – this is the process of immunological 
memory (Ahmed, 1996). The innate immune system, on the other hand, relies on germline-
encoded Pattern Recognition Receptors (PRRs) (Akira, 2006). PRRs can recognise a variety 
of different Pathogen Associated Molecular Patterns (PAMPs), conserved motifs that are 
present in microorganisms but absent in healthy host cells. The subsequent PRR signalling 
can activate an immune response but cannot induce immunological memory. This is the first 
line of defence against invading microorganisms, which occurs in the first hours and days of 
infection. An immune response can also be triggered in the absence of infection, this is 
termed sterile inflammation (Chen, 2010). This can be the result of chemicals or physical 
trauma. Sterile inflammation has been linked to several autoinflammatory disorders (Wright, 
2000). PRRs can recognise Damage Associated Molecular Patterns (DAMPs) as well as 
PAMPs (Janeway, 2002). DAMPs are endogenous factors normally not visible to the 
immune system, such as dsDNA (Imaeda, 2009), mitochondrial DNA (Zhang, 2010), or 
HMGB1 (High Mobility Group Box 1) a chromatin modifying protein normally in the nucleus 
which alerts the immune system to danger when it is secreted from the cell (Yu, 2006).  
Innate responses are our first line of defense against a multitude of threats to host cells, from 
bacterial infection to cancerous cells. These responses are effectively mediated by a variety 
of cells including granulocytes, such as neutrophils, macrophages, dendritic cells (DCs), 
Natural Killer (NK) cells and Innate Lymphoid Cells (ILCs). Neutrophils, macrophages and 
DCs take up antigens by phagocytosis. Neutrophils are very short-lived cells which travel to 
the site of infection within minutes, take up antigens and then die within hours. Macrophages  
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TLR Ligand Location Reference 
TLR1 Peptidoglycan, triacylated 
lipoproteins 
Cell surface Takeuchi, 2002 
TLR2 Zymosan, triacylated 
lipoproteins 
Cell surface Kang, 2009 
TLR3 Poly(I:C), dsRNA Endosomal Alexopoulou, 2001 
TLR4 LPS (Lipopolysaccharide) Cell surface Medzhitov, 1997 
TLR5 Bacterial flagellin Cell surface Hayashi, 2005 
TLR6 Zymosan Cell surface Takeuchi, 2001 
TLR7 ssRNA Endosomal Hemmi, 2000 
TLR8 ssRNA Endosomal Heil, 2004 
TLR9 Hypomethylated CpG DNA Endosomal Hemmi, 2000 
TLR10 Unknown Cell surface Hess, 2017 
Table 1.2: Summary of human TLRs, their ligands, and their cellular location. 
 
are specialised in the proteasomal degradation of antigen within the phagosome and are 
very important in the early stages of infection in the clearance of microorganisms and dead 
immune cells at the site. DCs are professional antigen presenting cells. They degrade 
antigen but to a lesser extent than macrophages, leaving larger fragments of intact antigen 
to be presented to lymphocytes on MHC (Major Histocompatibility Complex) molecules. The 
presentation of antigen in the context of MHC is essential for antigen recognition by the 
immune system (Zinkernagel, 1974). An exception to this is NK cells which can mount an 
immune response to cells lacking MHC, an occurrence that is common in virally infected 
cells and cancerous cells (Vivier, 2011). ILCs produce effector cytokines in response to 
cytokines they detect in their microenvironment, produced by both myeloid and 
nonhematopoietic cells in tissues, to activate innate and adaptive cells (Eberl, 2015). Aside 
from immune cells, PRRs are present on many cell types, including epithelial cells, such as 
keratinocytes, and fibroblasts. These non-immune cells can present antigen to lymphocytes 
only upon infection with pathogens due to their lack of specialised phagocytic machinery.  
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Keratinocytes are the main constituent of our skin epidermis, forming our barrier to the 
outside world, and as such they are routinely being infected with pathogens and reacting to 
environmental stresses. Keratinocytes are one of the main host cells for Staphylococci 
bacteria and well as Herpes Simplex Virus 1 (HSV-1) virus infection. However, they also 
interact with the many commensal bacteria that colonise our skin (Pasparakis, 2004). In the 
absence of infection, UV has also been shown to induce keratinocyte-induced inflammation 
(Uchi, 2000). Through the production of anti-microbial peptides and cytokines, and 
coordinating skin-resident immune cell responses, keratinocytes are key to maintaining 
tissue homeostasis in the skin (Nestle, 2009). 
1.2.2 TLRs 
One class of PRR is the Toll-like Receptor (TLR) family. The Toll protein was first identified 
and found to have a role in the immune response in Drosophila (Hashimoto, 1988; Lemaitre, 
1996). Flies deficient in Toll showed a defect in immune responses (Lemaitre, 1996). 
Comparisons were drawn between Drosophila Toll and the human IL-1R, which both contain 
homologous Toll-IL-1 receptor (TIR) domains and can regulated cytokine expression through 
activation of NFκB (Nuclear Factor Kappa-light-chain-enhancer of activated B cells). The 
human homologue of the Drosophila Toll protein was then cloned and shown to drive NFκB 
signalling and cytokine production (Medzhitov, 1997). The human TLR family consists of 10 
transmembrane receptors (Table 1.2). TLR genes are highly conserved among vertebrates 
(Roach, 2005). Each TLR recognizes various PAMPs derived from bacteria, viruses, fungi, 
and protozoa (Akira, 2006; Janeway, 2002). TLRs 1, 2, 4, 5, 6, and 10 are expressed 
extracellularly, on the cell surface, while TLRs 3, 7, 8, and 9 are found in intracellular 
compartments, called endosomes (Table 1.2). Phagosomes of DCs and macrophages that 
engulf particles are a type of endosome which can kill and digest pathogens. The expression 
of TLRs 3, 7, 8, and 9 inside these endosomes detects the presence of nucleic acids 
indicative of pathogens. Plasmacytoid DCs (pDCs) are specialised in their antiviral response 
(Asselin-Paturel, 2001). pDCs rely on TLRs, especially TLR7 and TLR9, expressed in 





Diagram 1.2: Innate immune signaling pathways. There are several different innate 
immune pathways that respond to a diverse range of stimuli but all activate shared 
signalling pathways. Cell surface Toll-like Receptors (TLRs) can detect fungal, bacterial 
and viral components. Most TLRs signal through MyD88 or TRIF to activate downstream 
signaling including NFκB. There are also endosomal TLRs, 3, 4, 7, 8, and 9, which 
respond to viral components. These can also signal through MyD88 or TRIF depending on 
the TLR activated. These can activate NFκB signaling as well as IRF signalling via TBK1. 
Double stranded DNA is detected by DNA receptors including cGAS, which produces the 
cyclic di-nucleotide 2’3’ cGAMP, which activates STING, leading to TBK1-IRF3 signaling. 
2’3’ cGAMP can also be released from the cell and transmitted via gap junctions to warn 
neighbouring cells of infections. Double stranded RNA is detected by RNA sensors such 
as RIG-I, which activates MAVS, a signaling adaptor which subsequently actives TBK1-




Both drosophila and human Toll proteins are type-I transmembrane proteins containing a 
leucine-rich repeat (LRR) domain in the extracellular domain and a cytoplasmic TIR domain. 
The LRR domain binds ligands and the TIR domain allows the transmission of downstream 
signals via the recruitment of TIR-containing adaptor proteins, such as myeloid differentiation 
primary response gene 88 (MyD88) (Hultmark, 1994).  All TLRs, except TLR3, activate a 
MyD88-dependent pathway; only TLR3 and TLR4 activate a pathway dependent on another 
adaptor protein, TRIF (TIR domain containing adaptor-inducing IFN) (Akira, 2004). Both 
pathways activate NFκB and the mitogen-activated protein kinase (MAPK) pathway. TRIF 
signalling also activates IRFs (Interferon Regulatory Factors) to contribute to Type-I 
Interferon (IFN) gene expression. 
1.2.3 Inflammasomes 
Inflammasomes are another type of sensor for diverse classes of molecules in the cytoplasm 
including DNA, pore-forming toxins, and uric acid crystals. Inflammasomes are complexes 
which induce production of the cytokines IL-1β and IL-18. First pro-IL-1β and pro-IL-18 
mRNA is transcriptionally upregulated by NFκB, and after translation these precursor 
proteins are proteolytically processed to form biologically active mature cytokines by 
activated caspase-1 (Cerretti, 1992; Martinon, 2002). Caspase-1 activation occurs after the 
interaction of a sensor protein, an adaptor molecule containing a Caspase Activation and 
Recruitment Domain (CARD), and procaspase-1 which together make up an inflammasome 
complex. This inflammasome activation can also induce pyroptosis, an inflammatory form of 
cell death (Fink, 2006). There are several PRRs that can act as the sensor protein of the 
inflammasome, including NLRs (nucleotide-binding domain, leucine-rich repeat containing 
proteins NOD-like receptors), and ALRs (absent in melanoma 2 (AIM2)-like receptors) 
(Ogura, 2000; Ting, 2008; Fernandes-Alnemri, 2009; Hornung, 2009). NLR family proteins 
have C-terminal LRRs that allow bacterial ligand sensing, a central NACHT (NAIP, CIITA, 
HET-E and TP1) oligomerisation domain, and an N-terminal signaling domain such as CARD 
or PYD (pyrin) domain (Inohara, 2005). NLRs recruit the adaptor protein ASC (Apoptosis-
associated speck-like protein containing a caspase recruitment domain) with their PYD 
domain (de Alba, 2009). AIM2 is a predominantly cytoplasmic protein that is essential for the 
inflammasome response to cytoplasmic DNA (Fernandes-Alnemri, 2009; Hornung, 2009). 
29 
 
AIM2 is composed of a PYD domain and HIN-200 (hematopoietic interferon-inducible 
nuclear proteins with a 200-amino acid repeat) DNA binding domains, which bind to DNA 
from both host and pathogens, whereupon its PYRIN domain interacts with the PYRIN 
domain of ASC to induce oligomerisations and formation of the inflammasome (Fernandes-
Alnemri, 2009; Hornung, 2009). ASC oligomerisation forms a scaffold that activates 
caspase-1 and induce IL-1β, IL-18, and pyroptosis (Hersh, 1999). 
1.2.4 RLRs 
The presence of dsRNA or RNA with a 5’ triphosphate is unusual in mammalian cells, and 
their presence is recognised as a sign of infection. As well as being detected by TLRs 3, 7, 
and 8 in endosomes, RNA can also be detected in the cytosol by RLRs (RIG-I-like 
receptors). These include Retinoic acid-Inducible Gene I (RIG-I), Melanoma Differentiation-
Associated protein 5 (MDA5), and Laboratory of Genetics and Physiology 2 (LGP2) 
(Yoneyama, 2004; Kato, 2008; Satoh, 2010). RIG-I detects 5’ triphosphate-containing short 
dsRNA sequences, whereas MDA5 recognises long dsRNA sequences. Both RIG-I and 
MDA5 contain RNA helicase domains to interact with dsRNA, and CARD-like domains to 
interact with their downstream adaptor protein MAVS (Mitochondrial Antiviral-Signaling 
Protein). MAVS is an integral membrane protein that functions on both mitochondria and 
peroxisomes (Seth, 2005; Xu, 2005; Meylan, 2005; Kawai, 2005). MAVS facilitates 
TBK1/IKKε-mediated activation of IRF3/7 and NFκB that lead to induction of Type-I IFNs 
(Kawai, 2005; Meylan, 2005).  
1.2.5 Intracellular dsDNA sensing 
Host nucleic acids are thought to be sequestered from the view of the immune system. 
Several immune receptors are known to recognise immunostimulatory nucleic acids, such as 
TLR3 and dsRNA, TLR7/8 and ssRNA, and TLR9 and unmethylated CpG DNA in 
endosomal compartments (Liu, 2008; Lund, 2004; Hemmi, 2000; Bauer, 2001 Latz, 2004). 
TLRs 3, 7, 8, and 9 all sense nucleic acids located within endosomal compartments and this 
was thought to be essential to prevent recognition of self DNA. Forced expression of TLR9 
on the cell surface instead of the endosome stops it responding to virus-encapsulated DNA 
but allows an autoimmune response to self-derived genomic DNA in the extracellular milieu  
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Diagram 1.3: Summary of the receptors reported to bind dsDNA in the cytoplasm and instigate 
a Type-I IFN response through STING signaling.  
cGAS (Wu, 2013) DAI (Takaoka, 2007), DDX41 (Zhang, 2011), DNA-PK (Ferguson, 2012), 
IFI16 (Unterholzner, 2010), and MRE11 (Kondo, 2012) have all been reported to activate 
STING after dsDNA transfection or infection with DNA viruses or intracellular bacteria. DNA-
PK, IFI16, and MRE11 are all detectable in the nucleus. After its activation, STING has been 
shown to be essential for the activation of the kinases TBK1, as shown by phosphorylation of 
TBK1 and of phosphorylation and nuclear translocation of the downstream signalling factor 
IRF3. It is unclear how NFκB is regulated by this pathway, some authors have reported very 
little NFκB activation while others have reported a STING-TBK1 dependent NFκB pathway 
(Abe, 2014). In the nucleus IRF3 (and NFκB) translocate to their binding sites of the Type-I IFN 






(Barton, 2006). Cytoplasmic double-stranded DNA (dsDNA) was subsequently shown to 
trigger a robust innate immune response independently of TLRs or RIG-I (Ishii, 2006; 
Stetson, 2006a). The immune response produced by this dsDNA could protect cells from 
subsequent viral infection (Ishii, 2006). These findings led to the search for a new DNA 
sensing pathway.  
Transfected DNA was found to stimulate a Type-I IFN response, independent of sequence 
but dependent on its length, with oligonucleotides smaller than 25bp failing to induce Type-I 
IFN production (Stetson, 2006a). ISD (Interferon Stimulatory DNA) is a 45bp DNA oligomer 
derived from the L. monocytogenes genome, which strongly enhances expression of Type-I 
IFN when transfected into cells (Stetson, 2006a). The optimal stimulatory activity of dsDNA 
is dependent on the DNA having the right-handed B-form helical structure, with Z-form DNA 
demonstrating very low activity, suggesting that the recognition of cytosolic dsDNA depends 
on its structure (Ishii, 2006). The native sugar-phosphate backbone of dsDNA is essential for 
ISD activity (Stetson, 2006a). This Type-I IFN response to cytosolic DNA requires IRF-3 and 
TBK1 (Ishii, 2006; Stetson, 2006a). Several candidate PRRs have since been identified that 
sense dsDNA in the cytoplasm; these include cyclic GMP-AMP synthase (cGAS) (Sun, 
2013), DNA-dependent activator of IFN-regulatory factors (DAI) (Takaoka, 2007), RNA 
polymerase III (RNA-Pol III) (Ablasser, 2009; Chiu, 2009), IFN inducible gene 16 (IFI16) 
(Unterholzner, 2010), DEAD/H-box helicase (DDX41) (Zhang, 2011), Meiotic Recombination 
11 (MRE11) (Kondo, 2011), and DNA-dependent protein kinase (DNA-PK) (Ferguson, 2012) 
(Diagram 1.3). These proposed receptors all signal through the adaptor protein STING 
(Stimulator of IFN Genes) which is located at the Endoplasmic Reticulum (ER) and activates 
TBK1 and IRF3 (Ishikawa, 2009). STING has been shown to be a non-redundant adaptor 
protein in the innate immune response to cytosolic dsDNA (Barber, 2015). 
1.2.6 cGAS 
cGAS (cGAMP synthase) also known as MB21D1 (Mab-21 Domain Containing 1), is a 
cytoplasmic dsDNA sensor previously identified in a viral inhibitor screen (Schoggins, 2011). 
cGAS is found mainly in the cytosol and is barely detectable in the nucleus (Sun, 2013). 
32 
 
cGAS is composed of an DNA-binding N-terminus followed by a highly conserved Mab21 
domain belonging to the nucleotidyl transferase (NTase) superfamily (Sun, 2013). 
NTase superfamily proteins transfer nucleotides to an acceptor hydroxyl group, a key step in 
many biological processes including DNA replication and repair (Kuchta, 2009). The Mab21 
domain of cGAS comprises two lobes, separated by a deep cleft (Civril, 2013; Diagram 1.4). 
The cleft is lined which catalytic site residues to coordinate Mg2+ ions and nucleotides. The 
molecular surface opposite the active site is a slightly concave platform, referred to as the 
spine, and the nucleotide-binding loop. At one end of the platform is a Zn thumb, a protrusion 
containing highly conserved histidine and cysteines which together coordinate a Zn2+ ion 
(Civril, 2013). cGAS binds DNA, in a sequence independent manner, by interacting with both 
(Civril, 2013; P.Gao, 2013a; Wu, 2013). DsDNA of 36bp or longer has been shown to be the 
optimal length for cGAS activation (P. Gao, 2013a). cGAS binds seven nucleotides at the 
core of the platform. Two arginine fingers are inserted into the minor groove, stabilizing the 
interaction (Civril, 2013). The Zn thumb does not undergo a conformation change upon DNA 
binding, and instead serves as a structural stabilizer of the protruding loop to specifically 
recognise B-form dsDNA (Civril, 2013). Disruption of the Zn-binding site of the thumb, or 
mutation of catalytic pocket residues, abolishes DNA-induced NTase activity, and 
subsequently cGAS activity (Civril, 2013; P. Gao, 2013a). DNA binding triggers a 
conformational change in cGAS, closing its two lobes through repositioning of residues in the 
catalytic pocket, allowing access (Civril, 2013). In the steady state, the entrance to the 
catalytic pocket is very narrow (P. Gao, 2013a). This allows cGAS to be active only when 
bound to DNA.  
cGAS, in the presence of ATP (Adenosine Triphosphate), GTP (Guanine Triphosphate), 
dsDNA, and Mg2+ or Mn2+ produces a cyclic dinucleotide known as 2’3’ cGAMP (Cyclic 
GMP-AMP) (Sun, 2013; Wu, 2013; P. Gao, 2013a; Ablasser, 2013a). The cGAS-derived 
dinucleotide product is a non-canonical cyclic dinucleotide containing a single 2’-5’ 
phosphodiester linkage at the GpA step and a 3’5’ linkage at the ApG step, hence 2’3’ 




cGAMP was discovered through the presence of a non-protein, non-nucleic acid constituent 
of DNA stimulated cell extracts which could activate STING in permeabilised human 
monocytes (Wu, 2013). 2’3’ cGAMP was found to be a high affinity ligand for the adaptor 
protein STING (Wu, 2013; Diner, 2013). The presence of the 2’-5’ linkage in cGAMP was 
required to exert potent activation of human STING (Ablasser, 2013a; P. Gao, 2013a). High 
concentrations of c-di-GMP or c-di-AMP can compete for STING binding, however 2’3’ 
cGAMP is the most potent STING binding ligand (Wu, 2013). 
Diagram 1.4: Crystal structure of cGAS in complex with dsDNA, GTP, and ATP. 
PDB ID: 4KB6 as published in Civril, et al. (2013) Structural mechanism of cytosolic DNA sensing 
by cGAS. Nature; 498: 332–337. doi:10.1038/nature12305. 
dsDNA binds along the spine of cGAS and to the Zinc thumb which stabilises B-form DNA 
binding specifically. cGAS undergoes a conformational change when bound to dsDNA; the two 
cGAS lobes are repositioned allowing ATP and GTP access to the NTase catalytic pocket, and 
subsequent 2’3’ cGAMP production. 
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Cyclic dinucleotides (CDNs) are critical second messenger signaling molecules widely 
dispersed throughout prokaryotes (Danilchanka, 2013). The importance of cyclic 
dinucleotides as bacterial second messengers is well established (Ross, 1987). c-di-AMP 
and c-di-GMP are bacterial second messenger molecules which regulate a range of bacterial 
functions such as biofilm formation, motility, and virulence. These cyclic dinucleotides have 
been shown to induce IFN production in the host via detection by STING (Sauer, 2011). 
The ability to synthesise 2’-5’ phosphodiester bonds makes cGAS a member of the 
Oligoadenylate Synthase (OAS) family of enzymes, like 2'-5'-Oligoadenylate Synthetase 1 
(OAS1), which produces 2’-5’-linked oligoadenylates upon binding double stranded RNA. 
Both cGAS and OAS enzymes require nucleic acid binding for their activation, allowing the 
synthesis of their products independent of their template (Sun, 2013; Hornung, 2014). ATP 
and GTP are bound in the catalytic pocket positioned within the interior of the cGAS in the 
ternary complex (P. Gao, 2013a). cGAS first catalyses the synthesis of a linear 2’-5’-linked 
dinucleotide, which is then subject to cGAS-dependent cyclization in a second step through 
a 3’-5’ phosphodiester linkage on pppGp(2’-5’)A substrate (Ablasser, 2013a).  
cGAMP can also activate neighbouring cells by transfer via connexins at gap junctions, 
where it promotes STING activation and thus antiviral immunity independently of Type-I IFN 
signaling (Ablasser, 2013b). Cells possessing cGAS were found to transactivate bystander 
cells possessing STING through direct cell-to-cell contact, only after stimulation with dsDNA 
species (Ablasser, 2013b). This is a much faster way to activate uninfected cells than by 
cytokine production, which can be blocked by many viruses. 
Knockdown or knockout of cGAS has been shown to ablate the immune response to HSV-1, 
and Vaccinia Virus (VACV), which are DNA viruses, but not to RNA viruses (Wu, 2013; Sun, 
2013). cGAS−/− mice have reduced immune responses after HSV-1 infection, higher virus 
titre, including brain infection, and reduced survival compared to WT mice (Li, X.D., 2013). 
Infection with Modified Vaccinia Ankara (MVA), also stimulated transfer of cGAMP across 
gap junctions, which could activate STING in neighbouring cells (Ablasser, 2013b). Human 
Immunodeficiency Virus (HIV) infection has been shown to activate cGAS to produce 2’-3’ 
cGAMP activating the STING-TBK1-IRF3 pathway (D. Gao, 2013). cGAS-/- or STING-/- cells 
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were unable to mount an immune response to HIV, or similar murine and simian retroviruses 
(D. Gao, 2013). Retroviruses generate complementary DNA from the viral RNA genome by 
reverse transcription, which can then be detected by cGAS in the cytoplasm. Cytosolic 
bacteria such as M. tuberculosis have also been shown to be detected by cGAS, leading to 
Type-I IFN induction (Wassermann, 2015; Watson, 2015). 
Cyclic dinucleotide signalling is thought to have deep ancestral roots. cGAS homologues are 
found in animals but not fungi, plants or protists (Kranzusch, 2014; Wu, 2014). Many of 
cGAS’s key residues are highly conserved among vertebrates and in earlier branching 
species (Wu, 2014). The overexpression of a predicted cGAS homologous sea anemone 
gene, nv-A7SFB5.1, can activate a hSTING-dependent IFN-β response (Kranzusch, 2015). 
Despite less than 30% sequence homology with vertebrate STING, sea anemone STING 
can bind to 2’3’ human cGAMP and has structural homology to the human protein 
(Kranzusch, 2015). Both sea anemone cGAS and the bacterial nucleotidyl transferase 
Dinucleotide cyclase Vibrio (DncV) cGAS homologue produce a canonical CDN with two    
3’-5- linkages (3’-3’ cGAMP) which activate STING but not as well as 2’3’ cGAMP (Davies, 
2012; Kranzusch, 2014; Diner, 2013). Modern cGAS and STING have acquired structural 
features only recently in vertebrates, including the zinc-ribbon domain and DNA binding 
residues in cGAS, as well as the CTT domain for transducing signals in STING (Wu, 2014). 
1.2.7 Other Intracellular DNA Sensors 
Alongside cGAS, several other sensors have been previously reported to make an immune 
response to cytoplasmic dsDNA through STING activation. DAI is an IFN-inducible protein 
found to bind to dsDNA at its N-terminus, and IRF3 and TBK1 at its C-terminus upon 
stimulation (Takaoka, 2007; Wang, 2008). However, DAI-deficient cells and mice have since 
shown that DAI is dispensable for the immune response to cytosolic DNA (Ishii, 2008; 
Lippmann, 2008). However, DAI has been shown to have an anti-viral role independent of 
IFN signalling, through induction of virus-induced necrosis (Upton, 2012).  
RNA polymerase III can transcribe cytoplasmic poly(dA-dT), a dsDNA mimic, to dsRNA 
leading to DNA induced IFN induction via the RIG-I-MAVS RNA sensing pathway. RNA-Pol 
III was found to bind to AT-rich dsDNA, poly(dA-dT) in the cytoplasm, leading to the 
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transcription of dsRNA with a 5’-triphosphate motif (Ablasser, 2009; Chiu, 2009). This 
dsRNA was then sensed by RIG-I and MAVS to induce an innate immune response 
(Ablasser, 2009; Chiu, 2009). However, other DNA, such as that from viruses, is not 
transcribed by RNA-Pol III (Unterholzner, 2010). 
DDX41 is a member of the DEAD-like helicases (DEXDc) family of helicases, including the 
RIG-I-like receptor subfamily. Knockdown of DDX41 expression reduced the Type-I IFN 
response to cytosolic DNA (Zhang, 2011; Parvatiyar, 2012). Overexpression of both DDX41 
and STING together had a synergistic effect in promoting IFN-β promoter activity (Zhang, 
2011). DDX41 has been reported to bind to DNA, CDNs, and STING, localising together with 
STING in the cytosol (Zhang, 2011; Parvatiyar, 2012). 
Some DNA damage repair factors have been proposed to function as DNA sensors. DDR 
factor MRE11 was shown to partially colocalise with ISD in the cytoplasm (Kondo, 2012). 
The MRN complex, containing MRE11, RAD50, and NBS1, plays crucial roles in the early 
response to DSBs and is required for ATM phosphorylation. Both UV damage and DNA 
transfection were found to induce phosphorylation of ATM, whereas the RNA mimic poly(I:C) 
did not (Kondo, 2012). Use of mirin, an MRE11 inhibitor, reduced the IFN-β response to 
transfected DNA but not to HSV-1 or L. monocytogenes (Kondo, 2012). MRE11 acts 
upstream of STING-TBK1-IRF3 (Kondo, 2012). Nuclease-deficient MRE11 mutants show 
increased responses to dsDNA indicating that the nuclease activity has inhibitory effects on 
downstream signal transduction (Kondo, 2012).  
Another DDR component, DNA-PK, was also found to bind to cytoplasmic DNA to activate 
an innate immune response in fibroblasts (Ferguson, 2012). DNA-PK is a heterotrimeric 
protein complex consisting of three proteins, Ku70, Ku80 and the catalytic subunit DNA-
PKcs. Ku70 and Ku80 form a heterodimer and the absence of one subunit de-stabilises the 
expression of the other (Nussenzweig, 1996; Gu, 1997). Both the Ku heterodimer and DNA-
PKcs can bind directly to DNA but, in the absence of Ku the affinity of DNA-PKcs for DNA is 
greatly reduced (Yaneva, 1997; Walker, 2001). DNA-PK functions in DNA repair, specifically 
NHEJ after DSBs (Ma, 2002). DNA-PK has also been shown to localise to VCV viral 
replication factories in the cytoplasm (Ferguson, 2012). MEFs lacking DNA-PKcs show an 
37 
 
impairment in cytokine transcription in response to transfected, viral, and bacterial DNA 
(Ferguson, 2012). Mice lacking Ku70 or Ku80 also exhibit defects in cytokine induction 
(Ferguson, 2012). DNA-PKcs has been shown to phosphorylate IRF3 after dsDNA 
stimulation (Karpova, 2002). IRF3 does not translocate in response to dsDNA stimulation in 
DNA-PK-/- MEFs, however p65 translocation was unaffected (Ferguson, 2012). Kinase Dead 
DNA-PKcs mutants show no defect in induction of IFN-β or other cytokines in response to 
DNA stimulation showing that the kinase function of DNA-PK is not necessary for the 





IFI16 is a member of the PYHIN family of proteins, possessing a typical PYHIN domain 
architecture of a pyrin domain (PYD), and two HIN-200 (Hematopoietic Interferon-inducible 
nuclear proteins with a 200-amino acid repeat) DNA-binding domains. PYHIN proteins are a 
family of IFN-inducible genes with 4 human protein members and 13 mouse protein 
members (Diagram 1.5). IFI16, AIM2, MNDA (Myeloid cell Nuclear Differentiation Antigen), 
and IFIX (IFN-inducible protein X) are the human PYHIN proteins. p202-p209, p211-p214, 
and AIM2 are the PYHIN proteins in mice (Cridland, 2012). The PYD domain is a death 
domain which facilities interactions with other PYD-containing proteins. The PYD domain is 
frequently found in regulators of inflammatory immune responses and apoptosis (Bertin, 
2000). Family member AIM2 has been shown to form an inflammasome using its PYD 
domain (Fernandes-Alnemri, 2009; Hornung, 2009). Most PYHIN proteins are located 
primarily in the nucleus, except for cytoplasmic AIM2 (Trapani, 1994). In fractionated IFN-
treated cells, most IFI16 and p204 is detected in the nucleus, with ~40% being nucleolar, 
and ~60% nucleoplasmic (Dawson, 1996). Both human and mouse members of the HIN-200 
family are positively regulated by Type-I and -II IFNs (Dawson, 1996).  
IFI16 was the first isolated human HIN200 protein and was initially reported as a human IFN-
γ-inducible gene with nucleotide sequence similarity to the previously discovered mouse 
genes, p202 and p204 (Trapani, 1992). The closest mouse orthologue to IFI16 in humans is 
p204 which has the same domain structure – one pyrin and two HIN domains – and 37% 
amino acid identity (Johnstone, 1998; Unterholzner, 2010). Due to the number of murine 
PYHIN family members, the existence of a mouse IFI16 homologue was previously not clear. 
However, recent genetic analysis has indicated that while p204 and IFI16 share the same 
domain arrangement, these expansion events probably arose independently. There is no 
evidence of other non-primate species with two tandem HIN domains (Cridland, 2012). 
IFI16 was initially thought only to reside in haematopoietic cells but has since been shown to 
be present in many more cell types, including endothelial and epithelial cells, IFN-treated 
epithelial carcinoma cells, and lymphoid tissue (Trapani, 1992; Dawson,1996; Gariglio, 2002;  
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Wei, 2003). Type-I IFN, IFN-γ, Retinoic Acid, vitamin D3, H2O2, bleomycin, and transfected 
DNA have been reported to induce IFI16 expression (Dawson, 1996; Gugliesi, 2005; Duan, 
2011; Unterholzner, 2010). 
IFI16 can be detected as three isoforms - A, B, and C - spanning 85-95kDa, resulting from 
differential mRNA splicing of the exon 7 region (Johnstone, 1998). This differential splicing 
gives rise to variability in the hinge domain of the molecule which separates the two HIN 
domains. The IFI16B isoform can homodimerise and heterodimerise with the A and C 
isoforms via the leucine zipper domain at the amino terminus (Dawson, 1996; Johnstone, 
1998). To date, no functional differences between the isoforms have been described. 
HIN-200 proteins share common structural and biochemical properties including the 
presence of at least one common 200-amino acid repeat motif and the ability to bind dsDNA 
(Dawson, 1996). The HIN domain has been implicated in DNA-binding, homo- and hetero-
dimerization, and mediating protein–protein interactions for transcription regulation (Dawson, 
1996). There are three subtypes of HIN-200 domain – A, B, and C. IFI16 possess a HIN-A 
and a HIN-B domain (Schattgen, 2011). HIN-AB in tandem bind DNA stronger than HIN-A or 
HIN-B alone (Unterholzner, 2010; Jin, 2012). Each HIN domain has an α/β fold 
conformation, organised as two tandem β-barrels of 80 residues which form OB 
(oligonucleotide/oligosaccharide-binding) folds (Liao, 2011). The HIN domains of HIN-200 
proteins consists of two consecutive OB folds (Albrecht, 2005). These OB-fold β-barrels 
contain conserved, often hydrophobic, amino acids, facilitating the interaction with DNA 
(Albrecht, 2005). 
Figure 0.1 Diagram 1.5: PYHIN family proteins in human and mouse and their domains. 
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The DNA-binding surface of the IFI16 HIN domains consists of both OB folds and the linker 
between them (Jin, 2012). The HIN-DNA interactions are exclusively mediated by the dsDNA 
sugar-phosphate backbone, in agreement with IFI16’s sequence-independent DNA binding 
(Jin, 2012). The HIN domains are dispersed throughout the DNA double helix, across both 
major and minor grooves (Jin, 2012). The majority of the DNA-binding residues of HIN-B are 
found at the OB1-OB2 linker and OB2 (Jin, 2012). Only OB2 was found to be essential for 
DNA association (Jin, 2012). The HIN-B structure shows no conformational changes upon 
DNA binding indicating that the binding surface is preformed (Jin, 2012). Bound dsDNA can 
tilt and slide relative to the HIN domains, due to the flexible lysine and arginine residues that 
dominate the HIN:DNA interface (Jin, 2012). The N-termini of the HIN domains are located 
away from the DNA-binding interface, to allow PYD domain interactions with other proteins 
(Jin, 2012).  
IFI16 exists in an auto-inhibited conformation in which the PYD blocks the DNA-binding 
surface of the HIN200 domain (Jin, 2012). Upon encountering dsDNA, the PYD is displaced 
and interacts with its downstream partners. Long dsDNA fragments act as oligomerisation 
platforms, allowing more IFI16 molecules to accumulate (Morrone, 2014). Full-length IFI16 
cooperatively binds dsDNA laterally in a length-dependent manner (Unterholzner, 2010; Jin, 
2012; Morrone, 2014). This correlates with the length dependence of the DNA-induced IFN 
response (Stetson, 2006a). One full-length IFI16 molecule is accommodated per 15bp of 
dsDNA, with one HIN200 domain occupying 8-9bp (Morrones, 2014). A 15bp dsDNA 
fragment was found to be insufficient for strong IFI16 binding and downstream signalling, 
suggesting that oligomerisation of IFI16 is important for tight binding (Morrone, 2014). 60-
70bp of dsDNA has been shown to be required for optimal IFN induction by IFI16 
(Unterholzner, 2010). It has been estimated that 70bp of DNA would allow 9 IFI16 molecules 
with 18 HIN-AB domains to oligomerise as a signaling complex (Jin, 2012). The HIN 
domains of IFI16 were also found to bind ssDNA with high affinity, but this was not sufficient 
for oligomerisation (Yan, 2008; Morrone, 2014). The isolated HIN200 domains of IFI16 do 
not oligomerise and thus engage dsDNA with weak affinity. The PYD domain of IFI16, which 
cannot itself bind to DNA, was found to drive IFI16 oligomerisation and filament assembly 
upon DNA binding (Morrone, 2014). Oligomerisation of IFI6 allows a quick, high-affinity 
41 
 
response to foreign dsDNA (Morrone, 2014). IFI16 preferentially binds to adjacent IFI16 
molecules after detection of dsDNA, but not ssDNA, of greater than 60bp in length (Morrone, 
2014). 
PTMs have been shown to regulate IFI16 subcellular localization and function (Li, 2012). 
IFI16 phosphorylations occur within the linker region and the C terminus (Li, 2012). Lysine 
acetylations are distributed throughout IFI16 in all domains (Li, 2012). IFI16 has an 
evolutionarily conserved multipartite Nuclear Localisation Signal (NLS) with two 
lysine/arginine rich motifs, motif-1 and motif-2 (Li, 2012). These NLS motifs are conserved 
among nuclear HIN-200 proteins (Li, 2012). Deletions of either NLS motif caused the 
normally nuclear IFI16 to be predominantly cytoplasmic, indicating that both NLS motifs are 
necessary for nuclear localisation (Li, 2012). Acetylation of the NLS motifs 1 and 2 promotes 
cytoplasmic localization by inhibiting nuclear import (Li, 2012). K99 of motif-1 was found to 
be a p300 binding motif and acetylation site, and overexpression of p300 led to acetylation of 
this site and cytoplasmic accumulation of IFI16 (Li, 2012). 
1.3.2 IFI16 and the dsDNA response 
IFI16 was first identified as a DNA receptor using VACV DNA pulldown from cytoplasmic 
extracts of human monocytes (Unterholzner, 2010). IFI16 is predominantly nuclear, but has 
been shown to shuttle to the cytoplasm, and in both locations IFI16 colocalises with viral 
DNA (Unterholzner, 2010; Kerur, 2011). IFI16/p204 depletion has been shown to reduce the 
innate immune response to many DNA viruses, including VACV and HSV-1, as well as 
transfected dsDNA (but not RNA), as shown by reduced Type-I IFN and inflammatory 
cytokine production, and decreased IRF3 and NFκB nuclear translocation (Unterholzner, 
2010; Hansen, 2014; Orzalli, 2015). Intact HIN domain DNA-binding residues are important 
for IFI16’s ability to respond to the transfected DNA (Jin, 2012).  
IFI16 has been shown to interact with both cGAS and STING in the cytoplasmic DNA 
sensing pathway in human fibroblasts, keratinocytes and macrophages (Unterholzner, 2010; 
Orzalli, 2015; Almine, 2017; Jønsson, 2017). The interaction between IFI16 and cGAS has 
been shown to be dependent on the presence of DNA (Almine, 2017). IFI16 requires STING 
to make a Type-I IFN response to dsDNA. In both keratinocytes and macrophages, IFI16 
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has been shown to facilitate STING downstream signaling after cGAMP binding (Almine, 
2017; Jønsson, 2017). In IFI16-/- cells, STING fails to be phosphorylated, to dimerise or 
translocate to perinuclear clusters after dsDNA or 2’3’ cGAMP stimulation (Almine, 2017; 
Jønsson, 2017). This results in the failure of IRF3 to translocate to the nucleus, and reduced 
Type-I IFN and inflammatory cytokine production (Almine, 2017; Jønsson, 2017). In human 
macrophages, IFI16 was also reported to promote 2’3’ cGAMP production by cGAS through 
its Pyrin domain (Jønsson, 2017). However, IFI16-dependent cGAMP production has not 
been observed in human keratinocytes or in fibroblasts (Almine, 2017; Orzalli, 2015). IFI16 
protein levels have also been shown to be stabilised by cGAS in fibroblast cells, protected 
from proteasomal degradation (Orzalli, 2015). Recent work generating mice lacking all 13 
PYHIN proteins has shown that the PYHIN locus in mice is not required for the cytoplasmic 
dsDNA response, indicating that murine cGAS acts independently of this locus, in contrast to 
in humans (Gray, 2016).  
Despite its predominantly nuclear localisation, IFI16 is present in the cytoplasm and this 
presence increases upon treatment with DNA virus (Unterholzner, 2010; Kerur, 2011). IFI16 
colocalises with both transfected DNA and with DNA-containing viral factories in the 
cytoplasm of cells and KSHV in the nucleus of cells (Unterholzner, 2010; Kerur, 2011; 
Almine, 2017). IFI16 NLS mutants, predominantly present in the cytoplasm, were more 
responsive to cytoplasmic VACV infection, but less responsive to infection with nuclear DNA 
viruses (Li, 2012). IFI16 can bind to different types of DNA with similar affinity, independently 
of sequence or DNA source - host, microbial, or synthetic (Unterholzner, 2010; Jin, 2012). 
IFI16, cGAS, and STING have also been shown to be necessary for the innate immune 
response to the intracellular bacteria L. monocytogenes (Hansen, 2014). 
Herpesviruses are dsDNA viruses that replicate in the nucleus of infected cells. 
Herpesviruses enter the cytosol and are rapidly trafficked to the nucleus, where the viral 
dsDNA interacts with the host cell environment (Schattgen, 2011). IFI16 has been shown to 
be colocalised with HSV-1 DNA in the nucleus (Li, 2012). IFI16 is required for the innate 
immune response to HSV-1 in fibroblasts (Orzalli, 2012). IFI16 has also been shown to have 
IFN-independent antiviral functions. Upon herpesviral infection, chromatinisation of the viral 
genome is triggered – this allows to immune evasion and the activation of DNA damage 
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responses to promote viral replication (Knipe, 2008). IFI16 promotes the addition of 
repressive heterochromatin marks and the reduction of active euchromatin marks on viral 
chromatin, restricting viral replication (Orzalli, 2013). 
IFI16 has also been associated with inflammasome formation and pyroptosis. KSHV 
infection induces an increase in IFI16 levels and interaction between IFI16, caspase-1 and 
ASC, important inflammasome components (Kerur, 2011). IFI16 expression was necessary 
for KHSV-induced caspase-1 and inflammasome activation as well as IL-1β and IL-6 gene 
expression (Kerur, 2011). IFI16 has also been reported to detect incomplete HIV reverse 
transcripts in CD4+ T cells, which can accumulate in the cell cytoplasm (Monroe, 2014). 
Upon viral DNA detection, IFI16 triggers caspase-1 activation and pyroptosis (Monroe, 
2014). Depletion of IFI16 rescued CD4+ T cells from cell death after HIV infection (Monroe, 
2014). IFI16 has also been shown to regulate the innate immune response to HIV in human 
macrophages (Jønsson, 2017). 
The importance of IFI16 in antiviral immunity can be observed by the number of viruses 
which have evolved mechanisms to degrade, sequester, or subvert the function of IFI16. 
HSV-1 has multiple mechanisms for inhibiting IFN production (Melroe, 2004). HSV-1 protein 
ICP0 (Infected Cell Polypeptide 0) is an E3 ubiquitin ligase which limits the host antiviral 
response. ICP0 promotes the degradation of IFI16, inhibiting IRF3 signaling (Orzalli, 2012). 
IFI16 partially localised with nuclear ICP0 foci, moving from the nucleoplasm/nucleoli to 
distinct nuclear foci, before being degraded (Orzalli, 2012). IFI16 restriction of HSV-1 ICP0-
null viral growth is independent of the STING DNA sensing pathway (Orzalli, 2012). Another 
example of viral inhibition of IFI16 is found in Human Cytomegalovirus (HCMV) infection, 
IFI16 is necessary for the innate immune response to HCMV DNA (Li, T., 2013). The HCMV 
tegument protein pUL83 inhibits this response by interacting with the IFI16 pyrin domain, 
blocking IFI16 oligomerization, and subsequent downstream activation, upon DNA binding 
(Li, T., 2013). pUL83 also inhibits other PYHIN proteins (Li, T., 2013). 
1.3.3 Senescence and Other Functions 
IFI16 has been reported to promote cellular senescence (Xin, 2003; Aglipay, 2003; Xin, 
2004). Senescent cells withdraw from the cell cycle but are resistant to apoptosis, a 
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phenotype first described by Hayflick et al. (Hayflick, 1961; Sasaki, 2001). Senescence may 
be triggered by excessive mitogenic stimulation or by various forms of cellular damage. 
Overexpression of p204 correlates with delayed transition through the G1/S checkpoint of 
the cell cycle and reduction in cell growth (Lembo, 1998). Cellular senescence limits the 
proliferation of damaged cells. However, senescent cells are metabolically active and 
secrete proinflammatory cytokines and chemokines, known as senescence-associated 
secretory phenotype (SASP) (Shelton, 1999). “Old” passage fibroblasts show increased 
expression of IFI16 protein compared to “young” passage fibroblasts, and this has been 
associated with the induction of IFN-β (Duan, 2011).  
HIN200 proteins are known to function as scaffolding proteins that can interact with and 
modulate the activities of transcriptional factors, this is true of IFI16. IFI16 can function as a 
transcriptional repressor when bound upstream of a functional promoter (Johnstone, 1998). 
IFI16 contains a separate DNA binding domain and a transcriptional regulatory domain 
(Johnstone, 1998). IFI16 also contains PYD, a protein domain associated with apoptosis and 
interferon response, and it directly binds p53 at its first 200-amino acid repeat region 
(Johnstone, 2000). 
IFI16 is known to associate with components of the DDR, including BRCA1, and has been 
shown to assemble on genomic sites of DNA damage in a BRCA1-dependent manner 
(Aglipay, 2003). IFI16 is a component of the DNA repair multi-protein complex known as 
BASC (BRCA1-associated genome surveillance complex), which forms after DNA damage 
(Aglipay, 2003). The BRCA1 mutations are responsible for approximately 20% of familial 
breast and ovarian cancers (Nathanson, 2001). IFI16 has been previously reported to be 
nucleoplasmic, then after DNA damage to move predominantly to nucleoli, then to disperse 
in the nucleoplasm again hours after damage, at which point it is seen to colocalise with 
BRCA1 (Aglipay, 2003). IFI16 did not relocate to nucleoli upon damage in the absence of 
WT BRCA1, but nucleolar accumulation of IFI16 was restored by re-expression of WT 
BRCA1 in BRCA1-mutant cells, suggesting that IFI16 is involved in the BRCA1 pathway 
activated by DNA damage (Aglipay, 2003).  
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IFI16 has been shown to directly interact with p53, and p53 phosphorylated at Ser15 
(Johnstone, 2000; Gugliesi, 2005). The HIN-A region of IFI16 recognises the C terminus of 
p53, whereas HIN-B binds to the DNA-binding region of p53 to stabilise the p53-DNA 
complex (Liao, 2011; Johnstone, 2000). HIN-A interactions with the basic C-terminus of p53 
relies on an acidic area on the HIN-A surface around the OB-fold commonly interacting with 
binding partners (Liao, 2011). It has been reported that IFI16 overexpression drives p53-
mediated transcriptional activity (Johnstone, 2000; Gugliesi, 2005). Treatment with DNA 
damaging agents or overexpression of IFI16 was sufficient to induce expression of the p53 
target gene, p21 (Gugliesi, 2005; Fujiuchi, 2004). DNA damaging agents also lead to an 
increase in IFI16 abundance (Gugliesi, 2005). IFI16 has been shown to enhance p53-
mediated apoptosis in cells undergoing IR treatment (Fujiuchi, 2004). Expression of IFI16 
HIN-A and HIN-B domains co-operatively enhanced p53 activity as measured by DNA 
binding and transcriptional activity (Liao, 2011). Blocking IFI16 function inhibits p53 binding 
to p53 consensus oligonucleotides (Johnstone, 2000). 
1.3.4 IFI16 in Disease 
Mutations in the p200 family of genes have been associated with the autoimmune disease 
systemic lupus erythematosus (SLE). The HIN-200 locus is located within the SLE 
susceptibility locus, highly expressed in mouse models of SLE (Choubey, 2002). Antibodies 
against IFI16 have been detected in the sera of 46% of SLE patients, as well as in other 
autoimmune diseases including cutaneous systemic sclerosis, Sjogren syndrome, and 
psoriasis (Caposio, 2007; Costa, 2011; Cao, 2016). UV-B exposure induced the cytoplasmic 
translocation of IFI16 in cultured cells and skin explants, as well as in diseased skin sections 
from SLE patients (Costa, 2011). IFI16 has been found in the supernatants of UV-B-exposed 
keratinocytes (Costa, 2011). UV-B exposure induces cellular apoptosis, a process that can 
expose self-antigens to the immune system (Caricchio, 2003). Keratinocytes apoptose 24 
hours after UV-B exposure, and extracellular IFI16 expression levels increased in line with 
this apoptosis (Costa, 2011). The knockdown of IFI16 decreases inflammatory cytokine 
production, and clinical symptoms, in psoriasis patients (Cao, 2016).  
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IFI16 has been shown to be lost in several breast cancer cell lines (Fujiuchi, 2004). IFI16 
expression pattern differs in benign versus malignant breast epithelial cells, so may play a 
role in normal mammary epithelial cell phenotype (Fujiuchi, 2004).  
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1.4 STING  
1.4.1 STING Structure and Function 
STING (Stimulator of Interferon Genes), also known as TMEM173 (Transmembrane Protein 
173), is an immune adaptor for cytosolic dsDNA (Ishikawa, 2008; Zhong, 2008; Jin, 2008; 
Ishikawa, 2009; Sun, 2009). STING has been found to be essential for the IFN response to 
cytoplasmic DNA species either transfected or produced by DNA pathogens, such as 
cytomegalovirus (CMV), VCV, VSV, HSV-1, L. monocytogenes, and M. tuberculosis after 
infection (Ishikawa, 2008; Ishikawa, 2009; Hansen, 2014; Manzanillo, 2012). STING 
functions downstream of the DNA sensor cGAS, binding to cGAMP produced by cGAS after 
dsDNA binding. STING was initially identified as a sensor of bacterial cyclic dinucleotides.  
Human STING is composed of a N-terminal domain with four transmembrane regions (aa 1–
154), a central globular c-di-GMP binding domain (CBD, aa 155–341), and a C-terminal tail 
(CTT, aa 342–379) which is involving in binding to cyclic dinucleotides and signal 
transduction (Burdette, 2011; Shang, 2012; Shu, 2012). All STING homologues have the 
conserved CBD and dimerisation domains (DD), however, the CTT, critical for transducing 
signals is only observed in vertebrates indicating that modern STING proteins have gained 
structural domains in early vertebrate evolution (Wu, 2014). It is thought that STING has 
coevolved with cGAS protein, with both protein origins being traced back to a 
choanoflagellate Monosiga brevicollis, the closest relative of metazoans (Wu, 2014).  
Upon 2’-3’ cGAMP binding, STING changes conformation, with two C-terminal domains of 
STING monomers forming a V-shaped dimer interface around cGAMP, mediated by van der 
Waals interactions and hydrogen bonds (Sun, 2009; Shang, 2012). The STING dimer goes 
from ~60 A° wide to ~38 A° wide in the closed complex (P. Gao, 2013b). This conformation 
results in a deeper pocket between the two protomers to embrace cGAMP (Zhang, 2013). 
The hydrogen bonds are contributed by at least eight residues, most of which are conserved 
in STING proteins (Shang, 2012). The cGAMP binding site is then covered by a lid of four-
stranded antiparallel β-sheet and the connecting loops from each of the two protomers, 





2’3’-cGAMP binds to STING with a greater affinity than canonical cGAMP molecules with 
different combinations of phosphodiester linkages (Zhang, 2013). The STING dimers 
maintain a more obtuse angle, without changing conformation when bound to c-di-GMP, 
without a closed lid conformation, suggesting the dimer is rigid (Shu, 2012; Shang, 2012). 
Bound 2’-3’ cGAMP sits ~2.5 Å deeper in the STING dimer than c-di-GMP (Zhang, 2013).  
Human and mouse STING exhibit 68% amino acid identity and 81% similarity (Diner, 2013). 
Natural variant alleles have been reported in humans, including the R232H variant of 
hSTING and the R231A variant of mSTING, which are activated by dsDNA and 2’-3’ cGAMP 
but not by c-di-GMP or 3’-3’ cGAMP (Burdette, 2011; Diner, 2013). This residue is located in 
loops that cover the binding pocket; therefore, the CDN can still bind but is not responded to 
(Diner, 2013). Expression of the R231A point mutant abolishes Type-I IFN production in 
Diagram 1.6: Crystal structure of STING in complex with 2’3’ cGAMP. 
PDB ID: 4KSY as published in Zhang, et al. (2013) Cyclic GMP-AMP Containing Mixed 
Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING. Mol. Cell; 51: 226–
235. doi:10.1016/j.molcel.2013.05.022. 
STING binds 2’3’ cGAMP in the pocket produced at the dimer interface of two STING monomers. 
STING then covers cGAMP with a lid of anti-parallel β-sheets, restricting access to the ligand. 
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response to endogenous cyclic di-GMP production and cGAMP, but not upon stimulation 
with DNA, or overexpression of cGAS, uncoupling responsiveness to CDNs and dsDNA 
(Ablasser, 2013a; Diner, 2013). STING can also bind DNA, but DNA was found not to 
compete with cyclic dinucleotides for STING binding (Burdette, 2011). Human mutant STING 
variants with amino acid substitutions in the CDN binding interface are no longer able to 
stimulate the IFN pathway in response to dsDNA (Burdette, 2011; P. Gao, 2013b).  
STING is located at the ER as determined by calreticulin marker co-staining (Ishikawa, 2008; 
Sun, 2009; Saitoh, 2009). Fractionation has shown that STING is associated with 
microsomes – a complex of continuous membranes that comprise the ER, Golgi, and 
transport vesicles – and the mitochondria, similarly to calreticulin (Ishikawa, 2009). After 
stimulation with dsDNA or DNA viruses such as HSV-1, activated STING traffics to the ER-
Golgi intermediate compartment (ERGIC) where it recruits TBK1 and IRF3 to trigger type I 
IFN expression and this behaviour is referred to as STING clustering (Ishikawa, 2009; 
Dobbs, 2015). The translocation of STING after activation has been linked to the activation 
of autophagy (Saitoh, 2009). Autophagy related proteins including ATG9A (Autophagy 
Related 9A), p62, and LC3 (Microtubule-associated protein 1A/1B-light chain 3) have been 
shown to associate with STING to prevent excess activation of the immune response 
(Saitoh, 2009). This process of autophagy is crucial for clearing the cytosol of intracellular 
bacteria and viruses. 
STING-/- cells, fibroblasts, macrophages, DCs, and pDCs, show defects in inflammatory 
cytokine production and IRF nuclear translocation after dsDNA transfection (Ishikawa, 2008; 
Ishikawa, 2009). Goldenticket (Gt) mice have a point mutation in STING (T596A) that results 
in an isoleucine to asparagine substitution (I199N) (Sauer, 2011). Gt mice fail to make 
functional STING protein and are subsequently unable to produce an innate immune 
response to DNA viruses and intracellular bacteria (Sauer, 2011). STING-/- mice are 
susceptible to lethal infection with DNA pathogens including HSV-1 (Ishikawa, 2009). T cell 
responses after vaccination are also reduced in STING-/- animals (Ishikawa, 2009). 
Poly(I:C), an RNA mimic, and EMCV (Encephalomyocarditis Virus), an RNA virus, induce 
immune responses which are independent of STING (Ishikawa, 2009). However, STING has 
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been shown to participate in other immune responses to RNA. STING-/- cells display a 
reduced Type-I IFN response to negative single-stranded RNA virus VSV, a virus recognised 
by RIG-I and MAVS (Ishikawa, 2008). STING interacts with RIG-I and MAVS, an essential 
adaptor for RLRs, at mitochondria (Ishikawa, 2008; Zhong, 2008). STING was also 
necessary for the immune response to SeV (Sendai Virus), an RNA virus (Zhong, 2008). 
MAVS recruits STING to RIG-I in overexpression experiments, or upon treatment with SeV 
(Zhong, 2008). STING-/- cells are also sensitive to RNA virus infection (Ishikawa, 2008). 
Infection with RNA viruses induced elevated levels of STING dimers in non-denaturing 
protein lysates (Holm, 2016). RNA viruses, including Dengue virus and Coronavirus, have 
been shown to inhibit STING signaling (Aguirre, 2012; Sun, 2012). Despite this evidence, the 
involvement of STING in RNA sensing is disputed. 
Virus-like particles (VLPs) derived from HSV-1, lacking capsid and genomic material, induce 
a Type-I IFN response in primary mouse and human cells, as do cell–cell membrane fusion 
or exposure to fusogenic liposomes (Holm, 2012). This response is STING-dependent 
despite lacking DNA, RNA and viral capsid (Holm, 2012). The treatment of primary 
macrophages with liposomes or VLPs induced the translocation of STING and its 
colocalisation with TBK1 (Holm, 2012). Similarly, enveloped RNA viruses such as Influenza 
A Virus (IAV) have been shown to induce a STING-dependent, cGAS-independent Type-I 
IFN response (Holm, 2016). STING-deficient cells also show increased NDV, SeV, and VSV 
viral replication (Holm, 2016). These immune responses observed were also dependent on 
MAVS (Holm, 2016). IAV interacts with STING through its conserved hemagglutinin fusion 
peptide which antagonises STING activation and IFN production induced by membrane 
fusion but not by cGAMP or dsDNA (Holm, 2016). STING residues 162–172 are important 
for the interaction between STING and this fusion protein - this region is involved in binding 
to cGAMP, and overlaps with a region important for STING dimerisation (Ouyang, 2012).  
1.4.2 Post-Translational Modifications of STING 
STING is subject to many PTMs (Table 1.3). STING phosphorylation has been reported at 
many sites in a cluster of Serines at the CTD, including Ser358, Ser353, Ser366, and Ser379 
in ISD stimulated cells (Tanaka, 2012). Phosphorylation of STING Ser366 by TBK1 has been 
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shown to be essential for the STING-dependent innate immune response to dsDNA 
(Tanaka, 2012; Liu, 2015). STING is phosphorylated and subsequently degraded after 
approximately 3-6 hours’ dsDNA stimulation (Abe, 2014). This protein turnover is inhibited by 
chloroquine treatment, indicating that STING degradation occurs in the lysosomal 
compartment (Konno, 2013). STING degradation still occurs in cells deficient in TBK1, 
suggesting that another kinase is capable of phosphorylating and degrading STING (Abe, 
2014). ULK1, a serine/threonine kinase, has been reported to phosphorylate STING on this 
same residue, Ser366, after initial STING activation, as part of a negative feedback loop to 
prevent overactivation (Konno, 2013). 
STING is subject to both positive and negative regulation by several E3 ligases. TRIM56 
(Tripartite-motif 56) is an IFN-inducible E3 ubiquitin ligase (Carthagena, 2009). 
Overexpression of TRIM56 enhances dsDNA-mediated IFN-β induction and conversely, 
TRIM56 knockdown abrogates IFN-β and IL-6 induction after dsDNA and RNA viral 
stimulation (Tsuchida, 2010). The C-terminus of TRIM56 interacts with the C-terminus of 
STING (Tsuchida, 2010). TRIM56 targets lysine 150 of STING for K63-linked ubiquitination. 
This has been reported to be necessary for STING dimerisation, TBK1 association, 
phosphorylation by TBK1, and downstream STING signalling after dsDNA stimulation 
(Tsuchida, 2010). K150R STING mutants could not induce an innate immune response to 
dsDNA but still translocated normally after stimulation, indicating that ubiquitination is not 
necessary for STING trafficking (Tsuchida, 2010). 
TRIM32 (Tripartite-motif protein 32) also ubiquitinates STING to positively regulate the 
induction of Type-I IFN after virus infection (Zhang, 2013). Knockdown of TRIM32 abrogates 
the production of Type-I IFN in response to both SeV and HSV-1 (Zhang, 2013). TRIM32 
interacts with STING at the mitochondria and ER where it targets STING for K63-linked 
ubiquitination at K20/150/224/236 through its E3 ubiquitin ligase activity, facilitating the 
interaction between STING and TBK1 (Zhang, 2013). AMFR (Autocrine motility factor 
receptor), alongside the E3 ubiquitin ligase INSIG1 (insulin-induced gene 1), catalyses K27- 
linked polyubiquitin chains on STING, to facilitate the recruitment of TBK1 and translocation 




TRAF3 and TRAF6, members of the Tumour necrosis factor (TNF) Receptor-Associated 
Factors (TRAF) family signalling molecules, many of which are E3 ubiquitin ligases, have 
been shown to interact with STING in overexpression experiments (Abe, 2014). The C-
terminus of STING also contains putative TRAF2-binding motifs. Residues 228-236 in the 
loop connecting strands β3 and β4 of STING contain a putative TRAF2 binding motif 
(PQQTGD) and may play a role in signaling (Shu, 2012). TRAF6 is a RING domain ubiquitin 
ligase that mediates the activation of protein kinases, such as TAK1 and IKK, by catalysing 
the formation of K63-linked polyubiquitin chains. STING-dependent NFκB and IFN-β 
production is enhanced by co-expressing full length TRAF6 with STING, but not with TRAF6 
lacking the C-terminal TRAF domain which is important for TRAF oligomerisation and 
interactions (Abe, 2014). TRAF6 co-expression also enhances STING activity (Abe, 2014). 
TRAF6 silenced MEFs show decreased NFκB nuclear translocation but no effect on STING 
trafficking after dsDNA stimulation (Abe, 2014). TRAF6 silenced MEFs show a decrease in 
IL-6 and IFN-β production (Abe, 2014). 
Table 1.3: Summary of post-translational modifications to STING and their effect on STING 
function 
STING modification Modifier Effect of modification Reference 
Phosphorylation – S353 TBK1 Positive regulation Tanaka, 2012 
Phosphorylation - S358 TBK1 Positive regulation Tanaka, 2012 
Phosphorylation - S379 TBK1 Positive regulation Tanaka, 2012 
Phosphorylation – S366 TBK1 Positive regulation Liu, 2015 
Phosphorylation – S366 ULK1 Negative regulation Konno, 2013 
K48-linked Ub – K150 RNF5 Negative regulation Zhong, 2009 
K11-linked Ub – K150 RNF26 Positive regulation Qin, 2014 
K63-linked Ub – K150 TRIM32 Positive regulation Zhang, 2012 
K63-linked Ub – K150 TRIM56 Positive regulation Tsuchida, 2010 
K27-linked Ub – K150 AMFR Positive regulation Wang, 2014 
Palmitoylation – C88 DHHC3/7/15 Positive regulation Mukai, 2016 
Palmitoylation – C91 DHHC3/7/15 Positive regulation Mukai, 2016 
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Ubiquitin ligases have also been shown to negatively regulate STING function. The E3 
ubiquitin ligase RNF5 (RING Finger protein 5) has been reported to interact with STING after 
viral infection to negatively regulate the immune response (Zhong, 2009). Overexpression of 
RNF5 has been shown to inhibit virus-triggered IRF3 activation and IFN-β induction, 
conversely, knockdown of RNF5 promoted these responses (Zhong, 2009). RNF5 targets 
STING on Lys150 for K48-linked ubiquitination and degradation at the mitochondria after 
viral infection (Zhong, 2009). The N-terminus transmembrane domain of STING was found to  
interact with C-terminus of RNF5 (Zhong, 2009). RNF5 was also found to regulate STING to 
inhibit the immune response to poly(I:C) (Zhong, 2009).   
Another PTM reported to be important for STING function is Palmitoylation (Mukai, 2016). 
Palmitoylation is the addition of fatty acids, such as palmitic acid, to cysteine, serine, or 
threonine residues of membrane proteins (Linder, 2007). STING was found to be 
palmitoylated at cysteine 88/91, and this modification was necessary for the Type-I IFN 
response but not for STING trafficking (Mukai, 2016). 
1.4.3 Downstream Signalling of STING 
STING functions as an adaptor protein that recruits and activates the protein kinases IKK 
and TBK1, which in turn activate the transcription factors NFκB and IRF3 to induce 
interferons and other cytokines (Abe, 2014). Transfection of dsDNA induces phosphorylation 
of IRF3 and NFκB p65 as well as nuclear translocation of these signaling factors in a STING-
dependent manner (Ishikawa, 2008; Ahn, 2012; Abe, 2014). MAPKs ERK1/2, JNK, c-Jun, 
and p38 have been reported to be activated following dsDNA treatment, only in STING 
competent cells (Abe, 2014). The C-terminus of STING containing just 39 amino acids (341-
379) is necessary and sufficient to activate TBK1 (Tanaka, 2012).  
STING has been proposed to be held in an inactivate state by its CTT, which is displaced 
upon ligand binding (Tanaka, 2012). Upon DNA stimulation, STING, TBK1, and IRF3 form 
an activation complex. TBK1 has been shown to activate STING through direct 
phosphorylation of Ser366 (Tanaka, 2012; Liu, 2015). The phosphorylated STING binds to a 
positively charged surface of IRF3, recruiting IRF3 for phosphorylation and activation by 
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TBK1 (Tanaka, 2012; Liu, 2015). IRF3 first binds to phosphorylated STING before itself 
becoming phosphorylated, dissociating from STING, and forming a homodimer (Liu, 2015). 
Two hours after ISD stimulation, STING can be seen to aggregate. Only these aggregated 
high molecular weight fractions can activate IRF3 when incubated with the cytosolic extracts 
(Tanaka, 2012). After its activation, STING is degraded to avoid sustained inflammatory 
signaling (Abe, 2014). 
STAT6 is a transcription factor that usually activated by cytokines via JAK signalling. In 
response to SeV, an RNA virus, and HSV, a DNA virus, STAT6 has been shown to be 
activated independently of JAK and cytokine signaling, instead relying on STING and TBK1 
(Chen, 2011). This STAT6 response induces CCL2, CCL20, and CCL26 production (Chen, 
2011). Both MAVS-/- mice and STING-/- mice cannot induce STAT6 nuclear translocation or 
CCL2/20 secretion in response to SeV (Chen, 2011). STAT6 colocalises with STING, but not 
MAVS or TBK1, in the perinuclear region of the cell at 7h post-infection before translocating 
to the nucleus by 14h post-infection (Chen, 2011). Functional TBK1 and a STAT6 responsive 
to TBK1 phosphorylation were essential for this response (Chen, 2011).  
1.4.3 STING in Disease 
In humans, there are STING Single Nucleotide Polymorphisms (SNPs) found throughout the 
population (Jin, 2011). R71H-G230A-R293Q, known as the HAQ haplotype, displays a 
significant reduction in innate immune responses to intracellular bacteria and virus infection 
(Jin, 2011). The constitutive activation of STING is also associated with pathology. The 
inflammatory syndrome SAVI (STING-associated vasculopathy with onset in infancy) is 
caused by mutations in STING which cause constitutive dimerisation and activation of the 
mutant STING protein in the absence of 2'3'-cGAMP (Liu, 2014). Patients with similar gain of 
function STING mutations display elevated serum IFN (Jeremiah, 2014). 
STING has also been shown to play a role in mouse models of autoimmune conditions. 
DNase II-/- mice die before birth due to uncontrolled inflammation. This can be avoided by 
crossing DNase II-/- mice with Ifnar1-/- mice or with STING-/- mice, suggesting that STING is 
the primary mediator of DNA-induced inflammation (Ahn, 2012). TREX1, which is essential 
for limiting self-DNA in the cytoplasm, preventing autoimmune responses, has been shown 
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to negatively regulate STING-dependent antiviral responses (Gall, 2011). Both transfected 
DNA and apoptotic self-DNA induce the production of inflammatory cytokines in BMDM and 
conventional dendritic cells in a STING-dependent manner, inducing STING trafficking (Ahn, 
2012).  
STING-dependent inflammation has been linked to the development of cancer. Tumour-
derived DNA has been shown to activate STING to induce a Type-I IFN response (Woo, 
2014). DMBA (7,12-dimethylbenz(a)anthracene) is a polyaromatic hydrocarbon known to 
induce cutaneous tumours when applied to the skin of mice. DMBA has been shown to 
activate inflammatory cytokine signalling, which facilitates tumorigenesis. 48 hours of DMBA 
treatment induced STING activation (Ahn, 2014). DMBA-treated cells produced inflammatory 
cytokines and chemokines dependent on STING and cGAS signalling (Ahn, 2014). ~90% of 
WT mice treated with DMBA developed Squamous Cell Carcinoma, with phagocytic 
infiltration and inflammation of the tumour microenvironment, whereas fewer than 20% of 
STING-/- mice did (Ahn, 2014). WT mice transplanted with STING-/- bone marrow developed 
fewer tumours than those who received WT bone marrow, indicating that haematopoietic 
cells are important in this inflammatory cancer phenotype (Ahn, 2014).   
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1.5 Transcriptional responses to DNA sensing and DNA 
damage 
1.5.1 NFκB 
NFκB is a transcription factor involved in a wide range of biological processes. Various 
stimuli, including genotoxic stress, mitogens, cytokines, viruses, and bacteria can activate 
NFκB. Ligand bound, cell surface and intracellular receptors recruit distinct proximal 
signaling molecules, but utilise common intermediates to activate the NFκB complex.  
NFκB was originally identified as responsible for transcription of the κ light chain gene, but 
hundreds of genes have since been shown to contain the κB binding sequence (Pahl, 1999). 
NFκB-regulated genes include those regulating diverse processes such as cell repair, 
immune induction, proliferation, acute phase proteins, mitotic arrest and cell death. NFκB is 
known for its activation in response to a wide range of inflammatory stimuli, such as 
pathogens and cytokines but is also induced by ‘‘non-inflammatory’’ activators such as 
genotoxic stress (Pahl, 1999). NFκB can either positively or negatively regulate gene 
expression through binding to κB binding sequences in DNA promoters and enhancers (Sen 
& Baltimore, 1986). Single binding sites for transcription factors CEBPB (CCAAT/enhancer-
binding protein beta) and NFκB are present in the promoter of a wide variety of inflammatory 
genes. NFκB acts synergistically with CEBPB, utilising its DNA binding and transcriptional 
activation domains (Matsusaka, 1993). 
There are five NFκB family members, RelA (p65), RelB, c-Rel, p50/p105 (NFκB1) and 
p52/p100 (NFκB2), and these exist as hetero- or homodimers (Ghosh, 1998). The most 
common form of NFκB is a heterodimer composed of p50 and p65 subunits. Most types of 
DNA damage, as well as other stimuli such as TNF-R and TLR signalling, have been found 
to activate the canonical NFκB pathway converging at the level of IκB phosphorylation by 
IKKs (IκB kinases) (Brach, 1991; Piret, 1996; Huang, 2000; Janssens, 2006; Scheidereit, 
2006; Wu, 2007). The IKK complex is composed of two related kinases, IKKα and IKKβ 
(Stancovski, 1997), and the NFκB essential modulator, NEMO (NF-kappa-B essential 
modulator). NFκB is sequestered in the cytoplasm by Inhibitors of KappaB (IκBs) which can 
mask the nuclear localisation sequence of NFκB subunits (Baeuerle, 1998; Huxford, 1998). 
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Upon NFκB activating stimuli, IκB is phosphorylated by the IKK complex (Zandi, 1997; 
Régnier, 1997). This phosphorylation makes IκB a substrate for ubiquitination and 
proteasomal degradation (Yaron, 1998). The degradation of IκB revels the NLS of NFκB, 
allowing the translocation of NFκB to the nucleus (Chen, 1995).  
The alternative NFκB pathway, is NEMO-independent and is triggered by certain cytokines 
and ligands, including lymphotoxin b, and CD40 (Cluster of Differentiation 40) ligand. The 
alternative pathway relies on TRAF recruitment to the membrane and NFκB-inducing kinase 
(NIK), which activates an IKKα homodimer to induce C-terminal processing of NFκB2/p100, 
generating p52 complexes. UV radiation induces atypical NFκB signaling which is initiated in 
the cytoplasm and is mediated by Src tyrosine kinases rather than the IKK complex (Devary, 
1993). 
The activation of the IKK complex in response to irradiation or topoisomerase-targeting 
drugs is dependent on the presence of an intact nucleus and the formation of DSBs (Boland, 
2000). DNA-damage-induced NFκB activation controls the transcription of genes which allow 
cells to escape cell death after DNA damage and to initiate DNA repair. In this way, 
chemotherapeutic agents which activate NFκB can contribute to acquired chemo-resistance, 
impeding effective cancer therapy (Baldwin, 2001). ATM is required for NFκB signaling in 
response to DNA strand breaks (Li, 2001; Piret, 1999). Cells from Ataxia Telangiectasia (AT) 
patients, lacking a functional ATM, are unable to activate NFκB in response to ionizing 
irradiation or treatment with camptothecin, and this phenotype can be rescued with 
exogenous ATM, indicating that ATM plays a pivotal role in activation of NFκB (Piret, 1999; 
Li, 2001).  
The issue of how nuclear ATM activates the cytoplasmic IKK complex has been widely 
studied. NEMO is critical for the activation of NFκB in response to a wide range of stimuli. 
Several models have been proposed to explain the activation of NEMO after DNA damage. 
NEMO is reported to participate in a nuclear complex known as the PIDDosome, alongside 
PIDD (p53-inducible death-domain containing protein), and the kinase RIP1 (Receptor-
interacting protein kinase 1) upon genotoxic stress (Tinel, 2004; Janssens, 2005). RIP1 then 
promotes NFκB activation (Janssens, 2005).  
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Diagram 1.7: NFκB signaling converges at the IKK complex in response to diverse stimuli. 
Upon DNA damage, several complex signaling pathways initiate to repair the damaged DNA. 
One of these pathways is the NFκB pathway which is important in the transcriptional repair 
response. PARP-1 and ATM have both been shown to associate rapidly with damaged DNA. 
PARP-1 undergoes PARylation and PARylates other signaling factors, such as ATM, PIASy, 
and NEMO, bringing them into proximity and facilitating interactions. The interaction between 
PIASy and NEMO allows NEMO SUMOylation and subsequent cytoplasmic translocation. After 
autophosphorylation, activated ATM translocates to the cytoplasm where it associates with E3 
ubiquitin ligase TRAF6, facilitating K63 linked ubiquitination of SUMOylated NEMO. NEMO 
activation leads to IKKα/β activation and the release of NFκB subunits from inhibition. NFκB 
subunits are then free to translocate to the nucleus and bind to genes to initiate transcription. 
Other signals such as TNF-R signalling can also activate NFκB, through different intermediates 





The formation of another complex with NEMO has been reported after DNA damage, 
containing ATM, PARP-1, and PIASy (the protein inhibitor of activated STAT) (Stilmann, 
2009). ATM and PARP-1 initiate two separate signaling branches which converge 
downstream and are both necessary for IKK activation. PARP-1 binds to DNA strand breaks 
within seconds and disassociates minutes later (Mortusewicz, 2007). PARP-1 synthesises 
poly(ADP-ribose) (PAR) (Amé, 2004). PAR synthesis leads to chromatin relaxation and 
facilitates further PARP recruitment as well as the recruitment of DNA repair factors to DNA 
lesions (Mortusewicz, 2007; El-Khamisy, 2003). Through PAR synthesis, PARP-1 assembles 
a nuclear signalosome containing NEMO, PIASy, and ATM following activation and 
dissociation from damage sites (Diagram 1.7) (Stilmann, 2009). After DNA damage, ATM 
leaves the nucleus in a calcium dependent process whereas PARP-1 remains in the nucleus 
(Hinz, 2010; Stilmann, 2009).  
Upon DNA damage, NEMO translocates to the nucleus and undergoes multiple 
posttranslational modifications. NEMO is first SUMOylated by PIASy, a component of the 
nuclear PARP-1 signalosome (Huang, 2003; Mabb, 2006), allowing NEMO to be a substrate 
for phosphorylation. ATM phosphorylates NEMO at S85, a prerequisite for 
monoubiquitination by TRAF6 and cIAP1 (Stillmann, 2009; Huang, 2003; Hinz, 2010; Wu, 
2006). Inhibitors of apoptosis (IAPs) interfere with the transmission of intracellular death 
signals (Rothe, 1995). The monoubiquitination of NEMO promotes its nuclear export in 
association with ATM to activate the IKK complex (Wu, 2006). cIAP1 binds to NEMO and 
TRAF6 after stimulation, facilitating the E3 ubiquitin ligase activity of TRAF6 to 
polyubiquitinate substrates (Chen, 2005; Scheidereit, 2006; Hinz, 2010). TRAF6 is a 
ubiquitin ligase that makes K63 ubiquitin chains with the help of Ubc13 and Uev1A (Ubiquitin 
conjugating enzyme E2 variant 1) (Deng, 2000). TRAF6 is polyubiquitinated in the cytoplasm 
after DNA damage, dependent on ATM (Hinz, 2010). Subsequent TRAF6 K63-ubiqutin chain 
formation recruits and activates a complex consisting of TAK1 (Transforming growth factor 
activated kinase-1) and TAB2/3 (TGF-beta activated kinase 2/3) (Wang, 2001). TAB2/3 
preferentially bind to polyubiquitin chains, recruiting TAK1 with them (Kanayama, 2004). 
TAK1 phosphorylates and activates NEMO and the IKK complex (Wang, 2001; Ea, 2004). 
TAK1 also phosphorylates MKK6 (MAP Kinase Kinase 6), allowing MKK6 to stimulate the 
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kinase activity of JNK, which phosphorylates c-Jun at S63 and S73, activating the pathway in 
a proteasome independent manner (Deng, 2000; Wang, 2001). 
In addition to the K63-linked ubiquitin chains, linear ubiquitin chains, in which the ubiquitin 
molecules are joined through Methionine 1, are also important in the activation of NFκB after 
DNA damage. LUBAC (Linear Ubiquitin Chain Assembly Complex) a RING finger E3 
ubiquitin ligase generates linear ubiquitination on NEMO K285/09 which are critical for NFκB 
activation after genotoxic stress and other NFκB signaling pathways (Niu, 2011). 
Ubiquitinated IκB is then degraded, allowing NFκB heterodimers to enter the nucleus to 
regulate gene expression (Yaron, 1998; Chen, 1995).  
While detection of nucleic acids by TLRs activates a robust NFκB response, ISD treatment 
does not stimulate NFκB-DNA binding (Stetson, 2006). The function of NFκB signaling in 
dsDNA responses has not been thoroughly studied. In one study, IKKα- or IKKβ-deficient 
MEFs treated with dsDNA, activation of NFκB, and transcription of inflammatory cytokines 
remained intact (Abe, 2014). However, when both IKKα/β were depleted, NFκB activation in 
response to dsDNA was ablated (Abe, 2014). In this same study, TBK1-/- MEFs were unable 
to phosphorylate NFκBp65, as well as IRF-3, in response to dsDNA (Abe, 2014). This 
indicates that TBK1 dominantly regulates NFκB activation in response to dsDNA through 
IKKα/β. 
1.5.2 MAPKs 
Another key branch of signalling components regulating inflammation is the Mitogen 
Activated Protein Kinases (MAPKs). MAP kinases are Ser/Thr kinases that include 
JNKs/SAPKs, ERKs and p38s (Arthur, 2013). In mammalian cells, 14 MAPKs have been 
described. Of these, extracellular signal-regulated kinase (ERK) 1 and 2, p38α, and Jun N-
terminal kinase (JNK) 1 and 2 have been studied for their importance in the innate immune 
response (Arthur, 2013). MAPKs function downstream of many signalling cascades, 
including TLRs (Arthur, 2013). MAPKs activate AP-1 either by direct phosphorylation or 
increased AP-1 transcription (Karin, 1996). Similarly, to NFκB transcriptional regulation, AP-1 
activity can promote inflammatory responses, elicit stress responses and promote cell 
survival or cell death (Shaulian, 2001; Honda, 2005). 
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MSKs (Mitogen- and Stress-activated protein Kinases) are phosphorylated and activated by 
ERK1/2 or p38α. MSK1 and 2 regulate gene transcription through activation of different 
transcription factors (MacKenzie, 2013). MSK1 has been shown to phosphorylate CREB, 
and, it has been proposed, the p65 subunit of NFκB, leading to increased transcriptional 
activity (MacKenzie, 2013). 
1.5.3 IRFs 
There are 9 Interferon Regulatory Factors (IRFs): IRF1-7, interferon consensus sequence-
binding protein, and Interferon Stimulated Gene Factor 3g (ISGF3g) (Mamane, 1999; 
Taniguchi, 2001). IRF proteins stimulate the expression of many genes with antiviral, anti-
proliferative, apoptotic, and immunomodulatory functions. All IRFs contain an N-terminal 
DNA binding domain with five tryptophan repeats. This domain forms a helix-turn-helix 
domain and recognizes similar DNA sequences with a recognition sequence of 5’-
AANNGAAA-3’ (Fujii, 1999). The IRF binding site contains an essential 5’ flanking AA 
sequence, which prevents their binding to the NFκB binding site. The interaction of an IRF 
with the core motif causes an alteration in DNA structure, which is thought to allow 
cooperative binding at the promoter (Fujii, 1999). The C-terminal regions of IRFs, except 
IRF1 and IRF2, have an IRF association domain that allows homo- and heteromeric 
interactions with other IRFs, and other transcription factors such as STATs (Mamane, 1999; 
Taniguchi, 2001). IRF1, 3, 5, and 7 have been implicated in Type-I IFN gene transcription. 
However, only IRF-3 and IRF-7 have consistently been shown to be essential in downstream 
signalling of PRRs. 
IRF3 and IRF7 are highly homologous (Honda, 2006). IRF3 is constitutively expressed in the 
cytosol, while IRF7 is induced by Type-I IFN signalling (Marie, 1998; Sato, 1998). IRF7 is 
required for the initial IFN response after PRR activation and for a positive feedback loop to 
amplify that response (Honda, 2005). Both IRF3 and IRF7 undergo phosphorylation, 
dimerization, and nuclear translocation upon viral infection (Lin, 1998; Sato, 1998; 
Yoneyama, 1998). IRF3 is phosphorylated at the C-terminal region at many sites (S385, 
S386, S396, S398, S402, S405, and T404), but phosphorylation of serine 386 has been 
shown to be the critical phosphorylation for IRF3 activation (Mori, 2004). The phosphorylated 
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IRF3 then translocates to the nucleus, forms a complex with the coactivators CBP and p300, 
and binds to its target DNA sequence in Type-I IFN genes and cytokine genes to alter the 
local chromatin structure and activate gene transcription. IRF3-deficient cells are unable to 
produce Type-I IFNs and are vulnerable to infection with a range of bacteria and viruses 
(Sato, 2000). TBK1 and IKKε (IκB Kinase epsilon), both IκB-related kinases, have been 
shown to phosphorylate IRF3 and IRF7 (Fitzgerald, 2003; Sharma, 2003; Hemmi, 2004).  
1.5.4 IFNs 
Interferons (IFNs) are a family of cytokines induced by the signalling of many PRRs that 
detect viruses, e.g. TLR3 and cytosolic nucleic acid sensors. They are transcriptionally 
induced and secreted early during infection. Signaling is autocrine and paracrine, acting on 
the infected cell itself, its neighbours, and immune cells in the vicinity. IFNs bind to IFN 
receptors to initiate signalling, named for their ability to interfere with viral signalling (Isaacs 
& Lindenmann, 1957). They exhibit multiple biological activities, including inhibition of cell 
growth, immunomodulation, and regulation of apoptosis, in combination these activities 
coordinate the immune response to viruses and other intracellular pathogens. IFNs induce 
hundreds of ISGs (Interferon Stimulated Genes), many with antiviral functions. Proteins 
encoded by IFN-inducible genes mediate the biological activities of IFNs. There are three 
classes of IFN genes. Type-I IFN consists of 13 IFN-α genes and one IFN-β gene, as well as 
IFN-ε, IFN-κ, and IFN-ω (Taniguchi, 1980; Weissmann, 1986, Pestka, 2004). All known 
vertebrates have a gene that encodes IFN-β and at least two genes that encode IFN-α 
(Stetson, 2006b). This conservation of Type-I IFNs indicates the importance of these genes 
for host survival. Type-II IFN, IFN-γ, it is produced mainly by activated immune cells such as 
T cells or NK cells. Type-III IFN includes IFN-λ1, -λ2, and -λ3, which are induced by virally 
infected cells (Pestka, 2004). These three types are distinguishable by their unique receptor 
complexes, IFNAR1 and IFNAR2 (IFN Alpha Receptor 1 and 2), IFNGR1 and IFNGR2 (IFN 
Gamma Receptor 1 and 2), and IFNLR1 (IFN lambda Receptor 1) and IL10RB (IL-10 
Receptor subunit beta), respectively (De Weerd, 2012).  
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1.5.5 Type-I IFN 
Type-I IFNs are induced by pathogens, such as viruses, as well as other cellular stresses, 
typically due to the activation of PRRs. Type-I IFN and IRF genes are found only in 
vertebrates, involved in the host defense against pathogens. IFN signaling, along with the 
signalling downstream of many other cytokines, is mediated by the JAK-STAT (Janus kinase 
- Signal Transducer and Activator of Transcription) pathway (Murray, 2007). These cytokines 
then act in an autocrine or paracrine manner to induce the production of ISGs which can 
form a local viral response (Stetson, 2006b). 
The induction of Type-I IFNs is controlled primarily at a transcriptional level, by Interferon 
Regulatory Factors (IRFs), NFκB, and AP-1. The IFN-β gene promoter contains positive 
regulatory domains (PRDs) I, II, III, and IV (Kim, 1997). The IFN-α promoter contains PRD I- 
and PRD III-like elements (PRD-LEs) (Ryals, 1985). PRD I and PRD III are the binding sites 
for IRF family members, whereas PRD II and PRD IV elements are for NFκB and AP-1 (a 
heterodimer of activating transcription factor 2 (ATF2) with c-JUN) binding. Viral infection 
triggers the assembly of IRFs, NFκB, AP-1 to form the enhanceosome (Kim, 1997). The 
enhanceosome recruits histone acetyl transferases (HATs) including CREB binding protein 
(CBP) to acetylate lysines of histones H3 and H4 in the nucleosome, located at the 
transcription start site of the IFN-β gene promoter inhibiting gene induction in the steady 
state (Agalioti, 2000). This acetylation facilitates the recruitment of a nucleosome 
modification complex, leading to nucleosome displacement from the transcription start site 
and recruitment of the transcription complex TFIID (Transcription Factor II D) to the 
promoter, allowing IFN-β gene expression (Agalioti, 2000; Honda, 2006).  
Type-I IFN binding to the IFNR activates ISGF3 (IRF9, STAT1, and STAT2), which then 
induces IRF7. IRF7 resides in the cytosol and, on viral infection, undergoes serine 
phosphorylation in its C-terminal region, allowing its dimerisation and nuclear translocation. 
In addition to inducing hundreds of antiviral genes in an infected cell and its neighbour, Type-
I IFN has also been linked to a variety of responses in adaptive immune cells. Type-I IFN 
been shown to promote differentiation and activation of Cytotoxic T lymphocytes (CTLs) and 
NK cells, as well as the differentiation of human peripheral blood monocytes into DCs 
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capable of stimulating immature T cells (Kolumam, 2005; Santini, 2000). IFN-α/β treatment 
of immature DCs is capable of inducing maturation of these cells, leading to expression of 
costimulatory molecules and MHC I and II (Major Compatibility Complex I and II) (Luft, 1998; 
Gallucci, 1999). Type-I IFNs also promote cross-presentation of viral antigens from DCs to 
CTLs (Le Bon, 2003). Type-I IFN treated DCs upregulate expression of CCR7 (C-C 
Chemokine Receptor Type 7), required for DC homing to lymph nodes to present antigen to 
T cells (Parlato, 2001). IFNα/β has been shown to work as an adjuvant to improve antibody, 
T cell responses to soluble antigen, and memory T cell responses (Gallucci, 1999; Le Bon, 





1.6 DNA Damage-Immune Overlap 
1.6.1 Evidence of an Immune Response to DNA Damage 
The innate immune system senses the presence of microbes and danger via germline-
encoded receptors, which detect PAMPs and DAMPs (Akira, 2006). DAMPs include stress 
signals released by cells, and by-products of dying cells (Chen, 2010). Direct genotoxic 
damage has also been shown to trigger immune responses. IR and UV irradiation have both 
been shown to induce the production of a variety of inflammatory cytokines including IL-6, IL-
8, and TNF-α (Hong, 1999; Müller, 2007; Kondo, 1993). Treatment of cells with 
chemotherapeutic drugs or UV, leads to JNK activation, and subsequent phosphorylation 
and nuclear translocation of IRF7 (Kim, 2000).  JNK has also been shown to phosphorylate 
and activate p53 (Fuchs, 1998). Brzostek-Racine, et al. showed that 24 hours of treatment 
with Etoposide, a topoisomerase II inhibitor, lead to induction of IFN-α and IFN-λ genes, as 
well as ISGs, such as ISG54, STAT1 and STAT2 activation. Camptothecin, Mitomycin C, 
and Adriamycin also upregulated IFN expression to some extent (Brzostek-Racine, 2011). 
NFκB activation was required and sufficient for the induction of IRF1 and IRF7 which could in 
turn stimulate IFNα and IFNλ transcription (Brzostek-Racine, 2011). This response required 
NEMO, IRF1, and IRF7 as well as the DDR kinase ATM (Brzostek-Racine, 2011). 
Anthracycline class drugs, such as doxorubicin, which, like etoposide inhibit topoisomerase II 
enzyme function, have been shown to induce cytokine secretion and acute inflammation 
when injected in the abdomen (Krysko, 2011) Conversely, treatment of mice with low doses 
of Anthracyclines, has been shown to confer resistance against severe sepsis, a systemic 
inflammatory condition, in mouse models by reducing the levels of cytokines produced upon 
bacterial challenge (Figueiredo, 2013). 
IRF1 has also been shown to be stabilized in cells exposed to DNA damaging agents to 
induce the gene that encodes p21/WAF1 (Wild-type Activating Fragment-1) (Tanaka, 1996).  
The expression level of IRF1 increases in response to viral infection and in response to 
DNA-damaging agents (Fujita, 1989). IRF1 regulates specific target genes, thereby inducing 
cell cycle arrest or apoptosis in response to genotoxic stress (Tamura, 1995; Tanaka, 1996). 
Other studies have reported that IRF3 and IRF7 undergo phosphorylation, mediated by 
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DNA-PK, and nuclear translocation in response to genotoxic stress (Karpova, 2002; Kim, 
2000). Treatment with several DNA-damaging agents, including Doxorubicin, Mitomycin C, 
Cisplatin, Etoposide, and UV radiation, lead to IRF3 phosphorylation, CBP binding, nuclear 
translocation, and increased transcription from its binding sites (Kim, 1999). Mutation of 
residues Ser-385 and Ser-386 block the activation of IRF3 in response to viral infection and 
to DNA damage (Yoneyama, 1998; Kim 1999).  
DNA damaging events can activate the adaptive immune system. Ara-C treatment has been 
found to upregulate expression of costimulatory molecules as well as Class I MHC 
molecules on fibroblasts, allowing the damage-activated cells to prime naïve CD8+ T cells 
(Tang, 2013). Inhibition of ATM and ATR in fibroblasts decreased their expression of 
costimulatory molecules and subsequent ability to prime naïve T cells (Tang, 2013). NK cell 
surface receptor NKG2D (Natural Killer Group 2 D), which recognises self-molecules that are 
upregulated in diseased cells, has been shown to be upregulated in non-tumour cell lines by 
genotoxic stress and stalled DNA replication (Gasser, 2006). This was the case after 
treatment with IR, inhibitors of DNA replication, chloroquine, cisplatin, and Ara-C treatment 
(Gasser, 2006). NKG2D ligand upregulation was prevented by ATM, ATR, or Chk1 
(Checkpoint Kinase 1) inhibition, depending on the damaging stimuli (Gasser, 2006). 
1.6.2 Interplay between DDR and Viruses 
DNA viruses are an ancient and persistent threat to cellular genome integrity. The genomes 
of viruses that infect human cells range in size from a few thousand nucleotides to several 
hundreds of kilobases and consist of single-stranded or double-stranded molecules of either 
DNA or RNA. Some virus, such as retroviruses, integrate into their host genome. Up to 40% 
of the human genome is estimated to be derived from ancestral viral fragments (Sverdlov, 
2000). Unlike bacteria and fungi containing microbe-specific structures, viruses are made 
entirely of host-derived components. All viruses require components from the host cell to 
replicate their genomes, in conjunction with virus-encoded enzymes. Many viruses, with 
distinct replication strategies, activate DNA-damage response pathways, including the 
lentivirus HIV and the DNA viruses EBV (Epstein-Barr Virus), HSV-1, ADV (Adenovirus), and 
SV40 (Sinclair, 2006). These viruses have evolved to circumvent certain harmful aspects of 
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the DNA damage response while exploiting advantageous ones (Lilley, 2007). DNA damage-
induced Type-I IFN responses have been shown to increase resistance to viral replication in 
mice, indicating that the DDR and the antiviral immune response may have coevolved 
(Mboko, 2012). 
Following HIV infection, reverse transcribed viral DNA is integrated into host DNA (Skalka, 
2005). This process can create SSBs and short gaps at the ends of the viral genome at the 
integration site within the host genome. If these go unrepaired, they will become DSBs 
during replication. HIV requires catalytic activities activated during the DNA-damage 
response to complete its replicative cycle (Daniel, 1999). ATM becomes activated upon T 
cell infection with WT HIV but not with integrase-mutant strains of HIV (Lau, 2005). ATM has 
been reported to enhance HIV replication by stimulating the viral posttranscriptional regulator 
gene Rev (Ariumi, 2006). It has also been reported that ATM−/− murine embryonic stem cells, 
primary T cells isolated from AT patients, and human T-cell lines treated with KU55933, an 
ATM inhibitor, have a reduced efficiency of transduction of a viral vector (Lau, 2005). The 
transduction and integration of other retroviruses has also been shown to require the 
function of PI3K-related kinases, including ATM, ATR, and DNA-PK (Daniel, 2001). 
EBV has a linear dsDNA genome, and replicates in B cells and epithelial cells. Following 
infection, the EBV genome circularises through the association of the terminal repeat regions 
at each end of the genome. The virus is maintained as an extrachromosomal episome in 
infected cells and can replicate once per cell cycle, using the host replication machinery 
(Tsurumi, 2005). During initial EBV infection, the exposed ends of the viral linear DNA could 
resemble DSBs. DDR response factors have not been found to be essential for EBV 
replication, however, EBV infected cells show ATM and downstream protein phosphorylation 
(Kudoh, 2005). ATM, Nbs1 and Mre11 colocalise at sites of EBV viral replication but 
downstream signal transduction through the ATM pathway is blocked; despite activation of 
p53 by phosphorylation on Ser15 (Kudoh, 2005). EBV proteins have been shown to 
physically interact with p53, inhibiting its transactivation (Kudoch, 2005). 
HSV-1, like EBV, belongs to Herpesviridae viral family, unlike EBV requires the DDR to form 
viral replication centres (Lilley, 2005). HSV-1 has been shown to activate the DDR during the 
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replication of its genome (Schattgen, 2011). HSV-1 and adenovirus incubated with either 
DNA damaging agents prior to transfection into mDCs showed enhanced immune responses 
compared to those untreated (Gehrke, 2013). This damaged DNA may act as an alarm to 
activate immune sensors to foreign DNA in the nucleus.  
HSV-1 regulatory protein ICP0 is a RING finger E3 ubiquitin ligase. It has been shown to 
induce the degradation of certain cellular proteins through ubiquitination and proteasome 
mediated degradation. ICP0 has been shown to induce the proteasome-mediated 
degradation of PML (Everett, 1998), the catalytic subunit of DNA-PK (Lees-Miller, 1996), p53 
(Boutell, 2003), and IFI16 (Orzalli, 2012). The expression of ICP0 results in the sequestration 
of p53 to nuclear foci where ICP0 then promotes the ubiquitination and degradation of p53 
(Wilcock, 1991; Boutell, 2003). In this way, ICP0 inhibits the apoptotic response to DNA 
damage in irradiated and virus-infected cells (Boutell, 2003). 
Several other DNA viruses have been shown to affect the stability of p53. The E6 protein of 
human papillomaviruses 16 and 18, and the adenovirus E1B-55K/E4-orf6 complex, both 
induce the degradation of p53 through ubiquitination (Scheffner, 1993). The adenovirus E1B 
55K protein has been shown to inhibit specific p53 transcriptional functions through its 
sequestration (Maheswaran, 1998; O’Shea, 2004). Human cytomegalovirus (HCMV) has 
also been shown to recruit p53 to viral replication sites (Luo, 2007). 
Adenovirus 5 (Ad5) encodes early viral proteins that target MRN in multiple ways: MRE11 
can be directly targeted for proteasomal degradation (Stracker, 2002); it can be mislocalised 
in the nucleus; or the entire MRN complex can be sequestered (Stracker, 2002; Shah, 2015). 
MRN degradation or mislocalisation is sufficient to prevent MRN binding to virus genomes 
(Shah, 2015). Without a functional MRN complex, the DDR fails to be activated in response 
to the adenovirus genome (Carson, 2003). 
At cellular DSBs, ATM signaling is amplified by the phosphorylation of H2AX across 
megabases of chromatin to promote repair and prevent cellular replication (Polo, 2011). 
MDC1 binds to γH2AX in a feedforward loop that recruits additional MRN, DDR kinases, and 
effectors into foci that facilitate global phosphorylation. Etoposide treatment induces this 
global damage response; however, MRN-ATM activation at viral genomes is not amplified 
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through γH2AX to induce DDR foci and a global cellular DDR (Shah, 2015). The binding of 
MRN and activation of a localised, but not a global, ATM response prevents viral genome 
replication (Shah, 2015). Treatment with Etoposide and the induction of cellular DNA breaks 
sequesters MRN and prevents the restriction of viral replication (Shah, 2015). This indicates 
that yH2AX foci may discriminate ‘‘self’’ and ‘‘non-self’’ genomes and determine whether a 
localized anti-viral or global ATM response is appropriate.  
1.6.3 The Immune Response and Cancer 
The immune system protects the host against tumour development. This can sculpt the 
immunogenic phenotypes of developing tumours thereby promoting the emergence of 
established tumours with reduced immunogenicity. The efficacy of chemotherapeutic agents 
is thought to be through induction of cell death in rapidly dividing cells (Viktorsson, 2005) but 
it may also be through immune cell activation to clear the tumour (Dunn, 2005).  
Chronic activation of the DDR is common in human cancers (DiTullio, 2002; Bartkova, 2005). 
Persistent DDR signaling has been detected in vivo in premalignant and malignant lesions in 
human breast, lung, skin, bladder and colon (Bartkova, 2005). This indicates that DDR 
signaling drives the inflammation that is also a hallmark of premalignant, malignant and 
aging tissues (Rodier, 2009). Cells and tissues with accumulating DNA damage produce 
endogenous IFN-β and stimulate IFN signaling in vitro and in vivo (Yu, 2015). In turn, IFN 
acts to amplify DNA-damage responses, activate the p53 pathway, promote senescence, 
and inhibit stem cell function in response to telomere shortening. Type-I IFNs are used in 
clinical settings to treat a range of malignancies, including hairy cell leukaemia, melanoma, 
renal cell carcinoma and Kaposi sarcoma. Neutralization of IFN-α/β with polyclonal 
antiserum in mice enhances the growth of transplanted, syngeneic tumour cells that grow 
progressively in immunocompetent hosts. WT mice reject transplanted tumours unless they 
were pre-treated with anti-IFNαR1 blocking antibody (Dunn, 2005). IFNγR1-/- and IFNαR1-/- 
mice are more susceptible to chemical-induced carcinogenesis than are wild-type mice 
(Dunn, 2005). This indicates that endogenously produced IFNα/β, like IFNγ, inhibits the 
formation of chemically induced primary tumours and thus is a critical, physiologically 
relevant component of the host protective cancer immunosurveillance network (Dunn, 2005). 
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Tumour cell sensitivity to IFNγ but not to IFNα/β is a critical determining factor regulating 
tumour immunogenicity in vivo (Dunn, 2005). Tumour cells were not found to be 
physiologically relevant targets of endogenously produced IFNα/β yet tumour rejection 
requires host IFNα/β responsiveness (Dunn, 2005). IFNα/β sensitivity within hematopoietic 
cells is required for tumour rejection (Dunn, 2005). The reduction in tumour size after IR 
treatment is dependent on Type-I IFNs (Deng, 2014). 
The existence of a T cell-inflamed tumour microenvironment is associated with positive 
clinical responses in metastatic disease (Harlin, 2009; Ji, 2012). In early-stage colon cancer 
the presence of effector-memory CD8+ T cells have been reported to be more predictive of 
positive outcomes (Pagès, 2009). Similar prognostic markers have been reported in breast 
and ovarian cancer (Mahmoud, 2011; Hwang, 2012). Ionizing radiation-mediated tumour 
regression depends on Type-I IFN and the adaptive immune response (Deng, 2014). IR-
treated tumours induce IFN-β and CXCL10, dependent on cGAS and STING (Deng, 2014). 
CD11c+ DCs were the major producer of IFN-β after radiation (Deng, 2014). DCs were not 
activated by irradiated tumour cells in a transwell assay, indicating that direct cell-to-cell 
contact in necessary (Deng, 2014). These DCs were then able to cross-prime T cells, which 
were found to be key in the antitumour response (Deng, 2014). Tumour-specific T cell 
priming was shown to depend on Type-I IFN production and signaling in CD8α+ DCs which 
cross-present tumour antigens (Diamond, 2011; Fuertes, 2011). This response allows 
tumour rejection in immune competent mice, and is dependent on STING and IRF3 (Woo, 
2014; Deng, 2014). IFN-β production and DC activation are triggered by tumour-cell derived 
DNA, via cGAS, STING, and IRF3 (Woo, 2014). Induction of inflammatory cytokines, 
including IL-6, TNF-α, and IL-12, by tumour stimulated DCs was dependent on STING (Woo, 
2014). The tumour ablating effect of PDL1 (Programmed Death Ligand 1) antibody treatment 
was also ablated in STING-/- mice (Woo, 2014).  
Conventional cancer treatments such as radiotherapy and chemotherapy, which were 
originally thought to mediate their effects through direct killing of tumour cells, have been 
shown to rely on innate and adaptive immune responses for their efficacy. However, more 
recently, radiotherapy and chemotherapy have been shown to enhance tumor-specific 
immune responses (Lugade, 2005). Ionizing radiation induces inflammatory cytokines 
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production by human tumour cells in vitro (Hallahan, 1989). IFN-related gene signatures are 
found in cells and tissues exposed to anti-cancer drugs and ionizing radiation known to 
induce DNA damage (Weichselbaum, 2008; Moschella, 2013). These agents were shown to 
either activate IRF3 (Kim, 1999) or stimulate production of IFN (Brzostek-Racine, 2011). 
Anti-tumorigenic effects of ionizing radiation and chemotherapy are at least in part mediated 
by effects of Type-IFNs (Burnette, 2011; Deng, 2014; Sistigu, 2014). Tumour cells which are 
unable to make Type-I IFN responses failed to respond to chemotherapy without the addition 
of Type-I IFN (Sistigu, 2014). Genotoxic drug-induced cellular senescence correlates with 
production of IFN and induction of IFN-stimulated genes (Novakova, 2010). DNA damage 
itself can stimulate the production of IFN-β within a few hours of the induction of DSBs (Yu, 
2015). 
Intratumoural production of IFN-β by CD45+ cells after radiotherapy has also been reported 
(Burnette, 2011). Radiotherapy can increase MHC Class I expression and the intracellular 
peptide pool that is presented to the immune system by tumor cells (Reits, 2006). This 
enhanced the efficacy of subsequent immunotherapy by altering tumour cell phenotype, 
resulting in increased T-cell killing (Reits, 2006; Chakraborty, 2004). A time-dependent 
increase in the infiltration of CD45+ hematopoietic cells into tumours has been reported in the 
days following radiotherapy (Burnette, 2011). Tumour-infiltrating DCs have been shown to 
prime naïve T cells, promoting tumour clearance (Yu, 2004; Burnette, 2011). The antitumour 
response to radiotherapy is ablated in Ifnar1-/- mice and WT mice with Ifnar1-/- bone marrow 
chimeras (Burnette, 2011). This indicates that the activation of tumour-infiltrating 
haematopoietic cells relies on autocrine production of Type-I IFNs.  
Tumour cell death induced by Ionising Radiation can promote a DC-mediated CTL response 
that confers permanent antitumor immunity (Apetoh, 2007). HMGB1 protein has been shown 
to be released from necrotic cells and act as an endogenous adjuvant (Rovere-Querini, 
2004). An increase in HMGB1 release and cytokine production was also observed in cells 
treated with Mitomycin C (MMC), dependent on ATM (Karakasilioti, 2013). HMGB1 has been 
shown to promote its immunostimulatory effects through TLR4 (Apetoh, 2007). During 
chemotherapy or radiotherapy, DCs require signaling through TLR4 and its adaptor MyD88 
for efficient processing and cross-presentation of antigen from dying tumour cells (Apetoh, 
72 
 
2007). Breast cancer patients with mutant TLR4 have a higher frequency of metastasis 5 
years after surgery than those with WT allele (Apetoh, 2007). However, TRIF-/- mice have 
also been reported to make an anti-tumour immune response after radiotherapy, indicating 
that there may be many immunostimulatory ligands produced in response to cancer therapy 
(Burnette, 2011). 
NKG2D is an immunoreceptor found on NK cells, certain T cells, and activated 
macrophages. NKG2D ligands are commonly upregulated on the surface of cells which are 
undergoing cellular stress, are virus-infected, or transformed (Eagle, 2007). The DDR 
triggers NKG2D ligand expression, and this is often constitutively active in cancer cells, 
causing constitutive ligand expression, revealing these cells to the immune system. Upon 
binding to its ligand, NKG2D can induce NK cell degranulation and target cell death. Retinoic 
acid early transcript 1 (RAE-1), a NKG2D ligand, has been reported to rely on STING-
dependent signaling via TBK1 and IRF3 for its upregulation (Lam, 2014). DNAX accessory 
molecule-1 (DNAM-1) is transmembrane glycoprotein constitutively expressed on most T 
cells, NK cells, and macrophages which acts as an immunoreceptor in the same way as 
NKG2D (Shibuya, 1996). Chemotherapeutic drugs have been shown to induce the 
expression of DNAM-1 and NKG2D ligands on patient-derived multiple myeloma cells 
(Soriani, 2009). The DDR molecules ATM, ATR and CHK1 are required for expression of 
NKG2D ligands in response to DNA damage and their constitutive expression in some tumor 
cell lines (Gasser, 2006). Treatment of lymphoma cells with the DDR-inducing agent Ara-C 
(Cytosine Arabinoside) leads to DNA species in the cytosol of cells, which induces an innate 
immune response and Type-I IFN induction after 15 hours (Lam, 2014).  
1.6.4 The DNA Damage Response in Autoimmunity 
Autoimmune conditions are defined by their abnormal immune responses to self-antigens. 
One such self-antigen in the case of Lupus Erythematosus (LE) is DNA. DNA released from 
dying cells has been shown to induce proinflammatory cytokines in immune cells (Ahn, 2012; 
Chamilos, 2012). UV-B irradiation of keratinocytes leads to the production of lupus 
autoantigens within 8 hours, the production of ROS, and the appearance of apoptotic surface 
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blebs (Caricchio, 2003; Masaki, 2009). ROS are thought to be responsible for skin damage 
due to UV-B radiation (Masaki, 2009). 
Accumulation of oxidised bases leads to genetic instability which can ultimately lead to 
carcinogenesis or worsening of inflammatory processes. The oxidation of guanine to 
80hydroxyguanine (8-OHG) is a hallmark of oxidative damage to DNA. 8-OHG oxidative 
modifications occurs in response to pathogens as well as UV-exposed skin lesions of LE 
patients (Gehrke, 2013). 8-OHG accumulation has been shown to correlate with IFN 
induction (Wiseman and Halliwell, 1996; Gehrke, 2013). DNA containing 8-OHG 
modifications is more resistant to degradation by TREX1, a 3’ exonuclease (Gehrke, 2013). 
This TREX1-resistant oxidised DNA was shown to accumulate the cytoplasm and activate a 
cGAS- and STING-dependent immune response (Gehrke, 2013). Lupus-prone mice, injected 
with naked UV-damaged self-DNA but not unaltered self-DNA developed the inflammatory 
symptoms of LE (Gehrke, 2013). 
Aberrant cytokine production can be harmful to self-tissue. ATM restrains spontaneous 
Type-I IFN production (Härtlova, 2015). In the absence of ATM, or in response to genotoxic 
stress, Type-I IFNs are induced that prime the innate immune system for pathogenic insults, 
via the cGAS-STING pathway by self-DNA released into the cytoplasm (Härtlova, 2015). AT 
patient cells, deficient in ATM, were shown to have constitutively elevated transcripts for 
Type-I and Type-III IFN genes and so were primed to mount an immune response upon viral 
or bacterial challenge (Härtlova, 2015). Sera from infection-free AT patients could protect 
cells against viral infection by activating expression of ISGs (Härtlova, 2015). This shows a 
clear overlap between the DNA damage response and the innate immune system. 
1.7 Project Aims 
In this thesis, we are observing the early hours after DNA damage, before the cell has begun 
to show nuclear leakage or signs of cell death.  
Our aims for this project are: 
• To determine if there is an innate immune response to DNA damage in human 
keratinocytes, fibroblasts, and monocytes. 
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• To determine the role of components of the cytosolic DNA sensing pathway in this 
response – IFI16, STING, and cGAS – using genetically modified cell lines, deficient 
in candidate signalling components. 
• To determine the role of DDR signalling factors in this response - using inhibitors 
and siRNA-mediated depletion. 
• To investigate how immune signalling to cell-intrinsic damaged DNA may differ from 
exogenous DNA stimulation – by observing activation of various signalling factors. 
By achieving these aims, we will shed light on the response of the immune system to DNA 
damage. An increased understanding of the overlap between these two fields can benefit the 




Chapter 2 - Materials and Methods 
2.1 Cells and reagents 
Immortalised human keratinocytes (HaCaTs) were grown in DMEM (Dulbecco's Modified 
Eagle's Medium) (Life Technologies) supplemented with 10% (v/v) Fetal Calf Serum (FCS) 
(Sigma) and 50μg/ml Gentamycin (Life Technologies). IFI16-/- HaCaT cells were generated 
by using TALENs by L. Unterholzner. cGAS-/- and STING-/- HaCaTs were generated using 
CRISPR Cas9 technology. 
Primary human keratinocytes from adult donors were obtained from Lonza, and grown in 
KGM‐Gold Keratinocyte Basal Medium supplemented with KGM-Gold SingleQuots (Lonza). 
Primary human fibroblasts (MRC-5) derived from normal lung tissue of a 14-week-old male 
foetus (ATCC) were grown in DMEM supplemented with 10% FCS and 50μg/ml Gentamycin. 
HEK293T cells (Thermo, #HCL4517) were grown in DMEM supplemented with 10% FCS 
and 50μg/ml Gentamycin. IFN Bioassay HEK cells stably expressing ISRE-luc were gifted by 
J. Rehwinkel (Oxford) and grown as HEK293T cells.  
Immortalised monocyte-like cells (THP-1) were grown in complete RPMI (Roswell Park 
Memorial Institute) 1640 medium (Life Technologies) supplemented with 10% (v/v) Fetal Calf 
Serum (Sigma), 50μg/ml Gentamycin (Life Technologies), 2mM L-glutamine (Sigma), and 
1mM sodium pyruvate (Life Technologies)). IFI16-/-, STING-/-, cGAS-/- and parental Wild Type 
THP-1 cell lines were obtained from C. Holm (Aarhus). Knockout cell lines were generated 
using lentiviral transfection of CRISPR Cas9 constructs. THP-1 cells were grown in 
suspension. For use in experiments, THP-1 cells were differentiated in 100nM PMA for 48 
hours, making them adherent and more closely resembling macrophages. 
2.2 Buffers frequently used in this thesis 
10X Tris Buffered Saline (TBS) (pH 7.6) 
0.2M Tris base 
1.5M NaCl 
H2O 








Mammalian Cell Lysis Buffer 
50mM Tris-HCl (pH 7.5) 
1mM EDTA 
1mM EGTA 
1% (v/v) Triton X-100  
1mM Sodium Orthovanadate 
50mM Sodium Fluoride 
5mM Sodium pyrophosphate 
10mM Sodium β-glycerophosphate 
0.27M sucrose 
0.1% (v/v) β-mercaptoethanol  
0.1mM PMSF 
10μl/ml Aprotinin 
Hypotonic Fractionation Buffer 






3x SDS Sample Buffer 
62.5mM Tris-HCl (pH 6.8) 
2% (w/v) SDS  
10% (v/v) Glycerol  
0.1% (w/v) Bromophenol blue  
H2O 
50X TAE 
2M Tris Base 
5.7% (v/v) Glacial acetic acid 
50mM EDTA (pH 8) 
H2O 
Resolving Gel Buffer (pH 8.8) 1.5M Tris base 
H2O 
Stacking Gel Buffer (pH 6.8) 0.5M Tris base 
H2O 
10X Running Buffer 
0.25M Tris base 
1.92M Glycine 
1% (w/v) SDS 
H2O 
10x Transfer Buffer 
0.25M Tris base 
1.922M Glycine 
H2O 
6x DNA Loading Buffer 
30% (v/v) Glycerol  
0.025% (w/v) Bromophenol blue  
0.025% (w/v) Xylene cyanol 
H2O 
Coelenterazine 2μg/ml Coelenterazine in PBS 
Table 2.1: Buffers frequently used in this thesis 
2.3 Generation of cGAS-/- and STING-/- HaCaT cell lines 
HaCaT cells deficient in cGAS or STING were generated using CRISPR-Cas9 technology. 
Plasmids encoding Cas9 nickase and two guide RNAs were designed by the MRC-PPU 
CRISPR service (University of Dundee): 
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Target Sense strand Antisense strand 
cGAS  
(exon 1) 
pBABED P U6 MB21D1 5’-3’: 
ATGCAGAGAGCTTCCGAGGCCGG 




pBABED P U6 TMEM173 5’-3’: 
AGAGCACACTCTCCGGTACCTGG 
pX335 TMEM173 5’-3’: 
GTGGCTCTCCTAGCCCCCAAAGG 
Table 2.2: CRISPR guide RNA sequences 
These plasmids were transfected into HaCaT cells using the Neon electroporation system 
(Life Technologies). Cells were selected for 48 hours with 2μg/ml Puromycin (Sigma), then 
allowed to recover and seeded as single cells in 96-well plates.  
DNA was extracted from individual colonies by centrifuging cells in a 96-well plate, removing 
the media, and adding Quickextract DNA extraction solution (EpiBio), before heating 
samples to 65oC for 2 minutes, then 98oC for 2 minutes, and cooling on ice. DNA was then 
diluted 1 in 4 and 2μl of this was added to 96-well real-time PCR plate (Roche) containing 
Lightcycler480 High Resolution Melting (HRM) master mix (Roche), MgCl2 (Roche), and 
primers directed around the guide RNA target site. The following primers were used to 
screen clones by HRM: 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
cGAS HRM GATTCTTCTTTCGGGGAA TGGCATTCCGTGCGGAA 
STING HRM GCTGAGTGCCTGCCTGGTGA CAGTCCCAGCTGCAGGGAGG 
Table 2.3: HRM primers used in this thesis and their sequences 
Clones were in this way screened for modifications of the target site, by HRM analysis on a 
LifeCycler 96 system (Roche) using the following protocol: 
Preincubation (1 cycle): 600 seconds at 95oC. 
3 Step Amplification (45 cycles): 10 seconds at 95oC; 15 seconds at 60oC; 15 seconds at 
72oC. 
HRM (1 cycle): 60 seconds at 95oC; 60 seconds at 40oC; 1 second at 65oC; continuous at 
97oC (approximately 10 minutes). 
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Candidate clones were screened for lack of protein expression by Western blotting of cGAS 
or STING and β-actin, and by immunofluorescence analysis for homogeneity of cell clones. 
2.4 Cell stimulation and transient transfection  
DNA transfections in keratinocytes and fibroblasts were performed using Lipofectamine 
(Novagen) to manufacturer’s instructions, using 1μg DNA :1µl of Lipofectamine per 
transfection in 12-well plates. Lipofectamine alone was used as a control. DNA transfections 
in HEK cells were performed using GeneJuice (Millipore) to manufacturer’s instructions, 
using 1μg DNA: 3μl of GeneJuice. For double stranded DNA, Deoxyribonucleic acid sodium 
salt from herring testes (HT-DNA; Sigma) was used.  
Transfection by electroporation was performed using the Neon electroporation system (Life 
technologies). 1x105 cells were transfected per well of a 24-well plate. The required volume 
of cells was then centrifuged and the supernatant removed to leave a cell pellet containing 
1x105 cells. The cell pellet was then resuspended in 10μl of Buffer R (Life Technologies). 
1μg of total plasmid/DNA was then added to each relevant cell mixture. A Neon tube was 
then placed into the docking station, and filled with 3ml of Buffer E (Life Technologies). Using 
a Neon pipette, the entire volume of Buffer R, cells, and DNA was taken up into a Neon 
pipette tip. The Neon pipette was then placed into the Neon tube and docking station. The 
Neon machine settings used were: Pulse 1150V, 30ms width, 2 pulses. The Neon pipette 
was then removed from the Neon tube and the contents of the pipette tip ejected into pre-
warmed antibiotic-free media supplemented with serum in the wells of a 24wp. The following 
day, media with changed to contain antibiotic and additional selection agent if required. 
Chemical mutagens – Etoposide (Sigma), Cisplatin (Sigma), Camptothecin (Sigma), 
Hydroxyurea (Sigma) diluted in DMSO (dimethyl sulfoxide) or water per manufacturer’s 
instructions, were added directly to media of plated cells, at indicated concentrations. DMSO 
or water alone was used as a control. For UV treatment, cells were seeded in 6-well plates, 
media removed and wells washed in PBS. Cells were then exposed to 5-20mJ/cm2 in the 
Stratagene UV Crosslinker 2400 using a 254-nm UV-C light source. Fresh media was 




ATM inhibitor KU55933 (Santa Cruz) was dissolved in DMSO and used at 10µM, applied to 
cells 1 hour before stimulation. TBK1 inhibitor MRT67307 (DSTT, University of Dundee) was 
dissolved in H2O and used at 2µM, and applied to cells 1 hour before treatment. PARP 
Inhibitor PJ-34 (Sigma) was dissolved in DMSO and used at 10µM, applied to cells 1 hour 
before treatment. JNK inhibitor 8 (DSTT, University of Dundee) was dissolved in DMSO and 
used at 3µM, applied to cells 3 hours before stimulation. p38 inhibitor VX745 (DSTT, 
University of Dundee) was dissolved in DMSO and used at 1µM, applied to cells 1 hour 
before stimulation. MEK inhibitor PD184352 (DSTT, University of Dundee) was dissolved in 
DMSO and used at 2µM, applied to cells 1 hour before stimulation. 
2.6 siRNA 
Pools of four dual strand modified siRNAs were obtained from GE Dharmacon (ON-TARGET 
plus SMARTpool siRNA). Cells were seeded at 50,000 cells/well in 24-well plates and 
transfected with 5nM of Non-targeting, IFI16, STING, p53, or cGAS siRNA pools using 3 
µl/ml of Lipofectamine RNAiMax (Life Technologies). Non-targeting scrambled siRNA was 
used as a control, as well as Lipofectamine alone. 




























Table 2.4: siRNA used in this thesis and their target sequences 
 
2.7 Immunoblotting 
Protein separation by size was performed using sodium-dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). 10% polyacrylamide gels, were made as follows: 
 
 
Cultured cells were lysed in Mammalian Cell Lysis Buffer (50mM Tris-HCl (pH 7.5), 1mM 
EDTA, 1mM EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid), 1% 
(v/v) Triton X-100, 1mM sodium orthovanadate, 50mM sodium fluoride, 5mM sodium 
pyrophosphate, 10mM sodium β-glycerophosphate, 0.27M sucrose, 0.1% (v/v) 2-
mercaptoethanol, 0.1mM PMSF, 10µl/ml Aprotinin). Lysate was centrifuged at 13,000 rpm 
for 10 minutes and supernatant lysate moved to a fresh tube. Lysates were denatured in 
SDS sample buffer (62.5mM Tris (pH 6.8), 2% (w/v) SDS, 10% Glycerol, 0.1% Bromophenol 
Blue, H2O, 50mM DTT (Dithiothreitol)) at 99oC before loading onto SDS-PAGE gels.  
SDS-PAGE gels were run in a Mini-Protean Tetra Cell tank (Biorad) at 120V for 1.5 hours. 
Gels were then transferred onto nitrocellulose membranes (Millipore) using a semi-dry 















4.1ml 3.3ml 3.3ml - 0.1ml 0.05ml 0.02ml 
Before adding Resolving gel to the plates to set, add a plug composed of 250ul resolving gel, 
5ul of 10% APS and 0.5ul of TEMED. 
Stacking 
Gel (4%) 
1.7ml 0.5ml - 0.75ml 0.03ml 0.03ml 0.003ml 
Table 2.5: Composition of SDS-PAGE gels 
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Western blot membranes were then blocked in either 5% non-fat milk (Marvel)/Tris-buffered-
saline (TBS)/0.1% Tween or 5% BSA (Sigma)/TBS/0.1% Tween depending on which buffer 
is compatible with the intended antibody. Membranes were then incubated with antibodies 
listed in the table below (Section: Antibodies used in this thesis) at a dilution of 1:1000 in 5% 
non-fat milk or BSA (Bovine Serum Albumin) at 4oC overnight. Blots were washed 5 x 5 
minutes in TBS-Tween and incubated with anti-Mouse-IgG-HRP or anti-rabbit-IgG-HRP 
(Horse Radish Peroxidase) as secondary antibodies, at a dilution of 1:3000 and incubated 
for 3 hours at room temperature. Clarity chemiluminescent HRP substrates (Biorad) were 
used for detection of HRP activity. Membranes were exposed to film, or analysed using an 
Odyssey Fc system (LI‐COR) or Chemidoc (Bio-Rad). 
2.8 Co-Immunoprecipitation 
Cells were lysed in Mammalian Cell Lysis Buffer (50mM Tris-HCl (pH 7.5), 1mM EDTA, 1mM 
EGTA, 1% (v/v) Triton X-100, 1mM sodium orthovanadate, 50mM sodium fluoride, 5mM 
sodium pyrophosphate, 10mM sodium β-glycerophosphate, 0.27M sucrose, supplemented 
with 0.1mM PMSF, 10µl/ml Aprotinin). Samples were pre-cleared by centrifugation at 
3,000xg for 10 min before incubation with antibodies overnight at 4°C, followed by the 
addition of Protein G Sepharose 4 Fast Flow beads (GE Healthcare) for 3 hours at 4oC. 
Beads were washed three times with Mammalian Cell Lysis Buffer. Bound proteins were 
eluted by boiling in SDS sample buffer for 10 minutes and analysed by Western blot. A 
portion of non-immunoprecipitated lysate was used for each experiment as an input control. 
2.9 Cell Fractionation 
Cells plated in 6-well plates, were washed in PBS and incubated in Hypotonic Buffer (10mM 
Tris-HCl (pH 7.4), 10mM KCl, 10mM MgCl2, 0.1mM PMSF, and 10µl/ml Aprotinin) with 
digitonin at a concentration of 25µg/ml for 15 minutes. Cells were then scraped into 
eppendorf tubes and centrifuged at 13000rpm for 10 minutes at 4oC. Supernatant was stored 
as “Cytoplasmic fraction”. Pellets were washed in hypotonic buffer before being lysed for 30 
minutes in Mammalian Cell Lysis Buffer (50mM Tris-HCl (pH 7.5), 1mM EDTA, 1mM EGTA, 
1% (v/v) Triton X-100, 1mM sodium orthovanadate, 50mM sodium fluoride, 5mM sodium 
pyrophosphate, 10mM sodium β-glycerophosphate, 0.27M sucrose, 0.1% (v/v) 2-
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mercaptoethanol, 0.1mM PMSF, 10µl/ml Aprotinin). After centrifugation, supernatant was 
stored as “Nuclear fraction”. 
2.10 qRT-PCR 
RNA was extracted from cell lysates and filtered through High Filter tubes using High Pure 
RNA Isolation Kit (Roche Applied Science). This RNA isolation included a DNase step using 
10μl DNase to 90μl DNase incubation buffer (Roche). The concentration of RNA was then 
measured by using a Nanodrop 2000c spectrophotometer (Thermo Scientific) and equal 
masses of RNA were taken from each sample.  
RNA was then reverse transcribed using iScript cDNA Synthesis Kit (Bio-Rad). This uses 
0.5μl iScript reverse transcriptase and 2μl 5x iScript reaction mix, made up to 10μl with RNA 
and nuclease-free H2O, assembled in 8-tube PCR strips (Brand). iScript mixtures were then 
run on Eppendorf Master Cycler for 5 minutes at 25oC, 30 minutes at 42oC, 5 minutes at 
85oC, then cooled to 4oC.  
qRT-PCR was carried out using 2x Fast SYBR green mastermix (Roche; SYBR Green I dye, 
AmpliTaq Gold DNA Polymerase, dNTPs with dUTP Passive Reference, and optimised 
buffer components). This mastermix contains Taq polymerase which, together with target-
specific oligonucleotide probes, amplifies target genes by PCR (Polymerase Chain 
Reaction). SYBR Green I is also present in the mastermix, a dsDNA specific fluorescent dye 
to detect and quantify amplified PCR products. This was performed on an Applied 
Biosystems StepPlus One Real-time PCR machine. The SYBR Green mastermix, primers, 
and DNA were cycled in the following program: 
Holding stage (1 cycle): 1 minute at 95oC. 
Cycling stage (40 cycles): 15 seconds at 95oC; 1 minute at 60oC. 
Melt Curve stage (1 cycle): 15 seconds at 95oC; 1 minute at 60oC; 15 seconds at 95oC;15 
seconds at 60oC. 
Primers were designed through NCBI Primer Blast and synthesised by MWG-Biotech. 
Primers were designed to be specific only for the gene of interest, and to span one or more 
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introns to avoid amplification of genomic DNA. The following primers were used at a final 
concentration of 500nM (forward and reverse):  
Gene Forward Primer Reverse Primer 
β-actin (human) CGCGAGAGAAGATGACCCAGATC GCCAGAGGCGTACAGGGATA 
IFN-β (human) ACACTGGTCGTGTTGTTGAC GGAAAGAGCTGTCGTGGAGA 
IL-6 (human) CAGCCCTGAGAAAGGAGACAT GGTTCAGGTTGTTTTCTGCCA 
CCL20 (human) AACCATGTGCTGTACCAAGAGT AAGTTGCTTGCTTCTGATTCGC 
TNFα (human) GCCCATGTTGTAGCAAACCC TATCTCTCAGCTCCACGCCA 
ISG56 (human) CAAAGGGCAAAACGAGGCAG CCCAGGCATAGTTTCCCCAG 








Table 2.6: qRT-PCR primers used in this thesis and their sequences 
mRNA expression levels were normalized to β-actin mRNA levels. 
2.11 Cytokine Production 
The Human Interleukin-6 (IL-6) cytokine was measured in supernatants obtained from 
treated tissue culture cells using the IL-6 DuoSet ELISA (Enzyme-Linked Immunosorbent 
Assay) (R&D Systems) per manufacturer’s instructions. Results were expressed as pg/ml of 
protein based on the absorbance recombinant IL-6 standards. IFN production was measured 
using an IFN bioassay. HEK cells stably expressing a pGreenFire-ISRE construct were 
overlaid with cell culture supernatant for 24 hours, then luminescence was measured using 
One-Glo Luciferase Assay System (Promega) per manufacturer’s instructions. 
2.12 Confocal Microscopy 
Cells grown on glass coverslips were fixed for 15 minutes either in 4% paraformaldehyde, or 
in -20oC methanol, and washed prior to permeabilisation for 12 minutes in 0.5% Triton X-
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100/PBS. Coverslips were blocked in either 5% BSA/0.05% Tween-20/PBS or 5% 
FCS/0.05% Tween-20/PBS for 1 hour, and stained overnight with primary antibodies in 
blocking buffer (1:600) at 4oC. Coverslips were then washed in PBS and stained with 
fluorescent secondary antibodies in blocking buffer (1:1500) for 2-3 hours. Coverslips were 
mounted in MOWIOL 4-88 (Calbiochem) containing 1µg/ml DAPI. Images were taken on a 
Zeiss LSM 700 confocal microscope. The antibodies used were anti-IFI16 (1:600, Santa 
Cruz), anti-yH2AX (1:600, Cell Signaling), anti-cGAS (1:600, Sigma Prestige), anti-STING 
(1:600, Cell Signaling), anti-p65 (1:600, Cell Signaling), anti-phospho-p65 (1:600, Cell 
Signalling), anti-IRF-3 (1:600, Cell Signaling) anti-rabbit-AF488 (1:1500, Invitrogen), anti-
mouse-AF488 (1:1500, Invitrogen), anti-rabbit-AF647 (1:1500, Cell Signaling), anti-mouse-
AF647 (1:1500, Invitrogen). 
Image files were analysed using OMERO and OMERO Figure software (University of 
Dundee) (Allan, 2012). 
2.13 cGAMP detection by LC-MS 
5x106 HaCaT cells per sample were lysed in cold 80% sequencing grade methanol (Sigma) 
diluted in Hi Per Solve H2O (Sigma) in lo-bind mass-spec grade eppendorf tubes 
(eppendorf). Cell debris was removed by centrifugation prior to the addition of 0.45pmol 
cyclic-di-AMP (Invivogen) as an internal standard. Samples were dried by vacuum 
centrifugation in a speed vac machine (Thermo). Dried samples were then resuspended in 
9% butanol/H2O and vortexed for 1 minute. A mixture of 90% butanol/H2O was then added to 
samples, which were vortexed for 2 minutes, then centrifuged at 13,000g for 1 minute. The 
solution separated into two distinct phases – the upper phase was discarded. This removed 
the lipids from solution. This butanol extraction was carried out 3 times.  
Samples were then dried under the aqueous solution setting in a speed vac for ~75 minutes. 
Dried samples were resuspended in 1ml H2O and purified by solid phase extraction using 
HyperSep Aminopropyl columns (ThermoFisher). Columns were first equilibrated using 80% 
methanol, then washed with 2ml H2O. Samples were then added to the columns and allowed 
to flow by gravity. Columns were then washed again with 1ml H2O, then washed twice with a 
solution of 2% (v/v) acetic acid/80% (v/v) methanol. Finally, the column was washed in 1ml 
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80% Methanol. Elution was performed using 500μl of 4% (v/v) ammonium hydroxide/80% 
(v/v) methanol into a fresh lo-bind eppendorf. This eluent was flushed through the column 3 
times to remove as much bound cyclic dinucleotide as possible. Samples were dried by 
speed vac under the aqueous solution setting for ~2 hours.  
Dried samples were resuspended in 50μl H2O for analysis by liquid chromatography-mass 
spectrometry (LC‐MS). cGAMP levels were measured using a TSQ Quantiva interfaced with 
a Dionex Ultima 3000 Liquid Chromatography system (ThermoScientific), equipped with a 
porous graphitic carbon column (HyperCarb 30x1mm ID 3μm (Part No: C-35003-031030, 
Lab Unlimited). Mobile phase buffer A was composed of 0.3% (v/v) formic acid adjusted to 
pH 9 with ammonia prior to a 1/8 dilution. Mobile phase buffer B was 80% (v/v) acetonitrile. 
The column was equilibrated with 13% buffer B for 15 minutes at a constant flow rate of 0.06 
ml/min. Compounds were eluted from the column with a linear gradient of 13%-80% buffer B 
over 20 min. Buffer B was then increased to 100% for 5 min and the column was washed for 
a further 5 min with Buffer B. Eluents were sprayed into the TSQ Quantiva which measured 
cGAMP and spiked in cyclic di-AMP levels through multiple reaction monitoring experiments. 
The TSQ Quantiva was run in negative mode with a spray voltage of 2600, sheath gas 40 
and Aux gas 10 at a flow rate of 10μl/min. 
2.14 Cytotoxicity Assay 
20,000 cells/well were seeded in 96-well plates and incubated with test treatment or left 
untreated for the length of treatment. Cyanine Dye and Assay Buffer from CellTox Green 
Cytotoxicity Assay (Promega) were incubated with cells for 15 minutes after treatment. 
Fluorescence was measured using fluorescence plate reader FLUOstar Optima (BMG 
Labtech) at wavelengths of 485-500nmEx/520-530nmEm. 
2.15 Clonogenic Survival Assay 
HaCaTs were seeded in 6-well plates, 12 wells per condition, and allowed to attach prior to 
treatment. Etoposide was added to cells for 24 hours before medium was replaced with fresh 
growth medium. After 14 days, cells were washed, fixed, and stained with Giemsa. The 
number of colonies with >50 cells was counted. Cell viability of untreated cells was used as 
the 100% value. 
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2.16 Luciferase Assay 
HEK293T cells were seeded in 96-well plates at 2x104 cells/well. The following day, these 
cells were transfected with 1ng of PG13 Renilla and 60ng of Firefly Luciferase Reporter 
(IFN-β-luc, NFκB-luc, or ISRE-luc) plasmids per well, as well as indicated experimental 
plasmids. 24 hours’ post-transfection, media was removed from 96wp and cells were lysed in 
50μl of 1x Reporter Lysis Buffer (Promega) and underwent 1 freeze-thaw cycle. 10μl of 
lysates was then divided between 2 white 96-well plates (Corning). For the Renilla luciferase 
assay, 50μl of 2μg/ml Coelenterazine in PBS. For the Firefly luciferase assay, 50μl luciferase 
assay mix (Promega) was added to 10 μl of lysate. Plates were then read on the Infinite 
M200 Pro plate reader (Tecan) for 10 seconds per well. Luciferase values are normalised to 
Renilla values and to a baseline control with the same firefly plasmid. 
2.17 Bacterial Transformation and Maxiprep 
NovaBlue Competent E. coli cells (Novagen) were incubated with DNA on ice for 5 minutes, 
before heat shock at 42oC for 30 seconds before returning the mixture to ice for a further 2 
minutes. 100μl of SOC (Super Optimal Broth with Catabolic repressor) medium (Novagen) 
was then added to the cell-DNA mixture which was then plated onto Ampicillin-resistant agar 
plates. For Kanamycin-resistant plasmids, a further incubation step of 30 minutes at 37oC 
was utilised before plating. Agar plates were made from LB Agar powder (5g yeast extract, 
10g peptone from casein, 10g NaCl, 12g agar; Calbiochem) dissolved in 1L distilled water 
and heated in a microwave until a rolling boil was achieved. Once allowed to cool to ~50oC, 
Ampicillin (Formedium) was added at 100μg/ml. LB broth was made from LB Broth powder 
(5g yeast extract, 10g peptone from casein, 10g NaCl; Calbiochem) dissolved in 1L of 
distilled water and heated in a microwave until a rolling boil was achieved. Once allowed to 
cool to ~50oC, Ampicillin (Formedium) was added at 100μg/ml. Transformed bacteria were 
plated and left overnight at 37oC. The following day single colonies were picked and 
incubated in 3ml of relevant antibiotic LB broth on a shaking incubator for 6 hours. After this 
time, bacteria were moved into a larger conical flask containing 100ml of antibiotic LB Broth 
in a shaking incubator at 37oC overnight. Bacteria were centrifuged in the J-Lite Series Rotor 
JLA-16.250 rotor of the Avanti J-26 XP centrifuge (Beckman Coulter). Bacterial pellets were 
lysed and plasmids purified using Maxiprep kit (Qiagen). 
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2.18 Plasmids used in this thesis 
pcDNA3.1(+) EV was purchased from Clontech. pcDNA3.1 (+) STING-Flag, and 
pcDNA3.1(+) STING-HA were a kind gift from G. Barber (University of Miami). pcDNA3.1 
IFI16-untagged was generated by J. Almine (University of Lancaster). pcDNA3 WT p53, 
pcDNA3 S15A p53, and pcDNA3 S15D p53 were a kind gift from D. Meek (University of 
Dundee School of Medicine (Loughery, 2014)). PG13 Renilla plasmid was generated by L. 
Unterholzner (Unterholzner, 2011). IFN-β-luciferase plasmid was a kind gift from T. 
Tanaguchi (University of Tokyo, Japan). 
2.19 Agarose Gel Electrophoresis 
1% Agarose gels were made using Ultrapure Agarose (Invitrogen) in 1xTAE (Tris-Acetate-
EDTA (Ethylenediaminetetraacetic acid)) buffer (2M Tris Base, 5.7% (v/v) glacial acetic acid, 
50mM EDTA (pH 8)). This mixture was heated in a microwave (ProLine) until the liquid was 
lightly boiling. Molten agarose was then cooled to ~50oC and 1X GelRed Nucleic Acid Gel 
stain (Biotium) added. Agarose was then poured into a gel tray with combs in place (VWR) 
and set at room temperature. The gel was placed in a gel tank filled with 1x TAE. 
DNA samples were run on the gel in combination with 3x DNA loading dye (50% glycerol in 
1xTAE, Bromophenol Blue, Xylene Cyanol). 2-log DNA ladder (Peqlab) was also added with 
DNA loading dye to provide size markers. Gels were run at 5-7V/cm using a power pack 
(VWR) until the dye front had moved sufficiently down the gel. Gels were then imaged on a 
GelDoc EZ Imager machine (Bio-Rad) using Image Lab software (Biorad).  
2.20 Antibodies used in this thesis 
Specificity Species Company Catalogue 
Number 
β-actin Mouse Sigma A2228 
IFI16 N-term Mouse Santa Cruz Sc-8023 
IFI16 C-term Goat Santa Cruz Sc-6050 
cGAS Rabbit Sigma Prestige HPA031700 
STING Rabbit Cell Signaling 13647 
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P53 Rabbit Cell Signaling 9282 
Phospho-p53 (S15) Mouse Cell Signaling 9286 
ssDNA Mouse Millipore MAB3299 
NFκB p65 Mouse Cell Signaling 6956 
Phospho-NFκB p65 (S536) Rabbit Cell Signaling 3033 
TBK1/NAK Rabbit Cell Signaling 3504 
TBK1 (A-6) Mouse Santa Cruz sc-398366 
Phospho-TBK1/NAK1 (S172) Rabbit Cell Signaling 5483 
IRF3 Rabbit Cell Signaling 11904 
Phospho-IRF3 (S396) Rabbit Cell Signaling 4947 
γH2AX (S139) Rabbit Cell Signaling 2577 
p38 MAPK Rabbit Cell Signaling 9212 
Phospho-p38 MAPK (T180/Y182) Mouse Cell Signaling 9216 
SAPK/JNK Rabbit Cell Signaling 9258 
Phospho-JNK1&2 (T183/Y185) Rabbit Invitrogen 44682G 
TRAF6 (D21G3) Rabbit Cell Signaling 8028 
TRAF6 (D-10) Mouse Santa Cruz sc-8409 
Fibrillarin Rabbit Cell Signaling 2639 
GAPDH Mouse Santa Cruz Sc-166545 
Lamin A/C Mouse Santa Cruz Sc-7292 
Flag-tag Mouse Sigma F3165 
HA-tag Mouse Cell Signaling 2367 
Anti-mouse-HRP Horse Cell Signaling 7076 
Anti-rabbit-HRP Goat Cell Signaling 7074 
Anti-goat-HRP Donkey Santa Cruz Sc-2020 
Anti-mouse-AF647  Life Technologies A21236 
Anti-mouse-AF488  Life Technologies A11029 
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Anti-rabbit-AF488  Invitrogen A11034 
Anti-rabbit-AF647  Cell Signaling 4414S 
Table 2.7: Antibodies used in this thesis, their species, supplier, and catalogue number. 
 
2.21 Statistics 
Results from real-time PCR, luciferase assay, ELISA, IFN bioassay, cytotoxicity assay and 
microscopy quantification analysis are presented as averages of triplicate samples with error 
bars representing standard deviations. Statistics were carried out using GraphPad Prism 5 
software. Statistical significance was determined using multiple student t tests. * = P ≤ 0.05, 
** = P ≤ 0.01, *** = P ≤ 0.001.  
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Chapter 3 – There is an innate immune response to 
DNA damage in human keratinocytes and fibroblasts 
3.1 Etoposide-Induced DNA damage stimulates an innate immune response in human 
keratinocytes 
In recent years, genotoxic stress has been reported to induce inflammatory phenotypes 
associated with antiviral immune responses and inflammation associated cancer (Härtlova, 
2015; Ahn, 2014). Skin cells are at the barrier between the body and the environment and so 
are routinely exposed to environmental toxins and UV damage. For this reason, when 
investigating cells that would be naturally exposed to genotoxic stress, we chose 
immortalised keratinocyte cells, HaCaT cells. To investigate the cellular response to DNA 
damage, we first had to determine whether there is such a response in keratinocytes. We 
first tested the chemotherapy agent Etoposide. Etoposide is a topoisomerase II inhibitor. 
Topoisomerases are enzymes which relax DNA that becomes supercoiled, a situation that 
can occur routinely during DNA replication. Etoposide inhibits this enzyme by forming a 
ternary complex with the DNA and topoisomerase II, which is irreversible. Upon DNA 
replication, this complex causes a stall, which can then result in a double strand break 
(Burden, 1996). To measure the innate immune response to Etoposide we used qRT-PCR 
(quantitative real-time polymerase chain reaction). Stimulated and control-treated cells are 
lysed and processed to extract RNA from each sample. This RNA is treated with DNase to 
remove any cellular DNA contamination before RNA is reverse transcribed into 
complimentary DNA (cDNA). qRT-PCR uses oligonucleotide probes specific for a gene of 
interest. The oligonucleotides hybridise with the target sequence and amplify it using Taq 
DNA Polymerase. This amplified DNA is then bound by the DNA dye SYBR Green, the 
fluorescence of which can be quantified. For each experiment, a housekeeping gene such as 
β-actin is amplified and quantified to normalise results to. In this way, we can quantify the 
level of mRNA induction of immune genes upon stimulation. We found that upon treatment 
with Etoposide, an inducer of double stranded breaks, keratinocytes made a substantial 
intrinsic innate immune response over the course of 24 hours, characterised by IFN-β, IL-6 




Figure 1: Etoposide-induced DNA damage stimulates an innate immune response in human 
keratinocytes. 
a-c. Immortalised HaCaT keratinocytes were treated with 50μM Etoposide over a 24 hour 
timecourse, before lysis for qRT-PCR analysis of mRNA expression of IFN-β (a), IL-6 (b), 
and CCL20 (c).  
d, e. Supernatants from HaCaT cells treated over 36 hours with Etoposide were analysed for 
protein expression of Type-I IFN (d) or IL-6 (e) by IFN bioassay or ELISA respectively.  
f, g. HaCaTs treated as in (a) were lysed and qRT-PCR analysis of mRNA expression of 
IRF-7 (f), and IFI16 (g) were performed.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. Data are representative of three experiments. 
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(Figure 1d, e). Type-I IFN protein was measured by IFN Bioassay. This bioassay uses 
HEK293T cells stably expressing an ISRE-luciferase construct. Upon detection of Type-I 
IFN, the ISRE promoter is activated and this activates the luciferase activity which can be 
measured and quantified. IL-6 protein expression was measured by ELISA (Enzyme-Linked 
Immunosorbent Assay). ELISA is an assay which uses a capture antibody specific for a 
protein of interest, in this case the cytokine IL-6, and a detection antibody specific for a 
different epitope of the same protein. Supernatant from stimulated and control treated 
samples are added to the capture antibody bound to a 96-well plate to immobilise the 
antigen and wash away all other proteins in the supernatant. The detection antibody, 
conjugated to the enzyme HRP (Horseradish peroxidase) is then added to samples and 
binds if its target protein is present. An enzyme substrate is then added, the processing of 
which by the enzyme creates a detectable product, with the level of signal produced 
correlating with the amount of antigen bound by the detection antibody, quantified in 
comparison to known concentrations of recombinant protein of interest.  
An upregulation of IFN stimulated genes IRF-7 and IFI16 was observed 24 hours after 
Etoposide treatment compared to control treated cells (Figure 1f, g). ISGs are known to be 
induced after nucleic acid detection by cellular PRRs (Cavlar, 2012), regulated by IRFs and 
NFκB (Honda, 2005). Here we show their induction after DNA damage, which correlates with 
the production of Type-I IFNs. IL-6 is largely controlled by the NFκB transcription factor 
(Libermann, 1990) and is known to be induced by a wide range of stimuli, including 
pathogens, cellular stress, and cytokine and growth factor signalling (Sehgal, 1992). IL-6 is 
implicated in inflammation, development and cancer development among its range of 
functions (Kishimoto, 1992). CCL20 has been reported to have a role in response to RNA 
viruses downstream of STAT6 activation (Chen, 2011). CCL20 is a chemokine which attracts 
CCR6+ DCs, T cells, and B cells to the site of infection or inflammation (Baba, 1997). 
To determine the optimum concentration of Etoposide to use for future experiments, we 
performed a titration of the drug, beginning from 0.25μM up to 250μM. Etoposide is a 
chemotherapeutic drug, and it is important to use physiologically relevant concentrations of 




Figure 2: Etoposide titration.  
a-c. WT HaCaT cells were treated with indicated concentrations of Etoposide for 6 hours 
before lysis for qRT-PCR analysis of IFN-β mRNA (a), IL-6 mRNA (b), and CCL20 mRNA 
(c).  
d. WT HaCaT keratinocytes were treated with indicated concentrations of Etoposide over 8 
hours before analysis for cytotoxicity using a fluorescent DNA binding assay. Lysed cells 
were used as a positive control and media alone as a negative control.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05 as determined by Student’s t-test. Data are 




Figure 3: The innate immune response to DNA damage occurs in live intact cells.  
a. Cells treated with 50μM Etoposide at times indicated over 24 hours or with transfected 
1μg/ml HT-DNA for 6 hours, then lysed for protein analysis by Western Blotting for 
expression of γH2AX and β-actin.  
b. WT HaCaT cells were seeded onto coverslips and treated with 50μM Etoposide for 15 
minutes, 30 minutes, or 6 hours, or DMSO alone in control cells. Cells were then fixed in 4% 
Paraformaldehyde and stained for yH2AX (green), and DAPI nuclear stain (blue) and 
imaged by confocal microscopy.  
c. WT HaCaT keratinocytes were treated with 50μM Etoposide over 24 hours as indicated 
before analysis for cytotoxicity using a fluorescent DNA binding assay. Lysed cells were 
used as a positive control and media alone as a negative control.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p ≥ 0.05; *** = p ≤0.01, as determined by Student’s t-test. 




Figure 4: No DNA leakage is detected at early timepoints of Etoposide treatment.  
a. WT HaCaT cells were seeded onto coverslips and treated with 50μM at times 
indicated over 24 hours. Cells were then fixed in 4% Paraformaldehyde and stained for 
ssDNA (green), and DAPI nuclear stain (blue) and imaged by confocal microscopy.  
Scale bar = 10μm. 
b. WT HaCaT keratinocytes were treated with 50μM Etoposide over 24 hours as 
indicated before fractionation into Cytoplasmic (Cyto) and Nuclear (Nuc) fractions, and 
lysis for western blot analysis of protein expression.  




that are treated with high-dose Etoposide have been shown to have a concentration range of 
~10-100μM in their plasma, starting high and reaching the minimum after 24 hours 
(Schroeder, 2004). All stimulations are compared to DMSO (Dimethyl sulfoxide) alone, as 
this is the solvent into which Etoposide is dissolved and diluted. After titration of Etoposide, 
50μM was confirmed to be an optimum concentration. At this concentration, the peak 
immune responses were induced, and this concentration did not lead to significant levels of 
cell death compared to control treated cells after 6 hours (Figure 2a-c). 
3.2 The innate immune response to DNA damage occurs in live intact cells  
Treatment with etoposide correlated with phosphorylation of H2AX (γH2AX) protein by 
western blot (Figure 3a) and by confocal microscopy of γH2AX protein detected by primary 
antibody against the endogenous protein and a fluorescently labelled secondary antibody 
(Figure 3b). H2AX is a histone marker that is rapidly phosphorylated upon DNA damage and 
allows the formation of a scaffold of repair factors at the site of damage (Polo, 2011). The 
increase in γH2AX in our cells upon Etoposide treatment confirms that Etoposide treatment 
is damaging the DNA in our cells as expected, and that cells are then undergoing DNA 
repair. To determine whether this level of treatment was lethal to the cells, we performed a 
cytotoxicity assay which involves measuring the ability of a fluorescent dye to bind to DNA, 
either by entering fragmented cells or by binding to DNA released by dying cells. Importantly, 
treatment with Etoposide within our stimulation time frame did not lead to significant cell 
death (Figure 3c). After 12 hours, there was no increase in the number of cells which could 
be permeated with the fluorescent DNA stain used in the assay. However, by 24 hours, there 
was a significant amount of cell death as measured by this assay, at which time the innate 
immune response in these cells has diminished (Figure 3c).  
To corroborate this, WT HaCaT cells seeded on coverslips were treated for 0, 6, 10, or 24 
hours with 50μM Etoposide before fixation and staining for confocal microscopy using a 
primary antibody targeting ssDNA (Figure 4a). Based on reports in the literature, Type-I IFN 
induction after DNA damage has been related to ssDNA species in the cytoplasm, activating 




Figure 5: Etoposide-induced DNA damage stimulates an innate immune response in 
primary human keratinocytes.  
a-c. Primary NHEK keratinocytes were treated with 50μM Etoposide over a 36 hour 
timecourse, before lysis for qRT-PCR analysis of mRNA expression of IFN-β (a), IL-6 
(b), and CCL20 (c).  
d-e. Supernatants from NHEK cells treated over 36 hours with Etoposide were analysed 
for protein expression of Type-I IFN (d) and IL-6 (e) by IFN Bioassay and ELISA, 
respectively.  
f. NHEK cells treated with 50μM Etoposide over 36 hours were analysed for cytotoxicity 
using a fluorescent DNA binding assay. Lysed cells were used as a positive control and 
media alone as a negative control.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p > 0.05, ** = p ≤0.01 as determined by Student’s t-




Figure 6: Etoposide-induced DNA damage stimulates an innate immune response in 
primary human fibroblasts.  
a-c. Primary MRC-5 fibroblasts were treated with 50μM Etoposide over a 12 hour 
timecourse, before lysis for qRT-PCR analysis of mRNA expression of IFN-β (a), IL-6 (b), 
and CCL20 (c).  
d. Supernatants from MRC-5 cells treated with 50μM Etoposide for 24 hours were 
analysed for protein expression of IL-6 by ELISA.  
e. MRC-5 cells treated with 50μM Etoposide over 36 hours were analysed for cytotoxicity 
using a fluorescent DNA binding assay. Lysed cells were used as a positive control and 
media alone as a negative control.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p > 0.05; ** p≤0.01; *** p≤0.001 as determined by 
Student’s t-test. Data are representative of three experiments. 
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increased by 24 hours’ after Etoposide treatment but this was not greatly in the cytoplasm 
and this did not agree with published data (Figure 4a). However, after 6 hours of Etoposide 
treatment, cells appeared to show only background levels of ssDNA staining, comparable to 
control treated cells (Figure 4a). By fractionation of cells treated at these same timepoints 
with Etoposide, we observed no Lamin A/C, a nuclear marker, present in cytoplasmic 
fractions (Figure 4b). Together, this data indicates that the response observed is cell 
intrinsic and does not rely on damaged cells dying and releasing their contents, including 
damaged DNA, to be detected by surrounding cells. 
3.3 Etoposide-induced DNA damage stimulates an innate immune response in primary 
human keratinocytes 
The immune induction observed in the HaCaT keratinocyte cell line could also be seen in 
primary keratinocytes, NHEK cells (Normal Human Epidermal Keratinocytes). The NHEK cell 
response peaked at the slightly later time point of 12 hours after Etoposide treatment (Figure 
5a-c). This delay could be due to the slower replication time of primary cells compared to 
immortalised cells. NHEKs also produced Type-I IFN protein as measured by IFN Bioassay 
(Figure 5d) and a substantial concentration of IL-6 protein following mRNA induction, as 
measured by ELISA (Figure 5e). As was the case in HaCaT keratinocytes, NHEK cells did 
not display characteristics of cytotoxicity within the timeframe of these etoposide treatments, 
by 24 hours’ post-treatment (Figure 5f). By 36 hours’ post-treatment, the level of cell death 
was significant compared to untreated control (Figure 5f). 
3.4 Etoposide-induced DNA damage also stimulates an innate immune response in 
human fibroblasts and monocytes. 
To determine if this response is specific to keratinocytes, we investigated other cell types. 
We first tested primary human fibroblasts, MRC-5 cells. MRC-5 cells are fibroblasts cultured 
from foetal lung tissue (Jacobs, 1970). We found that MRC-5 cells treated with Etoposide 
produced IFN-β, IL-6, and CCL20 mRNA but at lower levels than HaCaT and NHEK cells 
(Figure 6a-c). In line with this low mRNA induction, IL-6 protein production was detectable 
but only marginally increased from vehicle-alone treated cells by ELISA (Figure 6d). 
Although, of note is that MRC-5 fibroblasts were found to have very high basal levels of IL-6 




Figure 7: Etoposide induces a small late response in human monocytes.  
a-c. Human monocytes, THP-1 cells were treated with 50μM Etoposide for 0, 6, or 30 
hours. Cells were then lysed for qRT-PCR analysis of IFN-β (a), IL-6 (b), or CCL20 (c) 
mRNA.  
d-g. Human monocytes, THP-1 cells, differentiated for 48h in 100nM PMA were treated 
with 50μM Etoposide for 0, 6, 24, or 36 hours, or with 1μg/ml HT-DNA for 6 hours. Cells 
were then lysed for qRT-PCR analysis of IFN-β (d), IL-6 (e), CCL20 (f), or ISG56 (g) 
mRNA.  
h. THP-1 cells treated with 50μM Etoposide over 36 hours were analysed for cytotoxicity 
using a fluorescent DNA binding assay. Lysed cells were used as a positive control and 
media alone as a negative control.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; ** p≤0.01 as determined by Student’s t-test. Data 
are representative of at least two experiments. 
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etoposide treatment of MRC-5 cells did not induce significant levels of cytotoxicity at the time 
of peak immune induction, 6 hours’ post-Etoposide treatment (Figure 6e). However, by 10 
hours’ post-treatment, the level of cell death was increased compared to untreated controls 
(Figure 6e).  
We then tested the monocyte/macrophage cell line THP-1 cells. THP-1 cells exist in 
suspension resembling monocytes in the blood. After differentiation with PMA (Phorbol 12-
myristate 13-acetate), the cells differentiate and become adherent, resembling monocytes 
which enter tissue and differentiate into macrophages. After differentiation, the cells no 
longer divide. We tested both differentiated and undifferentiated THP-1 cells. After 6 hours of 
Etoposide treatment, undifferentiated THP-1 cells induced a very low immune response 
(Figure 7a-c). However, by 30 hours of Etoposide treatment, these cells greatly upregulate 
expression of IFN-β, IL-6, and CCL20 mRNA (Figure 7a-c). We then tested differentiated 
THP-1 cells, treated with PMA for 48 hours prior to stimulation with 50μM Etoposide for 6 or 
30 hours, or with 1μg/ml HT-DNA for 6 hours. HT-DNA mediated the largest immune 
response as measured by IFN-β, IL-6, CCL20, and ISG56 mRNA (Figure 7a-d). Relative to 
the HT-DNA values, the Etoposide response appears small, however Etoposide induced a 
fold change in IFN-β mRNA of 12, 89, and 348 at 6, 24, and 36 hours respectively (Figure 
7a). This is a substantial upregulation of IFN-β mRNA expression. Etoposide treatment in 
differentiated THP-1 cells did not lead to high levels of cell death as measured by cytotoxicity 
assay at 24 hours, but this increased significantly by 36 hours’ post-treatment (Figure 7e).  
3.5 Various genotoxic agents induce an innate immune response in human 
keratinocytes 
To test if the response observed is unique to Etoposide, various other DNA damaging 
agents, inducing distinct DNA lesions, were also tested. Cisplatin is a platinum complex 
which mediates interstrand and intrastrand crosslinks in DNA between purine bases 
(Eastman, 1987). Cisplatin was tested at 50μM and 100μM, based on reports in the literature 
(Zhang, 2010). Over a 10-hour timecourse, the higher concentration of Cisplatin was found 
to induce Type-I IFN induction in HaCaT cells (Figure 8a). Mitomycin C (MMC), an alkylating 




Figure 8: Various genotoxic agents induce an innate immune response in human 
keratinocytes.  
a. WT HaCaT were treated with 50μM or 100μM Cisplatin as indicated over a 10-hour 
timecourse, before lysis for qRT-PCR analysis of mRNA expression of IFN-β.  
b. WT HaCaTs were treated with DMSO, 0.25mM or 0.5mM Mitomycin C for indicated 
times over a 10-hour timecourse before lysis for qRT-PCR analysis of IFN-β mRNA.  
c. WT HaCaTs were treated with DMSO, 5μM, 25μM, or 50μM Camptothecin for 6 hours 
before lysis for qRT-PCR analysis of IFN-β mRNA.  
d, e. WT HaCaTs were treated with 0.25mM or 0.5mM Hydroxyurea as indicated over a 
10-hour timecourse before lysis for qRT-PCR analysis of IFN-β mRNA (d). Supernatants 
were taken from 0 hours and 10 hours at 0.5mM HU samples for quantification of IL-6 
production by ELISA (e).  
f. WT HaCaTs were treated with UV-C at 5mJ/cm2, 10mJ/cm2, or 20mJ/cm2 over a 6-hour 
timecourse before lysis for qRT-PCR analysis of IFN-β mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviation. Data are representative of at least two experiments. 
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including breast, head and neck, and lung cancers (Bradner, 2001). MMC was tested at 
0.25mM and 0.5mM, based on reports in the literature, over 10 hours, and found to induce 
much less Type-I IFN than etoposide or cisplatin (Figure 8b). Camptothecin is a 
topoisomerase I inhibitor, which forms a ternary complex between the topoisomerase I 
enzyme and DNA (Hsiang, 1985). We tested Camptothecin at various concentrations over 6 
hours and found it to induce a modest Type-I IFN response (Figure 8c). Hydroxyurea (HU) 
prevents synthesis of dNTPs by inhibiting the ribonucleotide reductase enzyme, preventing 
the function of DNA polymerase during DNA replication, resulting in cellular stress (Koç, 
2003). HU was used at 0.25mM and 0.5mM over 10 hours and resulted in modest induction 
of Type-I IFNs (Figure 8d). Hydroxyurea also induced substantial IL-6 protein production 
(Figure 8e). UV radiation is a type of DNA damage which induces pyrimidine dimers and 
induce photoproducts in DNA which can lead to helical distortion and prevents normal DNA 
replication (Jiang, 2009). UV radiation can be very damaging to skin cells and is linked to the 
development of a variety of skin cancers (Armstrong, 2001; Pleasance, 2009). WT HaCaTs 
responded to UV radiation with production of IFN-β mRNA (Figure 8f). The kinetics of this 
response was in a shorter timeframe than with etoposide. This indicates that different types 
of damage, which are repaired in different ways, could lead to immune response induction by 
varying routes and response kinetics. 
3.6 Conclusions 
Nucleic acids constitute a major molecular pattern that is recognized during infection with 
viruses and intracellular bacteria. The existence of nuclear dsDNA receptors has prompted 
the question of how self-DNA is differentiated from foreign DNA in the cell. Especially in the 
case of DNA damage, it is unknown how the immune response to this altered self-DNA is 
controlled. Here we show that the damage of DNA by Etoposide induces an innate immune 
response in primary and immortalised human keratinocytes (Figure 1, Figure 5). This 
immune response was also observed in primary human fibroblasts and human monocytes 
(Figure 6, Figure 7). Cisplatin, Hydroxyurea, Mitomycin C, and UV radiation induced similar 
immune responses to varying degrees (Figure 8). Given the wide range of DNA damage 
repair machinery that exists to recognise many different types of DNA lesion, it is possible 
that components of these repair pathways are involved. In keratinocytes, and fibroblasts, this 
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immune induction occurred before any signs of cytotoxicity were detected (Figure 3). No 
DNA leakage or nuclear protein leakage into the cytoplasm could be detected in the hours 
within the timeframe of Etoposide treatment (Figure 4). This indicates that this innate 
immune response arises in intact living cells.  
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Chapter 4 – IFI16 is required for the innate immune 
response to DNA damage 
4.1 IFI16-deficient HaCaT cell characterisation   
We next asked how the innate immune response to DNA damage was mediated, and what 
immune receptors could be involved. We hypothesised that the response to double stranded 
self-DNA in the nucleus may share similarities with the pathway that responds to double 
stranded foreign DNA in the cytoplasm. IFI16 has previously been shown to have a role in 
the innate immune response to double stranded DNA (Unterholzner, 2010; Almine, 2017). 
IFI16 is predominantly nuclear, but has been shown to shuttle between the nucleus and the 
cytoplasm (Li, 2012). IFI16 has two DNA binding HIN domains which have been shown to 
bind to both ssDNA and dsDNA (Dawson, 1996; Unterholzner, 2010). Despite binding to 
ssDNA with high affinity, only IFI16 binding to dsDNA induces Type-I IFN production 
(Unterholzner, 2010; Morrone, 2014). IFI16 has been shown to cooperate with the enzyme 
cGAS to activate STING after the detection of intracellular DNA (Almine, 2017; Jønsson, 
2017). 
IFI16 was therefore one of the first candidates tested to have a role in the innate immune 
response to DNA damage. IFI16-/- HaCaT cells were previously generated by L. 
Unterholzner using TALENs (Transcription Activator-Like Effector Nuclease). These cells 
were tested for expression of other DNA sensors and they were found to make a normal 
DNA damage response as seen by phosphorylation of H2AX upon damage (Figure 9a and 
9b). To test if IFI16-/- cells could repair damaged DNA as efficiently as WT cells, we 
performed a clonogenic survival assay. In this assay, cells are separated into single cells 
and seeded in 6-well plates, at around 2000 cells per well. Very soon after attaching, the 
cells are treated with varying concentrations of a DNA damaging agent and then left to grow 
for 7-10 days. At the end of this time, the number of colonies with more than 50 cells is 
counted and these numbers are compared between the different conditions. Colony 
formation indicates that the single cell that was damaged has repaired the damage and 
entered the cell cycle. Upon performing the clonogenic survival assay, we found that IFI16-/- 




Figure 9: IFI16-deficient HaCaT cell characterisation. 
a. Wild type HaCaT keratinocyte cells and two HaCaT clonal cell lines with a genetic deletion 
of IFI16 (IFI16-/-) were treated with 50μM Etoposide or DMSO control for 6 hours before lysis. 
Lysates were then analysed for protein expression by Western Blot. 
b. WT HaCaTs were seeded onto coverslips and treated with 50μM Etoposide for 30 
minutes, 1 hour, or left untreated. Coverslips were then washed in PBS and pre-cleared for 2 
minutes in 0.5% Triton-X/PBS before 10 minutes of methanol fixation. Cells were then 
permeabilised, incubated in blocking buffer and stained for IFI16 (red) and yH2AX (green) 
and analysed by confocal microscopy. Scale bar = 10μm. 
c. WT and IFI16-/- HaCaTs seeded in single cell colonies and treated with 0μM, 0.25μM, or 
0.5μM of Etoposide for 10 days, were analysed for colony survival, by counting colonies that 
grew to >50 cells. 
d. qRT-PCR analysis of p21/Waf1 mRNA expression in WT or IFI16-/- HaCaT cells 6h post 
treatment with 50μM Etoposide.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. ns = non-significant, p>0.05, as determined by Student’s T test. Data are 




Figure 10: IFI16 colocalises with the nucleoli marker Fibrillarin 
Wild type and IFI16-/- HaCaT keratinocyte cells were seeded onto coverslips and treated 
with 50μM Etoposide for indicated times. Coverslips were then washed in PBS and pre-
cleared for 2 minutes in 0.5% Triton-X/PBS before 10 minutes of methanol fixation. Cells 
were then permeabilised, incubated in blocking buffer and stained for IFI16 (red) and 
Fibrillarin (green) and analysed by confocal microscopy. Scale bar = 20μm. 
Data are representative of at least two experiments. 
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than WT cells after DNA damage, indicating that they could repair themselves just as well if 
not better than WT cells (Figure 9c). This is in line with the reported role of IFI16 as a 
senescence factor, and its removal promoting cellular replication (Xin, 2003).  IFI16-/- 
HaCaTs also showed activation of p21/Waf1 after Etoposide treatment, comparable to WT 
cells (Figure 9d). The confocal microscopy showed that IFI16 did not colocalise with γH2AX, 
and pre-clearing coverslips with 0.5% Triton-X/PBS before fixation showed that IFI16 mainly 
localised to distinct nuclear foci, resembling a nuclear body similar to nucleoli. To confirm 
this localisation, co-staining with the nucleolar marker Fibrillarin was performed (Figure 10). 
4.2 IFI16 is essential for the innate immune response to DNA damage in human 
keratinocytes 
We then tested the innate immune response of these IFI16-/- cells to DNA damage. 
Compared to WT HaCaT cells, IFI16-/- HaCaT cells showed a significantly reduced immune 
response to Etoposide as measure by IFN-β mRNA by real-time PCR (Figure 11a) and 
Type-I IFN protein using an IFN bioassay (Figure 11b). This was also the case with IL-6 
mRNA measure by real-time PCR (Figure 11c) and IL-6 protein as quantified by ELISA 
(Figure 11d). IFI16-/- cells also had a significant decrease in CCL20 mRNA measured by 
real-time PCR after Etoposide treatment compared to WT cells (Figure 11e). IFI16-/- HaCaTs 
also show a reduced response to transfected DNA but an intact response to transfected 
Poly(I:C) (Figure 11a, c, e) as has been previously reported (Almine, 2017; Jønsson, 2017), 
showing that IFI16-/- cells are still about to mount an immune response but are specifically 
impaired in their response to exogenous DNA and DNA damage. In one IFI16-/- clone, the 
response to Poly(I:C) was in fact significantly increased (Figure 11e). By comparing 
Etoposide and stimulation with transfected dsDNA, HT-DNA, it can be seen that while both 
induce IFN-β to the same extent under these conditions; the responses diverge in regards to 
other cytokines. Etoposide induces a robust NFκB response as seen by IL-6 activation, 
whereas HT-DNA induces this to a lesser extent. Strikingly, Etoposide induces robust CCL20 
production, whereas HT-DNA stimulation does not. This could indicate that while similar, 
these two stimuli may activate divergent immune pathways. These responses were validated 




Figure 11: IFI16 is essential for the innate immune response to DNA damage in human 
keratinocytes. 
a. WT and 2 clones of IFI16-/- HaCaTs were treated with DMSO control, 50μM Etoposide, 
Lipofectamine control, 1μg/ml HT-DNA, or 200ng/ml Poly(I:C) for 6 hours before lysing cells 
for qRT-PCR analysis of IFN-β mRNA. 
b. WT and IFI16-/- HaCaTs treated with 50μM Etoposide over a 36 hour timecourse, after 
which their supernatants were taken for quantification of Type-I IFN by IFN Bioassay. 
c. WT and 2 clones of IFI16-/- HaCaTs were treated as in (a) and lysed for qRT-PCR analysis 
of IL-6 mRNA.  
d. WT and IFI16-/- HaCaTs treated with 50μM Etoposide over a 24 hour timecourse, after 
which their supernatants were taken for quantification of IL-6 by ELISA. 
e. WT and 2 clones of IFI16-/- HaCaTs were treated as in (a) and lysed for qRT-PCR analysis 
of CCL20 mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = Non-significant, p>0.05; * p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001 as 
determined by Student’s t-test. Data are representative of at least two experiments in two 




Figure 12: IFI16 is essential for p65 translocation after DNA damage 
a. WT and IFI16-/- HaCaT cells grown on cover slips were stimulated with mock (DMSO), or 
50μM Etoposide for 3h. Cells were fixed and stained for p65 (green) and DNA (DAPI, blue). 
Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total cells. 
Data are presented as mean values of 5 different field of view of at least 50 cells each. Error 
bars indicate standard deviations. *** p≤0.001 as determined by Student’s t-test. Data are 




Figure 13: IFI16 is essential for the innate immune response to other DNA damaging 
agents in human keratinocytes. 
a. WT and IFI16-/- HaCaT keratinocytes untreated (UT) or treated with 10mJ/cm2 UV 
were left to recover for indicated times post-UV before lysis for qRT-PCR analysis of IFN-
β mRNA. 
b. WT and IFI16-/- HaCaT keratinocytes treated with DMSO or 5μM Camptothecin (CPT) 
for 6 hours before lysis for qRT-PCR analysis of IFN-β mRNA. 
c. WT and IFI16-/- HaCaT keratinocytes treated with DMSO or 10μM Cisplatin for 12 
hours then lysed for qRT-PCR analysis of IFN-β mRNA. 
d. WT and IFI16-/- HaCaT keratinocytes treated with DMSO or 500nM Hydroxyurea (HU) 
for 6 hours before lysis for qRT-PCR analysis of IFN-β mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. * p≤0.05, ** p≤0.01 as determined by Student’s t-test. Data are representative 
of at least two experiments in two independent IFI16-deficient cell clones. 
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We next looked to see the effect of IFI16 deficiency on signalling factors which could account 
for this decrease in immune induction in IFI16-/- cells. NFκB is known to be activated upon 
DNA damage, and we observe robust activation of IL-6 transcription which depends on 
NFκB, therefore we observed the translocation of NFκB subunit p65 by confocal microscopy. 
Upon Etoposide treatment, p65 was observed to translocate from its position predominantly 
in the cytoplasm to the nucleus of the cell in many of the cells observed (Figure 12a, b). This 
translocation was ablated in IFI16-/- cells (Figure 12a, b). This indicates that IFI16 has an 
effect at the signalling level of immune induction in response to DNA damage. 
4.3 IFI16 is essential for the innate immune response to other DNA damaging agents 
in human keratinocytes 
We then tested IFI16-/- HaCaTs with other DNA damaging agents. Upon treatment with 
10mJ/cm2 UV-C radiation, WT cells made a modest IFN-β mRNA response by 3 hours’ post-
treatment, and this response was significantly reduced in IFI16-/- HaCaTs (Figure 13a). 
When tested with Camptothecin (CPT), IFI16-/- cells also responded significantly less than 
WT cells (Figure 13b). This phenotype was consistent with Cisplatin (Figure 13c) and 
Hydroxyurea (Figure 13d). UV, Camptothecin, Cisplatin, and Hydroxyurea all induce 
different types of DNA damage, so this indicates that different mechanisms of DNA damage 
share common immune signalling pathways that involve IFI16. 
4.4 IFI16 is essential for the innate immune response to DNA damage in primary 
human keratinocytes. 
HaCaTs are a spontaneously immortalised keratinocyte cell line (Boukamp, 1988). To see if 
this was response was relevant in a tissue culture model more closely representative of 
human skin, we used NHEK (Human Epidermal Keratinocyte) cells. NHEKs are primary cells 
taken from adult human donors. Using IFI16 specific siRNA, and non-targeting (NT) siRNA 
as a control, IFI16 protein levels were knocked down in NHEK cells, as can be seen by 
western blot (Figure 14a). The involvement of IFI16 in the innate immune response to 
Etoposide was confirmed in NHEK cells, with both IFN-β mRNA and IL-6 mRNA as outputs 
(Figures 14b, c). This was also observed in primary human keratinocytes treated with UV 








Figure 14: IFI16 is essential for the innate immune response to DNA damage in primary 
human keratinocytes. 
a. Primary human keratinocytes (NHEKs) were treated with non-targeting (NT) siRNA or 
IFI16-depleting siRNA for 48 hours. Cells were then stimulated with Etoposide or DMSO 
control for 6 hours prior to cell lysis. Lysates were analysed for protein expression by 
Western Blotting.  
b, c. Cells treated as in (a) were lysed for qRT-PCR and mRNA expression of IFN-β (b) 
and IL-6 (c) was measured. 
d. Primary human keratinocytes (NHEKs) treated with non-targeting (NT) siRNA or IFI16-
depleting siRNA for 48 hours were then stimulated with 10mJ/cm2 UV or Mock, and 
allowed to recover in fresh media for 3 hours prior to cell lysis. Lysates were analysed for 
protein expression by Western Blotting.  
e, f. Cells treated as in (d) were lysed for qRT-PCR and mRNA expression of IL-6 (e) and 
CCL20 (f) was measured.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. * p≤0.05; *** p≤0.001 as determined by Student’s t-test. Data are 




Figure 15: IFI16 is essential for the innate immune response to DNA damage in primary 
human fibroblasts. 
a. Primary human fibroblasts (MRC-5s) were treated with non-targeting (NT) siRNA or IFI16-
depleting siRNA for 48 hours. Cells were then stimulated with Etoposide or DMSO control for 
6 hours prior to cell lysis. Lysates were analysed for protein expression by Western Blotting.  
b-d. Cells treated as in (b) were lysed for qRT-PCR and mRNA expression of IFN-β (c) and 
IL-6 (d) was measured.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. * p≤0.05; ** p≤0.01 as determined by Student’s t-test. Data are representative of at 
least two experiments. 
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early innate immune response to DNA damage in primary and immortalised human 
keratinocytes. 
4.5 IFI16 is essential for the innate immune response to DNA damage in primary 
human fibroblasts.  
To test if this response was specific to keratinocytes, we then looked to test human 
fibroblasts. For this we used primary human embryonic lung fibroblast (MRC-5) cells. Using 
IFI16 specific siRNA, and non-targeting (NT) siRNA as a control, IFI16 levels were knocked 
down in MRC-5 cells, as can be seen by western blot (Figure 15a). The innate immune 
response to Etoposide in MRC-5 cells was less than those seen in HaCaT cells and NHEK 
cells. Despite this, the reduction in response in IFI16 siRNA treated cells was still significant 
when measuring IFN-β mRNA (Figure 15b), IL-6 mRNA (Figure 15c), and CCL20 mRNA 
(Figure 15d).  
4.6 Conclusions 
Our results show that in immortalised and primary human keratinocytes, deficiency or 
knockdown of IFI16 led to a significant decrease in the innate immune response to 
Etoposide (Figure 11, Figure 12, Figure 14). This effect was reflected in the lack of 
signalling factor activation, and the decrease in inflammatory cytokine production by mRNA 
and protein analysis. IFI16 was also essential for the innate immune response to Etoposide 
in primary human fibroblasts (Figure 15). Other genotoxic agents, camptothecin, cisplatin, 
hydroxyurea, and UV radiation, with diverse mechanisms of DNA damage also induced 
innate immune responses dependent on IFI16 in human keratinocytes (Figure 13). We 
observed that IFI16 did not colocalise with γH2AX foci at the site of damage, but instead 
remained in distinct nuclear foci which we found to co-stain with the nucleolar marker 
fibrillarin (Figure 9, Figure 10). This data indicates that IFI16 is essential for the innate 




Chapter 5 – STING is required for the innate immune 
response to DNA damage 
5.1 Generating STING-deficient HaCaT cells and STING-deficient cell characterisation 
We next asked whether other components of the cytosolic sensing pathway were involved. 
IFI16 has been reported to signal through STING (Almine, 2017). IFI16 has been reported to 
signal through STING (Unterholzner, 2010; Almine, 2017) but has also been reported to 
have STING-independent functions in DNA damage and senescence (Xin, 2003). We 
therefore decided to test the involvement of STING in the innate immune response to DNA 
damage to determine if IFI16 was signalling through STING. To study the role of STING in 
this response, we first used STING-targeting siRNA, to knock down STING levels in HaCaT 
cells, and this was confirmed at the mRNA and protein level (Figure 16a, b). The STING gel 
mobility shift observed in HT-DNA treated lanes is indicative of activation-induced STING 
phosphorylation (Tanaka, 2012). When compared with non-targeting siRNA treated cells, 
STING knockdown cells had significantly reduced responses to Etoposide treatment as 
measured by IFN-β mRNA (Figure 16c), and CCL20 mRNA (Figure 16e). The IL-6 mRNA 
response in STING siRNA treated cells was decreased but not significantly so, this could be 
an authentic phenotype or due to incomplete knockdown of STING protein (Figure 16d). 
These results indicated that STING contributes to the Etoposide-induced innate immune 
response. A slight decrease in H2AX phosphorylation was also observed in STING siRNA 
treated cells (Figure 16a). 
To validate the siRNA results, we then generated STING-null HaCaT cells. This was done 
using CRISPR (Clustered regularly interspaced short palindromic repeat) Cas9 (CRISPR 
associated protein 9) technology. Cas9 is a DNA endonuclease which works, in prokaryotes, 
together with CRISPR sequences specific to pathogens, to defend against viral infection 
(Barrangou, 2007). This technology has been co-opted for use in genome editing in a wide 
variety of biological systems (Carroll, 2011). CRISPR works by transfecting a guide RNA 
targeting the gene of interest, as well as the Cas9 coding sequence. The Cas9 nuclease 
complexes with the guide RNAs which target the nuclease activity to cleave sequence 




Figure 16: STING siRNA verification in HaCaTs 
a, b. WT HaCaT cells were treated with Non-targeting (NT) siRNA or STING-targeting 
siRNA for 48 hours before treatment with DMSO control, 50μM Etoposide, 
Lipofectamine, or 1μg/ml HT-DNA. Cells were then lysed and analysed for protein 
expression by western blot (a) or STING mRNA expression by qRT-PCR (b).  
c-e. Cells treated with siRNA as in (a) were then stimulated with DMSO or 50μM 
Etoposide for 6 hours before lysis and quantification of IFN-β mRNA (c), IL-6 mRNA (d), 
or CCL20 mRNA (e) by qRT-PCR.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; ** p≤0.01, as determined by Student’s t-test. 
Data are representative of at least two experiments. 
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Wild type Cas9 nucleases produce double-stranded breaks in the target site, stimulating 
repair by either Non-Homologous End Joining, a faster but more error-prone mechanism, or 
Homologous Recombination. NHEJ can elicit a range of mutations or deletions at the site of 
the DNA break. The errors generated by NHEJ vary in size but even a small repair error can 
result in a frameshift mutation which is sufficient to be deleterious to the gene. This repair 
process can lead to the generation of cells deficient or mutated in the gene of interest 
(Figure 17). WT HaCaT cells were transfected with plasmids encoding Cas9, puromycin 
resistance genes, and two guide RNAs targeting the start of STING exon 3. Transfected and 
mock-transfected cells were then treated with puromycin over several days to eliminate cells 
which were not transfected. Selected cells were then left to recover for some days before 
they were seeded for clonal selection with approximately one cell per well in several 96-well 
plates. These clones were grown for several weeks or until wells appeared confluent. Plates 
were then split into three new plates; the first to continue growing clones, the second a PCR 
plate to test clones by HRM (High Resolution Melting), the third to be tested for protein 
expression by western blot. This process is simplified in Figure 17. By HRM, the DNA of 
each CRISPR clone was amplified around the site of the guide RNA. Any mutations in this 
sequence compared to WT cells should appear as a shift or an alteration in melt peaks 
(Ririe, 1997; Gundry, 2003). HRM increases the temperature of samples very slowly and 
precisely after PCR amplification under the two strands of amplicon DNA have separated. 
For two amplicons of the same sequence, the DNA should separate at the same 
temperature. Mutations in the DNA can alter the temperature at which the DNA strands 
separate or “melt” and when this occurs, the dye bound to dsDNA stops fluorescing, a 
process which is measurable. An example of these melt curves is shown in Figure 17c. 
HRM candidates were selected which differ in melt curve appearance from WT samples. The 
corresponding clones were then lysed for analysis of target protein expression by western 
blot (Figure 17d). Any clones which did not show expression of the target protein but did 
express the loading control β-actin were then moved from 96-well plates into 6-well plates 
and subsequently 25cm2 flasks. When sufficient cells were propagated, clones underwent a 
functional test, stimulation with transfected HT-DNA or lipofectamine control because 




Figure 17: STING-/- cell generation 
a. Diagram of STING-targeting guide RNAs used in combination with Cas9 to generate 
deleterious mutations in the STING gene in WT HaCaT cells. 
b. Schematic showing the workflow used for Cas9 clone generation. 
c. Examples of normalised melt peaks from HRM analysis of WT cells and STING 
mutant candidates. DNA extracted from CRISPR-Cas9 transfected cell clones are 
amplified using primers specific to the guide RNA target site before high-resolution 
melting and analysis of melt curves to identify possible mutations. 
d. An example of western blot screening of HRM candidates, further screened for STING 
protein expression. 
e. An example of qRT-PCR screening of candidates that test negative for protein 
expression by western blot. WT and candidate clone HaCaT cells were treated with 
lipofectamine control (Lipo), or 1μg/ml HT-DNA (HT) for 6 hours before lysis for qRT-





Figure 18: STING-/- cell characterisation. 
a. Wild type HaCaT keratinocyte cells and 2 clonal HaCaT cell lines with a genetic deletion of 
STING (STING-/-) were treated with 50μM Etoposide or DMSO control for 6 hours before lysis. 
Lysates were then analysed for protein expression by Western Blot.  
b.  WT and STING-/- HaCaTs seeded in single cell colonies and treated with 0μM, 0.1μM, or 
0.2μM of Etoposide for 10 days, were analysed for colony survival, by counting colonies that 
grew to >50 cells. 
c. qRT-PCR analysis of p21/Waf1 mRNA expression in WT or STING-/- HaCaT cells 6h post 
treatment with 50µM Etoposide.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05 as determined by Students t-test. Data are 
representative of at least two experiments in two independent STING-deficient cell clones. 
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2009). These cells were compared to stimulated WT cells by qRT-PCR (Figure 17e). Cells 
that passed this test were continued. Two STING-deficient cell clones were carried forward 
and tested for expression of other DNA sensors and they were found to make a normal DNA 
damage response as seen by phosphorylation of H2AX upon damage, however this was 
slightly reduced compared to WT cells (Figure 18a). This is similar to what was observed in 
STING-targeting siRNA treated cells (Figure 16a). By clonogenic survival assay we found 
that WT and STING-/- cells had no difference in cell colonies numbers after Etoposide 
treatment, indicating that they could repair themselves just as well as WT cells (Figure 18b). 
STING-/- HaCaTs also showed activation of p21/Waf1 after Etoposide treatment, comparable 
to WT cells (Figure 18c). 
5.2 STING is essential for the innate immune response to DNA damage 
To test the role of STING in the innate immune response to DNA damage, we stimulated WT 
and STING-/- HaCaTs with DMSO, 50μM Etoposide, Lipofectamine, or 1μg/μl HT-DNA. 
Compared to WT HaCaT cells, STING-/- HaCaT cells showed a significantly reduced immune 
response to Etoposide as measure by IFN-β mRNA measured by real-time PCR (Figure 
19a) and Type-I IFN protein by IFN Bioassay (Figure 19b). This was also the case with IL-6 
mRNA (Figure 19c) and secreted IL-6 protein (Figure 19d) measured by real-time PCR and 
ELISA respectively, and CCL20 mRNA (Figure 19e) measured by real-time PCR. STING-/- 
HaCaTs also show a reduced response to transfected DNA but an intact response to 
transfected Poly(I:C) (Figure 19a) and in the case of IL-6 mRNA and CCL20 mRNA, STING-
/- cells showed a slightly increased response to Poly(I:C) (Figure 19c, e). These responses 
were validated in two cell clones. 
As with IFI16, we then looked to see the effect of STING deficiency on NFκB signalling 
factors to account for the observed decrease in immune induction. Upon Etoposide 
treatment, NFκB-p65 was observed to translocate from the cytoplasm to the nucleus, by 
confocal microscopy in the majority of cells (Figure 20a, b). This translocation was ablated 
in STING-/- cells (Figure 20a, b). This indicates that STING is working at the level of 




Figure 19: STING is essential for the innate immune response to DNA damage 
a. WT and 2 clones of STING-/- HaCaTs were treated with DMSO control, 50μM Etoposide, 
Lipofectamine control, 1μg/ml HT-DNA, or 200ng/ml Poly(I:C) for 6 hours before lysing cells 
for qRT-PCR analysis of IFN-β mRNA. 
b. WT and STING-/- HaCaTs were treated with 50μM Etoposide or DMSO for 24 hours, after 
which their supernatants were taken for quantification of Type-I IFN by IFN Bioassay. 
c,d. WT and 2 clones of STING-/- HaCaTs were treated as in (a) and lysed for qRT-PCR 
analysis of IL-6 mRNA (c) and supernatants taken for IL-6 protein quantification by ELISA 
(d). 
e. WT and 2 clones of STING-/- HaCaTs were treated as in (a) and lysed for qRT-PCR 
analysis of CCL20 mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05; ** p≤0.01; *** p≤0.001, as determined 
by Student’s t-test. Data are representative of at least two experiments in two independent 





Figure 20: STING is essential for p65 translocation after DNA damage 
a. WT and STING-/- HaCaT cells grown on cover slips were stimulated with mock 
(DMSO), or 50μM Etoposide for 3 hours. Cells were fixed and stained for p65 (green) 
and DNA (DAPI, blue). Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total 
cells.  
Data are presented as mean values of 5 different field of view of at least 50 cells each. 
Error bars indicate standard deviations. *** p≤0.001 as determined by Student’s t-test. 




5.3 STING is essential for the innate immune response to DNA damage in primary 
keratinocytes 
The importance of STING in keratinocytes was then tested in primary NHEK keratinocyte 
cells. Using STING-specific siRNA, and non-targeting (NT) siRNA as a control, STING levels 
were knocked down in NHEK cells, and this was verified by western blot (Figure 21a). The 
involvement of STING in the innate immune response to Etoposide was confirmed in NHEK 
cells, with both IFN-β mRNA and IL-6 mRNA as outputs (Figures 21b, c). Together, these 
findings show that STING is necessary for the early innate immune response to DNA 
damage in primary keratinocytes. 
5.4 STING is essential for the innate immune response to DNA damage in primary 
human fibroblasts  
To test if this response was specific to keratinocytes, we then tested MRC-5 fibroblasts. 
Using STING-targeting siRNA, and non-targeting (NT) siRNA as a control, STING levels 
were knocked down in MRC-5 cells, as can be seen by western blot (Figure 22a). As we 
have previously seen, the MRC-5 fibroblasts make a modest immune response to Etoposide. 
In STING siRNA treated MRC-5 cells there was a significant reduction in IFN-β mRNA 
(Figure 22b) and IL-6 mRNA (Figure 22c) as measured by real-time PCR. The CCL20 
mRNA response in STING-knockdown cells was reduced but not significantly so (Figure 
22d). This could be due to insufficient knock down.  
5.5 Conclusions 
The adaptor protein STING has been shown to be essential for the immune response to 
foreign dsDNA in a variety of cell types (Ishikawa, 2009). IFI16 has also been shown to be 
necessary in a STING-dependent pathway in several cell types in response to viruses such 
as HSV, intracellular bacteria, and transfected dsDNA (Unterholzner, 2010; Hansen, 2014; 
Almine, 2017). We found that STING is essential for the innate immune response to DNA 
damage using siRNA (Figure 16) and STING-deficient cells (Figure 19). STING-deficient 
cells were unable to induce a Type-I IFN response after either Etoposide or dsDNA 





Figure 21: STING is essential for the innate immune response to DNA damage in primary 
keratinocytes.  
a. NHEK primary keratinocytes were treated with Non-targeting (NT) siRNA or STING-targeting 
siRNA for 48 hours before treatment with DMSO control or 50μM Etoposide for 6 hours. Cells 
were then lysed and analysed for protein expression by western blot.  
b-d. Cells were treated as in (a) and lysed for qRT-PCR analysis and quantification of IFN-β 
mRNA (b), IL-6 mRNA (c), and CCL20 mRNA (d).  
Data are presented as mean values of biological triplicates. Error bars indicate standard 





Figure 22: STING is essential for the innate immune response to DNA damage in primary human 
fibroblasts. 
a. MRC-5 primary keratinocytes were treated with Non-targeting (NT) siRNA or STING-targeting 
siRNA for 48 hours before treatment with DMSO control or 50μM Etoposide for 6 hours. Cells 
were then lysed and analysed for protein expression by western blot.  
b-d. Cells were treated as in (a) and lysed for qRT-PCR analysis and quantification of IFN-β 
mRNA (b), IL-6 mRNA (c), and CCL20 mRNA (d).  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05, as determined by Student’s t-test. Data are 
representative of at least two experiments. 
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keratinocytes (Figure 21) and fibroblasts (Figure 22). Together, this data shows that STING, 
as well as IFI16, is important in the innate immune response to DNA damage. STING-
deficient and STING siRNA treated cells both showed slightly reduced levels of γH2AX hours 
after etoposide treatment (Figure 16a, Figure 18a). Further investigation into a possible 




Chapter 6 – cGAS is not required for the innate 
immune response to DNA damage 
6.1 Generation of cGAS-deficient HaCaT cells 
The DNA receptor cGAS has been shown many times to be essential for the innate immune 
response to double stranded DNA, transfected or in the context of DNA viruses and 
intracellular bacteria, in both cGAS-deficient human cell lines, and cGAS-/- mice (Sun, 2013; 
Hansen, 2014; Li, X.D., 2013). IFI16 has been shown to be involved in the cGAS-STING 
DNA sensing pathway as well (Unterholzner, 2010; Hansen, 2014; Almine, 2017). We 
therefore wanted to test whether cGAS was necessary for the immune response observed to 
DNA damage. To study the role of cGAS in the innate immune response to DNA damage, 
we knocked down cGAS levels in HaCaT cells using cGAS-targeting siRNA (Figure 22a). 
When compared with non-targeting siRNA treated cells, cGAS knockdown cells had 
significantly reduced responses to transfected HT-DNA (Figure 23b). However, the immune 
response to Etoposide treatment was intact as measured by IFN-β mRNA (Figure 23b), IL-6 
mRNA (Figure 23c), CCL20 mRNA expression (Figure 23d) using real-time PCR. These 
results indicated that cGAS, while essential for the immune response to transfected DNA, 
was dispensable for the innate immune response to Etoposide-induced DNA damage. 
To confirm these findings, we generated cGAS-null HaCaT cells. This was done using 
CRISPR Cas9 and guide RNA targeted to cGAS exon 1 (Figure 24a). The process of  
cGAS-/- cell generation was the same as discussed in the previous chapter for STING-/- cells 
as discussed in Figure 17. WT HaCaT cells were transfected with Cas9 and cGAS-targeting 
guide RNAs, selected with puromycin and then clonally selected by seeding the transfected 
cell pool as single cells (Figure 24b). CRISPR clones were then screened by HRM (Figure 
24c), western blotting (Figure 24d), and functional tests using transfected HT-DNA as a 
control (Figure 24e).  
These cGAS-/- HaCaT cells were tested for expression of other DNA sensors and they were 
found to make a normal DNA damage response as seen by phosphorylation of H2AX upon 
damage (Figure 25a). cGAS-/- HaCaTs were also capable of activating p21/Waf1 after DNA 




Figure 23: cGAS siRNA verification in HaCaT cells 
a. WT HaCaT cells were treated with Non-targeting (NT) siRNA or cGAS-targeting 
siRNA for 48 hours before treatment with DMSO control, 50μM Etoposide, 
Lipofectamine, or 1μg/ml HT-DNA. Cells were then lysed and analysed for protein 
expression by western blot.  
b-d. Cells treated as in (a) were lysed for qRT-PCR expression of IFN-β (b), IL-6 (c), 
and CCL20 (d) mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate 
standard deviations. N.s. = non-significant, p>0.05; * p≤0.05, as determined by 
Student’s t-test. Data are representative of at least two experiments. 
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6.2 cGAS deficient cell response   
We then tested these cGAS-/- HaCaT cells for their ability to induce an immune response to 
transfected DNA and Etoposide treatment. In line with the cGAS siRNA results, despite 
showing a significantly reduced immune response to HT-DNA, cGAS-deficient cells 
produced a robust immune response to Etoposide, comparable to WT HaCaTs as measured 
by IFN-β mRNA (Figure 26a) and Type-I IFN protein (Figure 26b). This was also the case 
with IL-6 mRNA (Figure 26c), CCL20 mRNA (Figure 26e), and ISG56 mRNA (Figure 26f) 
as measured by real-time PCR, and IL-6 protein (Figure 26d) measured by ELISA. cGAS-/- 
cells were capable to producing an immune response to Poly(I:C) equivalent to or greater 
than WT cells (Figure 26a, c, d, f). 
We then looked to see if cGAS deficiency had any effect on signalling factors despite its lack 
of impact on immune induction. Upon Etoposide treatment, p65 was observed to translocate 
from the cytoplasm to the nucleus, by confocal microscopy, in most cells observed (Figure 
27a, b). This translocation was comparable in cGAS-/- cells (Figure 27a, b). This indicates 
that cGAS does not have an effect at the signalling level of immune induction in response to 
DNA damage. 
6.3 cGAS is dispensable for the innate immune response to DNA damage in primary 
human fibroblasts 
To test if this phenotype was specific to keratinocytes, we then tested MRC-5 fibroblasts. 
Using cGAS-specific siRNA, and non-targeting (NT) siRNA as a control, cGAS levels were 
knocked down in MRC-5 cells, as can be seen by western blot (Figure 28a). When 
stimulated with transfected HT-DNA, cGAS-depleted cells had significantly reduced immune 
responses as measured by IFN-β mRNA (Figure 28b) and IL-6 mRNA (Figure 28c), as 
compared to NT siRNA treated cells. However, the innate immune response to Etoposide 
was comparable between NT-siRNA and cGAS siRNA treated MRC-5 cells for both IFN-β 







Figure 24: cGAS-/- cell generation 
a. Diagram of cGAS-targeting guide RNAs used in combination with Cas9 to generate 
deleterious mutations in the cGAS exon 1 in WT HaCaT cells. 
b. Schematic showing the workflow used for Cas9 clone generation. 
c. Examples of normalised melt peaks from HRM analysis of WT cells and cGAS mutant 
candidates. DNA extracted from CRISPR-Cas9 transfected cell clones are amplified 
using primers specific to the guide RNA target site before high-resolution melting and 
analysis of melt curves to identify possible mutations. 
d. An example of western blot screening of HRM candidates, further screened for cGAS 
protein expression. 
e. An example of qRT-PCR screening of candidates that test negative for protein 
expression by western blot. WT and candidate clone HaCaT cells were treated with 
lipofectamine control, or 1μg/ml HT-DNA for 6 hours before lysis for qRT-PCR analysis 





Figure 25: cGAS-/- cell characterisation. 
a. Wild type HaCaT keratinocyte cells and 2 clonal HaCaT cell lines with a genetic deletion of cGAS 
(cGAS-/-) were treated with 50μM Etoposide or DMSO control for 6 hours before lysis. Lysates were 
then analysed for protein expression by Western Blot.  
b. qRT-PCR analysis of p21/Waf1 mRNA expression in WT or cGAS-/- HaCaT cells 6h post treatment 
with 50µM Etoposide.  
Data are presented as mean values of biological triplicates. Error bars indicate standard deviations. 
N.s. = non-significant, p>0.05 as determined by Students t-test. Data are representative of at least 
two experiments in two independent cGAS-deficient cell clones. 
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6.4 Detection of endogenous cGAMP by LC-MS   
The main function of cGAS in DNA sensing is as an enzyme in the production of the cyclic 
dinucleotide 2’3’ cGAMP after detection of double stranded DNA in the cytoplasm (Sun, 
2013). Despite the intact immune response observed to Etoposide in both cGAS-deficient 
cells and cGAS-depleted keratinocytes and fibroblasts, we looked for another way to confirm 
our findings that cGAS is not involved in this response. We therefore asked if Etoposide-
induced DNA damage led to the production of cGAMP to a similar level as transfected DNA.  
To do this, cells were stimulated with Etoposide or transfected DNA over various timepoints. 
These cells were then lysed in methanol and underwent a process of butanol extraction to 
concentrate nucleic acids and remove other components of the lysate, before being purified 
in aminopropyl columns. These purified samples were then injected an LC-MS machine, in 
this case a TSQ Quantiva. First the samples are separated by Liquid Chromatography. Then 
the separated samples are sprayed into a mass spectrometer which measures the mass-to-
charge ratio (m/z) of each ion. Endogenous cGAMP levels were quantified in cell extracts 
using this process of Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS) 
utilising multiple reaction monitoring to identify peaks that match the known m/z transitions of 
2’3’ cGAMP and its fragment ions. For full details of the sample preparation and machine 
setting, see Materials and Methods. A simplified schematic of the sample preparation 
process is shown in Figure 29a. Cyclic-di-AMP was added to samples at a known 
concentration as the equivalent of a loading control between samples. Both cGAMP and c-
di-AMP could be detected by this method (Figure 29b). Three m/z transitions were used to 
identify cGAMP, and one was used for c-di-AMP (Fig. 29c).   
To test if 2’3’ cGAMP production was taking place after DNA damage, we measured levels of 
cGAMP by LC-MS/MS, using a c-di-AMP spike-in as an internal standard. The method 
discussed above allowed picogram levels of sensitivity in quantifying cGAMP in cell lysates, 
as seen in the standard curve (Figure 30a). cGAMP was present at very low but detectable 
levels in untreated cells (Figure 30b, c). The level of 2’3’ cGAMP detected was increased in 
cells that had been stimulated with HT-DNA for 4 hours (Figure 30b, c). Despite this 




Figure 26: cGAS is dispensable for the innate immune response to DNA damage 
a. WT and 2 clones of cGAS-/- HaCaTs were treated with DMSO control, 50μM Etoposide, 
Lipofectamine control, 1μg/ml HT-DNA, or 200ng/ml Poly(I:C) for 6 hours before lysing 
cells for qRT-PCR analysis of IFN-β mRNA. 
b. WT and cGAS-/- HaCaTs were treated with 50μM Etoposide or DMSO for 24 hours, after 
which their supernatants were taken for quantification of Type-I IFN by IFN Bioassay. 
c, d. WT and 2 clones of cGAS-/- HaCaTs were treated as in (a) and lysed for qRT-PCR 
analysis of IL-6 mRNA (c) and supernatants taken for IL-6 protein quantification by ELISA 
(d). 
e, f. WT and 2 clones of cGAS-/- HaCaTs were treated as in (a) and lysed for qRT-PCR 
analysis of CCL20 mRNA (e) and ISG56 mRNA (f).  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05; ** p≤0.01; *** p≤0.001 as determined 
by Student’s t-test. Data are representative of at least two experiments in two independent 






Figure 27: cGAS and p65 translocation after DNA damage 
a. WT and cGAS-/- HaCaT cells grown on cover slips were stimulated with mock 
(DMSO), or 50μM Etoposide for 3h. Cells were fixed and stained for p65 (green) and 
DNA (DAPI, blue). Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total 
cells.  
Data are presented as mean values of 5 different field of view of at least 50 cells each. 
Error bars indicate standard deviations. *** p≤0.001 as determined by Student’s t-test. 






Figure 28: cGAS is dispensable for the innate immune response to DNA damage in 
primary human fibroblasts 
a. Primary human fibroblasts (MRC-5s) were treated with non-targeting (NT) siRNA or 
cGAS-depleting siRNA for 48 hours. Cells were then stimulated with Etoposide or DMSO 
control for 6 hours prior to cell lysis. Lysates were analysed for protein expression by 
Western Blotting.  
b-c. Primary human fibroblasts (MRC-5s) were treated with DMSO control, 50μM 
Etoposide, Lipofectamine control, or 1μg/ml HT-DNA for 6 hours before lysing cells for 
qRT-PCR analysis of IFN-β (b) and IL-6 (c) mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; ** p<0.01, *** p<0.001 as determined by 
Student’s t-test. Data are representative of at least two experiments. 
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in cGAMP after 1, 2, or 4 hours of Etoposide treatment (Figure 30b, c). These results can be 
seen represented as picogram values extrapolated from synthetic cGAMP standard curve 
(Figure 30b) or as chromatographs shown side by side with spiked-in c-di-AMP (Figure 
30c). These findings together indicate that the innate immune response to DNA damage 
does not involve cGAS. 
6.5 Conclusions 
In this chapter, we show by siRNA and cGAS-deficient cells, that the enzyme cGAS is not 
necessary for the innate immune response to Etoposide in keratinocytes (Figure 23, Figure 
26, Figure 27). cGAS was also dispensable for the innate immune response to DNA 
damage in primary human fibroblasts (Figure 28). cGAS has been shown to be essential for 
the innate immune response to dsDNA (Sun, 2013) as well as IFI16 (Almine, 2017; Jønsson, 
2017). We confirm in our cells that cGAS is essential for the dsDNA response (Figure 23, 
Figure 26). This is the first report of an IFI16-dependent, STING-dependent pathway which 
is cGAS-independent. In line with this finding, we found that Etoposide, unlike dsDNA, does 
not induce cGAMP production (Figure 30). Together, this data indicates that cGAS is not 




Figure 29: Quantification of endogenous cGAMP by LC-MS 
a. Schematic of the sample processing procedure for the quantification of endogenous cGAMP 
by LC-MS/MS.  
b. Extracted ion chromatographs for synthetic cGAMP and cyclic c-di-AMP standards (50pg 
each).  




Figure 30: Quantification of endogenous cGAMP by LC-MS 
a. Standard curve obtained by LC-MS analysis of synthetic cGAMP standards added to 
untreated cell lysates prior to extraction and sample preparation.  
b. Cells were treated with 50µM Etoposide for the times indicated, or transfected with 1µg/ml 
herring testis DNA for 4h. Endogenous cGAMP present in cell extracts was quantified by LC-
MS/MS, and normalised using synthetic cyclic di-AMP spiked into cell lysates prior to sample 
processing and analysis. Amounts of cGAMP (in pg) were estimated using the standard curve 
in (a). Data are shown as mean values from triplicate biological samples, with error bars 
representing standard deviations. 
c. Total and extracted ion chromatograms for endogenous cGAMP with indicated cell 
stimulation, and cyclic di-AMP standards (50pg).  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; *** p≤0.001, as determined by Student’s t-test. Data 
are representative of at least two experiments. 
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Chapter 7 – DDR factors are required for the innate 
immune response to DNA damage 
7.1 ATM is required for the innate immune response to DNA damage in keratinocytes 
The DNA damage response (DDR) is a complex network of signaling pathways with many 
functions downstream of DNA damage; detection of DNA damage, cell cycle control, the 
initiation of DNA repair, or the instigation of non-inflammatory cell death if the damage is too 
extensive (Ciccia & Elledge, 2010). ATM is a kinase which has been identified as one of the 
primary DDR factors, specialising in the response to DSBs, the principle damage that occurs 
after etoposide treatment (Bakkenist, 2003). ATM has also been reported to be essential for 
NFκB activation after DNA damage (Piret, 1999; Li, 2001). We therefore looked at the role of 
ATM in this pathway after Etoposide treatment by using the ATM inhibitor, KU55933 
(Hickson, 2004). Cells were pre-treated with KU55933 for 1 hour before Etoposide treatment, 
or DMSO vehicle control treatment. ATM inhibitor treatment lead to a reduction in 
phosphorylation of H2AX (γH2AX) and NFκB-p65, as observed by western blot (Figure 31a). 
By qRT-PCR, we observed that pre-treatment with KU55933 significantly reduced the innate 
immune response to etoposide treatment in HaCaTs as measured by IFN-β mRNA (Figure 
31b), IL-6 mRNA (Figure 31c), and CCL20 mRNA (Figure 31d). There was also a 
significant decrease in IL-6 protein with the ATM inhibitor, as measured by IL-6 ELISA 
(Figure 31e). The innate immune response to transfected HT-DNA was intact or, in the case 
of IFN-β mRNA, slightly increased by pre-treatment with ATM inhibitor (Figure 31b, c, d, e). 
We then looked at the effect of the ATM inhibitor on p65 translocation. The nuclear 
translocation of NFκB-p65 in response to Etoposide was ablated in ATM inhibitor treated 
cells (Figure 32a, b). This indicates that ATM is necessary for the activation of NFκB after 
DNA damage, as has been previously reported (Stilmann, 2009). 
7.2 ATM is required for the Etoposide-induced innate immune response in primary 
human keratinocytes 
To test if this phenotype was conserved in primary keratinocytes, we stimulated NHEK cells 




Figure 31: ATM is necessary for the innate immune response to DNA damage 
a. HaCaT cells were treated with ATM inhibitor KU55933 or vehicle control for 1 hour 
before stimulation with DMSO control, or indicated concentrations of Etoposide for 6 
hours before lysis for protein analysis by Western Blot. 
b-d. HaCaT cells were treated with ATM inhibitor KU55933 or vehicle control for 1 hour 
before stimulation with DMSO control, 50μM Etoposide, Lipofectamine control, or 
1μg/ml HT-DNA for 6 hours before lysing cells for qRT-PCR analysis of IFN-β (b), IL-6 
(c), and CCL20 (d) mRNA. 
e. HaCaT cells were treated with ATM inhibitor KU55933 or vehicle control for 1 hour 
before stimulation with DMSO control, 50μM Etoposide, Lipofectamine control, 1μg/ml 
HT-DNA, or 200ng/ml Poly(I:C) for 24 hours after which their supernatants were taken 
for quantification of IL-6 by ELISA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05, ** p≤0.01, *** p≤0.001 as 




Figure 32: ATM is essential for p65 translocation after DNA damage 
a. WT HaCaT cells grown on coverslips were pre-treated with ATM inhibitor for 1 hour, or 
mock treated, before 3 hours of stimulation with mock (DMSO), or 50μM Etoposide. Cells 
were fixed and stained for p65 (green) and DNA (DAPI, blue). Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total cells. 
Data are presented as mean values of 5 different field of view of at least 50 cells each. 
Error bars indicate standard deviations. *** p≤0.001 as determined by Student’s t-test. 
Data are representative of at least two experiments. 
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Etoposide alone showed a robust immune response (Figure 33a-c), as we have shown 
previously (Figure 5). This immune response was ablated in cells pre-treated with ATM 
inhibitor KU55933, as measured by IFN-β mRNA (Figure 33a), IL-6 mRNA (Figure 33b), 
and CCL20 mRNA (Figure 33c) by real-time PCR. Together, these findings show that ATM 
and the DNA damage response pathway is essential for the innate immune response to DNA 
damage in primary, as well as immortalised, keratinocyte cells. 
7.3 P53 is required for the innate immune response to DNA damage in keratinocytes 
There are many factors that function downstream of ATM activation, one of which is the 
transcriptional regulator p53, a multifunctional protein which is important in a range of 
activities after damage including repair and, in the case of irreparable DNA damage, 
senescence and cell death (Vousden, 2009). P53 has been previously shown to interact with 
IFI16 in overexpression experiments, and this interaction was hypothesised to contribute to 
cellular senescence (Liao, 2011). To test if p53 as well as ATM is important for the innate 
immune response to DNA damage, we knocked-down p53 in HaCaT cells using siRNA as 
can be observed by reduced protein expression of p53 by western blot (Figure 34a). To test 
the role of p53 in the innate immune response to DNA damage, we then stimulated p53 
siRNA treated cells and NT siRNA treated cells with DMSO, 50μM Etoposide, Lipofectamine, 
or 1μg/μl HT-DNA. Compared to NT-siRNA treated cells, p53 knocked down cells showed a 
significantly reduced immune response to Etoposide as measure by IFN-β mRNA (Figure 
34b), IL-6 mRNA (Figure 34c) and CCL20 mRNA (Figure 34d). 
7.4 DDR components are required for the Etoposide-induced innate immune response 
in primary human fibroblasts 
To test if the role of the DDR is specific to keratinocytes, we then tested the MRC-5 fibroblast 
cell line. It was important to test a different cell line in the case of the DDR component 
involvement because the spontaneously immortalised HaCaT cell line, that we use for most 
of our experiments, harbour a p53 mutation which may affect the protein function (Lehman, 
1993). Using the ATM inhibitor KU55933 for 1 hour pre-treatment prior to Etoposide 




Figure 33: DNA Damage Repair factor ATM is involved in the innate immune response to DNA 
damage in primary keratinocytes. 
a-c. Primary keratinocytes (NHEKs) were pre-treated for 1 hour with 10μM ATM inhibitor 
KU55933, or vehicle only control, before treatment with DMSO or 50μM Etoposide for 24 hours. 
Cells were then lysed for qRT-PCR analysis of IFN-β (a), IL-6 (b), and CCL20 (c) mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. * p≤0.05; ** p≤0.01; *** p≤0.001 as determined by Student’s t-test. Data are 
representative of at least two experiments. 
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and CCL20 mRNA (Figure 35c) compared to vehicle control and Etoposide treated cells. IL-
6 mRNA induction was decreased but not significantly so in ATM inhibitor treated fibroblasts 
(Figure 35b), We also tested the importance of p53 in this fibroblast cell line. Using p53-
specific siRNA, and non-targeting (NT) siRNA as a control, p53 levels were knocked down in 
MRC-5 cells, as can be seen by western blot (Figure 35d). We observed here that baseline 
levels of p53 were very low in untreated MRC-5 cells and the protein levels greatly increased 
upon Etoposide treatment (Figure 35d). Cells treated with p53 siRNA showed a significant 
reduction in production of IFN-β mRNA (Figure 35e), and IL-6 mRNA (Figure 35f) by real-
time PCR. A non-significant decrease in CCL20 mRNA was also observed by real-time PCR 
(Figure 35g) compared with NT siRNA treated controls. These results indicate that 
components of the DDR pathway are involved in the innate immune response to DNA 
damage in fibroblasts. 
7.5 PARP-1 is required for the innate immune response to DNA damage in 
keratinocytes 
PARP-1 has been shown to bind rapidly to broken ends of DNA and produce PAR filaments 
which attach to substrates in a process known as PARylation (Amé, 2004). PARP-1 has 
been shown to be essential, along with ATM, for the NFκB response to DNA damage (Hinz, 
2010). The substrates of PARP-1 include PARP-1 itself and ATM among others. This 
process brings together DDR factors to facilitate their interactions with each other and 
downstream signalling. Since PARP-1 has been shown to be important in ATM activation, 
we used the PARP inhibitor PJ-34 to test the role of PARP-1 in the innate immune response 
to DNA damage. Pre-treatment with PJ-34 for 1 hour before Etoposide treatment, led to a 
significant reduction in the innate immune response to etoposide treatment in HaCaTs as 
measured by IFN-β mRNA (Figure 36a), and IL-6 mRNA (Figure 36b). There was a small 
but non-significant decrease in CCL20 mRNA induction after PARP inhibitor treatment 
(Figure 36c). 
7.6 IFI16 and p53 interact after ATM-dependent p53 phosphorylation  
To understand the connection between the DDR components and the DNA sensing 




Figure 34: p53 is necessary for the innate immune response to DNA damage 
a. HaCaT cells were treated with non-targeting (NT) or p53-specific siRNA for 48 
hours before stimulation with DMSO or 50μM Etoposide for 6 hours before lysis for 
protein analysis by Western Blot. 
b-d. HaCaT cells treated with non-targeting (NT) or p53-specific siRNA for 48 hours 
before stimulation with DMSO, 50μM Etoposide, Lipofectamine, or 1μg/ml HT-DNA for 
6 hours before lysis for qRT-PCR analysis of IFN-β (b), IL-6 (c), or CCL20 (d) mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate 
standard deviations. N.s. = non-significant, p>0.05; ** p≤0.01, as determined by 
Student’s t-test. Data are representative of at least two experiments. 
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looked at IFI16 interaction with the DDR factor, p53. IFI16 and p53 have previously been 
reported to interact in in vitro experiments (Liao, 2011). Upon immunoprecipitation of 
endogenous IFI16, from HaCaT cells, we could detect a very small amount of p53 in 
unstimulated lysates with a substantial increase in IFI16-p53 binding upon Etoposide 
treatment (Figure 37a). This IFI16-p53 interaction was ablated by use of the ATM inhibitor 
(Figure 37a). We also immunoprecipitated STING from WT HaCaTs pre-treated with ATM 
inhibitor or vehicle-only control, before Etoposide treatment. We observed that STING 
interacts with IFI16 at steady state, and this interaction increases with Etoposide treatment 
(Figure 37a). STING also interacts with p53 after Etoposide treatment (Figure 37a). Both 
the interaction between STING and IFI16, and STING and p53, were dependent on ATM 
activity (Figure 37a).  
To test if it is the phosphorylation of p53 by ATM that is required for the IFI16 interaction, we 
reconstituted HEK293T cells with IFI16 and WT p53 or p53 mutated at the phosphorylation 
site targeted by ATM, Serine 15 (S15), to observe this interaction by overexpression 
experiment. We used mutant p53 plasmids to look at the importance of p53 phosphorylation 
and activation for this interaction. P53 is phosphorylated by ATM on Serine 15 (Banin, 1998; 
Canman, 1998). When this serine is changed to an alanine (S15A), p53 phosphorylation is 
blocked. When this serine is changed to an aspartate (S15D), this mimics constitutive 
phosphorylation (Loughery, 2014). We observed that IFI16 bound to WT p53 and the 
phosphorylation mimic S15D p53 but not to the S15A p53 mutant (Figure 37b). This was 
also observed in the interaction between STING and WT or mutant p53 protein (Figure 37c). 
This indicates that p53 phosphorylation at Serine 15 and activation by ATM is essential for 
the interaction between IFI16 and p53 and STING and p53. 
7.7 IFI16, p53, and STING form a complex dependent on ATM activation after DNA 
damage to promote IFN-β promoter activity. 
After observing the ATM-dependent interaction between IFI16 and p53, we then used WT 
and STING-/- HaCaTs treated with Etoposide for 0, 2, or 4 hours, to test if this interaction also 
depended on STING. Upon IFI16 immunoprecipitation we found that IFI16 and STING 
interact at steady state and this interaction increases slightly at 2 hours’ post-treatment, and 




Figure 35: Involvement of DDR components in the innate immune response to DNA 
damage in fibroblasts. 
a-c. MRC-5 fibroblasts were pre-treated with KU55933 or DMSO control for 1 hour prior to 
a 6-hour treatment with 50uM Etoposide or DMSO. Cells were then lysed for measurement 
of IFN-β (a), IL-6 (b) and CCL20 (c) mRNA by qRT-PCR. 
d-f. MRC-5 fibroblasts were treated with non-targeting (NT) or p53-targeting siRNA over 
48 hours before treatment with DMSO or 50μM Etoposide for 6 hours. Cells were then 
lysed for measurement of IFN-β (d), IL-6 (e) and CCL20 (f) mRNA by qRT-PCR.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant; * p≤0.05; ** p≤0.01 as determined by Student’s t-test. 
Data are representative of at least two experiments. 
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immunoprecipitate with p53, however this interaction was not ablated in STING-deficient 
cells, indicating that the IFI16-p53 interaction is not STING-dependent. We then reversed the 
order of the immunoprecipitation, using WT and IFI16-/- HaCaT cells and 
immunoprecipitating STING. In this way, we observed that STING also immunoprecipitates 
with p53 at 2 hours and at 4 hours, and that this interaction was dependent on IFI16 function, 
as the interaction is ablated in IFI16-/- cells (Figure 38b). 
To investigate the cellular mechanics of this response we looked to see the cellular 
localisation of these components by fractionation (Figure 38c). IFI16 is mainly nuclear, but is 
present in the cytoplasm in WT cells. P53 is also nuclear and it can be seen to increase in 
expression after Etoposide treatment (Figure 38c). This increase also leads to small yet 
detectable levels of p53 in etoposide treated cytoplasmic fractions (Figure 38c). Lamin A/C 
and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) were used as fractionation 
loading controls (Figure 38c).  
STING overexpression alone has been previously shown to drive Type-I IFN expression in 
HEK293T cells (Ishikawa, 2008). We confirmed this in our cells using an IFN-β luciferase 
construct and titration of STING-HA plasmid (Figure 39a). We then selected a lower 
concentration of STING, which did not drive IFN-β promoter activity on its own, and 
transfected this alongside increasing concentrations of IFI16. We found that IFI16 could drive 
IFN-β promoter activity in conjunction with as little as 5ng of STING, whereas Empty Vector 
(EV), STING alone or IFI16 did not drive this activity (Figure 39b). With the same low 
concentration of STING plasmid (5ng), increasing concentrations of p53 plasmid did not 
drive IFN-β promoter activity unless cells were also treated with 50µM Etoposide for 16 
hours prior to cell lysis (Figure 39c). P53’s synergistic activity with STING could be seen in 
the absence of Etoposide treatment when the STING concentration was raised to 20ng, 
which was still low enough to prevent STING alone driving the IFN-β promoter (Figure 39d). 
When IFI16 was added to STING and p53 together, this led to a significant increase in IFN-
β-luciferase expression (Figure 39e). These data indicate that STING, IFI16, and p53 can 





Figure 36: PARP-1 is Involved in the innate immune response to DNA damage in 
keratinocytes. 
a-c. HaCaT cells were treated with PARP inhibitor PJ-34 or vehicle only control for 1 hour 
before stimulation with DMSO control, 50μM Etoposide, Lipofectamine control, or 1μg/ml 
HT-DNA for 6 hours before lysing cells for qRT-PCR analysis of IFN-β (a), IL-6 (b), and 
CCL20 (c) mRNA.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; ** p≤0.01, *** p≤0.001 as determined by Student’s 




In this chapter, we have shown that DNA damage repair factors ATM (Figure 31), p53, 
(Figure 34), and PARP-1 (Figure 36) are required for the innate immune response to DNA 
damage. Both ATM and PARP-1 have been reported to be essential for NFκB activation 
after DNA damage (Hinz, 2010). We confirmed this involvement for ATM by western blot 
(Figure 31a), real-time PCR analysis of the NFκB-induced gene IL-6 (Figure 31c), and 
confocal microscopy observing p65 translocation (Figure 32). p53, which is activated by 
ATM, was found to associate with IFI16 and STING inducibly upon DNA damage dependent 
on ATM activity and p53 Ser15 phosphorylation (Figure 37). The interaction between STING 
and p53 required IFI16 but STING was not required for the IFI16 and p53 interaction, 
indicating that IFI16 and p53 interact first and then move to STING (Figure 38a, b). Using 
cellular fractionation, movement of small amounts of both IFI16 and p53 can be detected in 
the cytoplasm (Figure 38c). By luciferase assay, we then showed that the co-expression of 
STING, IFI16, and p53 led to a cumulative effect on the IFN-β response (Figure 39). 
Together, this data indicates that DDR factors ATM, PARP-1, and p53 signal to the innate 
immune response through IFI16 and STING, to activate the innate immune response we 




Figure 37: IFI16 and STING interact with p53 after ATM-dependent p53 phosphorylation 
a. WT HaCaT cells pre-treated for 1 hour with ATM inhibitor KU55933, or mock control, were 
further treated with 50μM Etoposide for 0, 2, or 4 hours before lysis for protein analysis by 
Western blot. Lysates were immunoprecipitated with anti-IFI16 antibody, anti-STING 
antibody, or anti-IgG antibody as a control, as indicated, and blotted for interaction partners.  
b. HEK293T cells were transfected with the indicated combination of IFI16, WT p53, S15A 
p53, or S15D p53 plasmids for 24 hours before lysis for protein analysis by Western blot. 
Lysates were immunoprecipitated with anti-IFI16 antibody, or IgG as a negative control, and 
blotted for interaction partners. 
c. HEK293T cells were transfected with the indicated combination of STING-Flag, WT p53, 
S15A p53, or S15D p53 plasmids for 24 hours before lysis for protein analysis by Western 
blot. Lysates were immunoprecipitated with anti-Flag antibody, or IgG as a negative control, 




Figure 38: IFI16, p53, and STING form a complex dependent on ATM activation after 
DNA damage. 
a. WT and STING-deficient HaCaT cells were treated with 50μM Etoposide for 0, 2, or 4 
hours before lysis for protein analysis by Western blot. Lysates were then 
immunoprecipitated with anti-IFI16 antibody and blotted for interaction partners. 
b. WT and IFI16-deficient HaCaT cells were treated with 50μM Etoposide for 0, 2, or 4 hours 
before lysis for protein analysis by Western blot. Lysates were then immunoprecipitated with 
anti-STING antibody and blotted for interaction partners. 
c. WT and IFI16-deficient HaCaT cells were treated with DMSO (D) or 50μM Etoposide (E) 
for 4 hours before non-stringent cell lysis to isolate the Cytoplasmic cell fraction (Cyto). 
Remaining cell pellets were then lysed in a more stringent buffer to release the contents of 
the Nuclear cell fraction (Nuc). Both Cytoplasmic and Nuclear fractions were compared by 





Figure 39: IFI16, p53, and STING work together to promote IFN-β promoter activity. 
a. HEK293T cells were transfected with IFN-β-luciferase and Renilla plasmids and stimulated 
with increasing concentrations of STING plasmid (0, 2, 5, 10, 20, 50, 100, and 200ng). Cells 
were then grown for a further 24 hours before lysis in assay lysis buffer and lysates analysed 
with either luciferase substrate, to measure IFN-β activity, or coelenterazine, to measure 
Renilla levels in cells. Luciferase levels were normalised to Renilla levels and presented as a 
fold change of untreated cells. 
b. Cells treated as in (a) were stimulated with 5ng of STING as indicated and EV, IFI16 alone, 
or increasing concentrations of IFI16 plasmid (0, 50, 100ng) before lysis and analysis of 
luciferase activity. 
c. Cells treated as in (a) were stimulated with 5ng of STING as indicated and EV or 50ng, or 
100ng of p53 as indicated for 24 hours. Cells were then treated with DMSO or 50μM 
Etoposide 16 hours prior to lysis and analysis of luciferase activity. 
d. Cells treated as in (a) were stimulated with 20ng of STING as indicated and EV, p53 alone, 
or increasing concentrations of p53 plasmid (0, 25, 50, 100ng) before lysis and analysis of 
luciferase activity. 
e. Cells treated as in (a) and stimulated with indicated plasmids for 24 hours before lysis and 
analysis of luciferase activity. Data are presented as mean values of biological triplicates. 




Chapter 8 – Differential signaling between dsDNA and 
DNA damage responses 
8.1 Differential gene induction between Etoposide and dsDNA stimulation. 
The results presented in this thesis indicate that there are two pathways, the cytosolic DNA 
sensing pathway, and the immune response to DNA damage pathway, which have some 
factors in common as well as other factors which distinguish them. Both Etoposide and 
transfected DNA induce IFN-β production (Figure 40a). We tested the expression of other 
cytokines and chemokines under conditions where both treatment stimulated IFN-β 
expression to the same extent (50μM Etoposide and 1μg/ml HT-DNA). We found that ISG56 
and CXCL10 are more greatly upregulated after dsDNA stimulation than with DNA damage 
(Figure 40b, c). Inversely, other cytokines, CCL20 and IL-6, are greatly induced after DNA 
damage, and not after dsDNA transfection (Figure 40a, e). The IFN-β promoter contains four 
positive regulatory domains (PRDs) I-IV (Kim, 1997). These are the sites to which IRFs, 
NFκB, and AP-1 bind, together called the enhanceosome (Kim, 1997). IL-6 is a cytokine that 
is induced by a wide range of stimuli and several transcription factors have been found to 
bind to the IL-6 promoter, with NFκB (Libermann, 1990), and NF-IL6 (Nuclear factor of IL-6 
gene) (Matsusaka, 1993) thought to be essential for IL-6 transcription. The IL-6 promoter 
also has a Multiple Response Element (MRE), a region of the IL-6 enhancer which can bind 
nuclear proteins that also bind to c-fos regulatory elements (Ray, 1989) and an AP-1 
consensus site (Tanabe, 1988). ISG56 and CXCL10 are IFN stimulated genes, induced in 
response to JAK-STAT signalling after Type-I IFN in response to many viruses (Guo, 2000; 
Luster, 1987) or by the combined activation of IRF-3 and NFκB (Brownell, 2013). The CCL20 
promoter has NFκB, C/EBP (CCAAT-enhancer-binding protein), AP-1, C-Ets, and Sp-1 
binding sites (Zhao, 2014). The common transcription factors responsible for the induction of 
these genes indicates additional levels of transcriptional regulation differentiating between 




Figure 40: Differential gene induction between Etoposide and dsDNA 
stimulation. 
a-e. HaCaT cells were treated with DMSO or 50µM Etoposide, mock transfected 
(Lipo) or transfected with 1µg/ml herring testis DNA. 6 hours’ post-treatment, cells 
were lysed for qRT-PCR analysis of IFN-β (a), ISG56 (b), CXCL10 (c), CCL20 (d), 
and IL-6 (e) mRNA expression.  
Data are presented as mean values of biological triplicates. Error bars indicate 
standard deviations. Data are representative of at least two experiments. 
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8.2 Differential signalling between Etoposide and dsDNA by Western Blot. 
In the canonical DNA sensing pathway, cGAS production of cGAMP activates STING, 
leading to STING clustering at the perinucleus, and subsequent recruitment and activation of 
TBK1 and IRF3 (Ishikawa, 2009; Zhang, 2013). After observing the involvement of STING in 
the Etoposide-induced innate immune response, we then looked by microscopy to observe 
STING localisation and behaviour in wild type HaCaT cells. After 3 hours of HT-DNA 
treatment, STING can be seen to undergo characteristic clustering; however, this is not 
observed in response to Etoposide (Figure 41). This result points to a non-canonical STING 
pathway in the innate immune response to DNA damage. 
The lack of STING translocation after Etoposide treatment indicates that without cGAMP 
production, a non-canonical STING pathway is involved in the innate immune response to 
DNA damage. STING clustering is also associated with a range of STING PTMs, including 
phosphorylation, and subsequent recruitment and activation of TBK1 and IRF3. We therefore 
investigated the activation of signalling components after Etoposide stimulation in a detailed 
timecourse, side by side with transfected DNA. STING undergoes phosphorylation upon 
DNA transfection, and this can be observed by western blot in the form of a band shift. This 
band shift was observed upon HT-DNA treatment but not at any time point of Etoposide 
treatment (Figure 42a). By the first Etoposide timepoint of 2 hours, phosphorylation of the 
NFκB subunit p65 could be detected in our cells (Figure 42a). However, this was not 
detected after dsDNA transfection (Figure 42a). Conversely, TBK1 and IRF-3 were robustly 
phosphorylated after DNA transfection but showed very low induction upon Etoposide 
treatment (Figure 42a). At later timepoints, Etoposide induced phosphorylation of MAPKs 
JNK and p38, which were also not observed in the transfected DNA treated sample (Figure 
42a). 
We then looked to see if phosphorylation of these signaling components was altered in our 
IFI16-, STING-, or cGAS-deficient cells. By stimulating cells with DMSO control, 50μM 
Etoposide, Lipofectamine, and 1μg/μl HT-DNA, we observed once more that Etoposide 
treatment did not stimulate a STING band shift, or robust phosphorylation of IRF-3 and TBK1 






Figure 41: STING does not translocate after Etoposide treatment 
HaCaT cells grown on cover slips were mock transfected (Lipofectamine), transfected 
with 1µg/ml herring testis DNA (HT-DNA), or treated with DMSO or 50μM Etoposide for 
1h. Cells were fixed and stained for endogenous STING (green) and DNA (DAPI, blue). 
Images are representative of cells from several fields of view per coverslip. Scale bar: 




Figure 42: Differential signalling between Etoposide and dsDNA by Western Blot. 
a. HaCaT cells were treated with 50μM Etoposide for indicated times or with 1μg/ml HT-DNA 
for 6 hours. After this treatment, cells were lysed for protein analysis by western blot and 
blotted for indicated proteins. 
b. WT and IFI16-/- HaCaTs were treated with DMSO, 50μM Etoposide, Lipofectamine, or 
1μg/ml HT-DNA for 6 hours before lysis for protein analysis by western blot. 
c. WT and STING-/- HaCaTs were treated with DMSO, 50μM Etoposide, Lipofectamine, or 
1μg/ml HT-DNA for 6 hours before lysis for protein analysis by western blot. 
d. WT and cGAS-/- HaCaTs were treated with DMSO, 50μM Etoposide, Lipofectamine, or 
1μg/ml HT-DNA for 6 hours before lysis for protein analysis by western blot. 
Data are representative of at least two experiments. 
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phosphorylation of NFκB subunit p65 upon Etoposide treatment (Figure 42b-d). This 
phosphorylation of p65 was reduced in IFI16-/- (Figure 42b) and STING-/- cells (Figure 42c). 
However, p65 phosphorylation was intact in cGAS-/- cells (Figure 42d). JNK and p38 were 
again phosphorylated upon Etoposide treatment and this was unchanged in IFI16-/- (Figure 
42b), STING-/- (Figure 42c), and cGAS-/- cells (Figure 42d). 
8.3 IRF-3 nuclear translocation 
By western blot, we observed an increased in IRF-3 phosphorylation 2 hours after Etoposide 
treatment (Figure 42a). This was not detected at the 6-hour timepoint that we used to 
compare with dsDNA transfection. Parallel to these experiments we looked at another 
marker of IRF-3 activation, nuclear translocation by confocal microscopy. By this method, we 
observed that a small population of Etoposide treated cells showed nuclear translocation of 
IRF-3 (Figure 43a, b). By 6 hours’ post Etoposide treatment, this was just over 10% of cells, 
a small but significant increase compared to untreated cells (Figure 43b). In comparison, 
transfected DNA lead to a large increase in IRF-3 nuclear translocation with 50-60% of cells 
showing IRF-3 activation (Figure 43a, b). This activation was significantly greater than both 
untreated cells and Etoposide treated cells (Figure 43b). IRF-3 activation could be observed 
after Etoposide treatment by microscopy but not by western blot, due to the need for a more 
sensitive method of detection for subtle changes. 
8.4 p65 nuclear translocation 
We have observed phosphorylation of p65 after Etoposide treatment by western blot (Figure 
42), and NFκB has been extensively reported to be activated upon DNA damage (Pahl, 
1999; Stillmann, 2009). We therefore looked to confirm this, and to observe the mechanics of 
the response by observing p65 nuclear translocation by confocal microscopy. After 1 hour of 
Etoposide treatment, we observed substantial p65 nuclear translocation (Figure 44a, b). 
After 3 hours of Etoposide treatment, this activation was still observable and was decreasing 
by 6 hours after treatment (Figure 44a, b). HT-DNA did not induce substantial p65 





Figure 43: IRF-3 translocation after DNA damage. 
a. WT HaCaT cells grown on coverslips were treated with 50μM Etoposide for indicated 
times or stimulated with 1ug/ml HT-DNA (HT) for 3 hours. Cells were then fixed and stained 
for IRF-3 (green) and DNA (DAPI, blue). Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total cells. 
Data are presented as mean values of 5 different field of view of at least 50 cells each. Error 
bars indicate standard deviations. ** p≤0.01; *** p≤0.001 as determined by Student’s t-test. 





Figure 44: p65 translocation after DNA damage. 
a. WT HaCaT cells grown on coverslips were treated with 50μM Etoposide for indicated 
times or stimulated with 1ug/ml HT-DNA (HT) for 3 hours. Cells were then fixed and 
stained for p65 (green) and DNA (DAPI, blue). Scale bar: 20µm. 
b. Quantification of translocation observed in (a), expressed as a percentage of total 
cells. Data are presented as mean values of biological triplicates. Error bars indicate 
standard deviations. Data are representative of at least two experiments. 
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8.5 TBK1 is involved in the Type-I IFN response to DNA damage but is dispensable in 
NFκB signalling.  
TBK1 has been shown to be essential for the innate immune response to transfected DNA, 
through its recruitment to STING and phosphorylation of STING at Serine 366, which 
facilitates the recruitment and phosphorylation of IRF-3 by TBK1 (Tanaka, 2012). By 
Western blot we observed a minimal level of TBK1, and downstream IRF-3, phosphorylation 
(Figure 42a). However, this small induction may contribute, together with the greater NFκB 
induction to induce Type-I IFN in response to Etoposide. We therefore looked at the role of 
TBK1 in this pathway after Etoposide treatment by using the TBK1 inhibitor, MRT67307 
(Clark, 2011). Pre-treatment with MRT67307 for 1 hour before treatment with Etoposide or 
HT-DNA transfection led to a reduction in IFN-β mRNA after both Etoposide and HT-DNA 
treatment (Figure 45a). Surprisingly however, the TBK1 inhibitor had no effect on the 
induction of IL-6 mRNA (Figure 45b) or CCL20 mRNA (Figure 45c) after Etoposide 
treatment. The induction of IL-6 mRNA after DNA transfection is low, despite this a 
significant decrease in IL-6 mRNA induced by DNA transfection could be observed in TBK1 
inhibitor treated cells (Figure 45b) as has been previously described (Abe, 2014). As a 
control for inhibitor efficacy, stimulated cells with or without TBK1 inhibitor pre-treatment 
were lysed for western blot (Figure 45d). TBK1 inhibitor pre-treatment reduces the 
phosphorylation of IRF-3, as well as TBK1 auto-phosphorylation, after DNA transfection, 
indicating that it is effectively inhibiting TBK1 (Figure 45d). Due to the TBK1 inhibitors 
inefficacy in reducing Etoposide-induced IL-6, a mainly NFκB controlled gene, we looked by 
microscopy to confirm this observation. Upon Etoposide treatment, p65 is observed to 
translocate from its predominantly cytoplasmic localisation to the nucleus (Figure 45e). This 
translocation is also observed in TBK1 inhibitor treated cells (Figure 45e) indicating that 
TBK1 is involved in the IFN induction in response to DNA damage but not the NFκB 
response. 
8.6 MAPKs are partially responsible for the innate immune response to DNA damage 
MAPKs are known to be activated upon a wide range of inflammatory stimuli including 




Figure 45: TBK1 is involved in the Type-I IFN response to DNA damage but is 
dispensable in NFκB-controlled signalling. 
a-c. HaCaT cells pre-treated with TBK1 inhibitor, MRT67307, or vehicle only control for 1 
hour were then treated with DMSO, 50μM Etoposide, Lipofectamine, or 1μg/ml HT-DNA, as 
indicated, for 6 hours. After this time, cells were lysed for qRT-PCR analysis of IFN-β (a), IL-
6 (b), CCL20 (c) mRNA expression. 
d. Cells treated as in (a-c) were lysed to analyse protein analysis by western blot.  
e. HaCaT cells seeded onto coverslips were pre-treated with TBK1 inhibitor, MRT67307, or 
vehicle only control for 1 hour were then treated with DMSO, or 50μM Etoposide, as 
indicated, for 3 hours. After this time, cells were fixed for confocal microscopy and stained for 
p65 (red) and DAPI (blue).  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05; ** p≤0.01, as determined by Student’s t-




Figure 46: MAPKs are partially responsible for the innate immune response to DNA damage. 
a-c. WT HaCaTs were pre-treated with JNK inhibitor, JNK Inhibitor 8, for 3 hours, or p38 
inhibitor, VX745, for 1 hour, or mock, before 6-hour stimulation with 50μM Etoposide. Cells were 
then lysed for analysis by qRT-PCR and expression of IFN-β (a), IL-6 (b), and CCL20 (c) mRNA 
was quantified.  
Data are presented as mean values of biological triplicates. Error bars indicate standard 
deviations. N.s. = non-significant, p>0.05; * p≤0.05; ** p≤0.01, as determined by Student’s t-test. 
Data are representative of at least two experiments. 
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DNA damage, and this has been confirmed in our cells by observing the phosphorylation of 
JNK and p38 by western blot (Figure 42). Upon DNA damage, we observe the 
phosphorylation of JNK and p38, which is a marker of their activation (Figure 42). We 
therefore looked to see if the MAPK activation in our cells after Etoposide treatment was 
contributing to the innate immune response observed. For this we used inhibitors against 
JNK and p38 activity. 3 hours’ pre-treatment with JNK inhibitor, JNK inhibitor 8, showed no 
difference in IFN-β mRNA production (Figure 46a), however there was a significant 
reduction in IL-6 mRNA (Figure 46b), and CCL20 mRNA (Figure 46c). Cells pre-treated 
with the p38 inhibitor, VX745, prior to Etoposide stimulation, showed a slight increase in IFN-
β mRNA (Figure 46a), and CCL20 mRNA (Figure 46c), and no difference in IL-6 mRNA 
(Figure 46b) as measured by qRT-PCR. 
8.7 STING Ubiquitination and Interaction Partners 
Our results so far indicate that in response to Etoposide, STING is signalling non-
canonically. To observe the actions of STING after DNA damage, we performed a more 
detailed timecourse of 0, 0.5, 1, 2, 3, and 4 hours Etoposide treatment. STING was then 
immunoprecipitated from these lysates to identify binding partners and the timing of their 
interactions. STING was seen to interact with IFI16 as previously shown, reaching a peak of 
intensity at around 2 hours’ post-treatment (Figure 47a). STING could also be seen to 
interact with TNF Receptor-Associated Factor 6 (TRAF6) at 1 to 2 hours post-Etoposide 
treatment (Figure 47a). There was also a slight increase in TBK1 band intensity after 4 
hours of Etoposide treatment (Figure 47a). TRAF6 is an E3 ubiquitin ligase which has been 
shown to be important in the NFκB response to DNA damage (Stillmann, 2009). TRAF6 is 
known to cause ubiquitylation of its target proteins, so we therefore performed another IP 
using K63 Ub antibody to precipitate ubiquitinylated proteins from cell lysates. After 30 
minutes to 1 hour of Etoposide treatment, STING was detected in K63 Ub IP samples 
(Figure 47b). This interaction was diminished by 2 hours and gone by 3 hours post-
Etoposide treatment (Figure 47b). 
We then compared STING interaction partners after treatment with Etoposide and after 




Figure 47: STING interactions and modifications 
a. WT HaCaTs were treated with 50μM Etoposide for indicated times before lysis for 
western blot. STING was immunoprecipitated from a proportion of these lysates using 
agarose beads before eluting STING and its binding partners from the beads using 
SDS sample buffer and sample boiling. Immunoprecipitated and whole cell lysates 
(Input) were then separated by SDS-PAGE and analysed by western blot for indicated 
proteins. 
b.  WT HaCaTs were treated with 50μM Etoposide for indicated times before lysis for 
western blot. K63 Ub was immunoprecipitated from a proportion of these lysates using 
agarose beads before eluting K63 Ub and its binding partners from the beads using 
SDS sample buffer and sample boiling. Immunoprecipitated and whole cell lysates 
(Input) were then separated by SDS-PAGE and analysed by western blot for indicated 
proteins. 




Figure 48: STING interactions after DNA damage and DNA transfection 
WT HaCaTs were treated with 50μM Etoposide or transfected with 1μg/ml HT-DNA 
for indicated times before lysis for western blot. STING was immunoprecipitated from 
a proportion of these lysates using agarose beads before eluting STING and its 
binding partners from the beads using SDS sample buffer and sample boiling. 
Immunoprecipitated and whole cell lysates (Input) were then separated by SDS-
PAGE and analysed by western blot for indicated proteins. 
Data are representative of at least two independent experiments. 
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Etoposide (Figure 48). TBK1 was only observed to interact with STING after DNA 
transfection (Figure 48). IFI16 interacted with STING at steady state as we have previously 
observed (Figure 37a, Figure 38a). The IFI16-STING interaction increased most after 2 
hours of Etoposide treatment and after 4 hours of DNA transfection (Figure 48). 
8.8 Conclusions  
In this chapter, we have investigated the downstream signalling that occurs after DNA 
damage.  The response to transfected DNA and DNA damage both induce similar levels of 
IFN-β, but the induction of other cytokines is different between the two stimuli (Figure 40). 
We have shown that STING is necessary for this innate immune response (Figure 19), 
however upon Etoposide treatment we do not observe the classic signs of STING activation, 
namely translocation to perinuclear foci (Figure 41) or STING phosphorylation (Figure 42). 
To understand the non-canonical activation of STING after Etoposide treatment, we 
observed potential interaction partners in the first hours after DNA damage and found that 
STING interacted with IFI16 and p53 as we have previously shown (Figure 38, Figure 47). 
STING also interacted with the E3 ubiquitin ligase TRAF6 (Figure 47a). This interaction was 
tested due to the known role of TRAF6 in DNA damage induce NFκB activation (Stillmann, 
2009). This interaction was inducible and transient. By immunoprecipitating K63 Ub, we 
found that the STING-TRAF6 interaction coincided with the ubiquitination of STING with 
K63-linked ubiquitin chains (Figure 47b). By comparing STING interactions after both 
Etoposide treatment and dsDNA transfection, we found that STING interacted with p53 and 
TRAF6 inducibly only after DNA damage, and with TBK1 only after DNA transfection (Figure 
48). Both NFκB and, to a much lesser extent, IRF-3 are activated after DNA damage (Figure 
43, Figure 44). Using a TBK1 inhibitor, we observed a significant decrease in IFN-β mRNA 
induction after Etoposide treatment and transfected DNA, however TBK1 inhibition had no 
effect on IL-6 or CCL20 induction after DNA damage (Figure 45). MAPKs JNK and p38 were 
found to be activated upon Etoposide treatment and not upon DNA transfection, and this was 
independent of IFI16, STING, or cGAS (Figure 42a-d). Use of a JNK inhibitor prior to 
Etoposide treatment led to a significant decrease in IL-6 mRNA and CCL20 mRNA induction, 
whereas no decrease was observed with p38 inhibitor (Figure 46). Together, these findings 
170 
 
indicate that while transfected DNA and DNA damage share IFI16 and STING in common, 




Chapter 9 - Discussion 
In recent years, there has been increased speculation about a possible immune response to 
DNA damage. Most research in this area has focussed on professional immune cells at later 
time points after high levels of genotoxic stress that indicate secondary responses are in play 
(Ahn, 2014; Härtlova, 2015; Vanpouille-Box, 2017). Here we report that non-professional 
immune cells, in this case keratinocytes and fibroblasts, can respond to the damage of their 
DNA as early as 4 hours after the damage event. This leads to significant upregulation of 
inflammatory cytokines and chemokines, which could potentially lead to the recruitment and 
activation of innate and adaptive immune cells. In these investigations, large amounts of 
DNA can be seen to leave the nucleus, and cluster with cytoplasmic components of the DNA 
sensing pathway. However, in our research the nuclei can be seen to be intact. This has 
previously been reported to be a prerequisite for the NFκB response to DNA damage 
(Huang, 2000). Therefore, this response appears to be distinct, in that it is not initiated in the 
cytoplasm. Keratinocytes are our bodies barrier to the outside world, and so our first line of 
defence against a range of genotoxic and pathogenic threats (Nestle, 2009). These innate 
cells have the immune machinery necessary to mount an anti-viral immune response, 
including nuclear DNA viruses such as HSV-1. It is therefore possible that nuclear DNA, 
upon damage, may appear as non-self to the immune system and be detected within the 
nucleus. 
Our study is not the first instance of the DNA damage response being reported to activate 
IFN signalling (Brzostek-Racine, 2011). Treatment of human monocytes with Etoposide for 
20-30 hours leads to an increase in IFNα and IFNλ (Brzostek-Racine, 2011). This is similar 
to the delayed immune response to Etoposide we observe in THP1 cells. The authors of this 
study found no activation of IRF3 but instead IRF1 and IRF7 activation (Brzostek-Racine, 
2011). ATM and IKKβ were required for the immune stimulatory effect of Etoposide 
(Brzostek-Racine, 2011). Another study has reported ATM-IKKα/β dependent IRF3 
activation (Yu, 2015). However, unlike the classic nuclear localisation of active IRF3 (Lin, 
1998), there was partial translocation and a distinct. focal pattern of nuclear IRF-3 (Yu, 
2015). This IRF-3 activation was independent of TBK1, STING, and RIG-I (Yu, 2015).  
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Unrepaired DNA lesions, which accumulate in the absence of ATM have been shown to 
activate the cGAS-STING DNA sensing pathway to induce Type-I IFNs in macrophages 
(Härtlova, 2015). This response required high doses of DNA damaging agents over long time 
periods (Härtlova, 2015). Similarly, repeated lower doses of ionising radiation in mammary 
carcinoma cell lines have been reported to allow the nuclear leakage of damaged DNA 
which activated the cGAS-STING pathway of DNA sensing and IFN-β production 
(Vanpouille-Box, 2017). Whereas high level radiation induced increased levels of the DNA 
exonuclease TREX1 to degrade accumulating cytosolic DNA (Vanpouille-Box, 2017). This 
cGAS-STING response to low dose radiation was shown to be essential for the radiation-
driven anti-tumour response (Vanpouille-Box, 2017). Oxidative stress has also been shown 
to confer TREX1 resistance to damaged DNA, facilitating its detection by cGAS in the 
cytoplasm (Gehrke, 2013).  
However, in this study, the innate immune response to DNA damage at early time points has 
been shown to be cGAS-independent. Our data show that there is a cell-intrinsic innate 
immune response to DNA damage, involving the DDR sensors ATM as well as PARP-1, 
which facilitates the downstream interaction of p53, IFI16, and STING. This is a rare 
example of a cGAS-independent, STING-dependent pathway, and opens up the possibility 
of non-canonical activity of the cytosolic sensing pathway components.  
Here, I have largely characterised the innate immune response to Etoposide. However, other 
DNA damaging agents were tested and found to induce various amounts of immune 
responses. Further work on each of these DNA damaging agents should be carried out to 
understand the differences in response timing and if the components of the Etoposide-
induced response are shared, as is the case with IFI16. These stimulations have been 
carried out on asynchronous cells, and it is not clear how much of a role cell cycle plays in 
the observed timing of the immune response, or if attempted cell division after genotoxin 
treatment is necessary for the immune induction observed. Testing the role of ATR and 
DNA-PK, as well as ATM, with these stimuli would begin to answer the question of whether , 
this is a general response to DNA damage, or whether it is tailored specifically to different 
types of damage, as is the DNA repair process. 
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Both STING and IFI16 are required for the early innate immune response observed to DNA 
damage. The involvement of both STING and IFI16 points to the cytoplasmic DNA sensing 
pathway; however, the response to damaged DNA that we observe is different on a 
signalling and transcriptional level. STING has been shown to become activated upon 
binding of the second messenger cGAMP, which requires the enzyme cGAS for its 
production (Wu, 2013; Sun, 2013; Gao, 2013; Zhang, 2013; Diner, 2013). cGAMP binding 
triggers a conformational change in STING, which induces STING clustering and the 
recruitment of signalling molecules to the site of clustering (Ishikawa, 2009; Zhang, 2013). 
This activity has been shown to be essential for Type-I IFN production after transfected 
dsDNA and viral and intracellular bacterial challenges (Barber, 2014).  
The cGAS-independent activation of STING is controversial; however, STING has previously 
been shown to signal non-canonically. It was originally reported to be activated directly by 
DNA as well as cyclic dinucleotides (Ishikawa, 2008). STING is also activated in response to 
virus-like particles lacking genomic material, by membrane fusion, as well as exposure to 
fusogenic liposomes (Holm, 2012). STING has also been shown to be activated in a cGAS-
independent manner in response to enveloped RNA viruses (Holm, 2016). Here we have 
found another example of cGAS-independent STING activation. This indicates that STING is 
a multifunctional signalling hub, essential in several innate immune processes within human 
cells. 
The lack of involvement of cGAS leaves open the question of the initial sensor which detects 
the damaged DNA to initiate an immune response. One such sensor is the DDR kinase 
ATM, which becomes rapidly activated upon DNA damage or changes in chromatin 
(Bakkenist, 2003). This leads to the activation of many other DDR response factors, some of 
which IFI16 has been shown to interact with, such as BRCA1 and p53 (Aglipay, 2003; Liao, 
2011; Fujiuchi, 2003). We observed that ATM was necessary for the immune response to 
DNA damage. The role of ATM in the NFκB response to DSBs has previously been reported 
(Piret, 1999; Hinz, 2010; Janssens, 2006). ATM has also previously been implicated 
indirectly in the response to viral dsDNA, via inhibition of Mre11-Rad50-Nbs1 (MRN)-ATM 
pathway (Kondo, 2013). However, it has not previously been shown that ATM can facilitate 










STING form a complex with the ATM target protein p53. This complex was formed upon 
phosphorylation of p53 at Ser15, a site phosphorylated by ATM, and inhibition of ATM could 
block the interaction. These data indicate that DDR components, in this case ATM, when 
activated by DNA damage, can communicate with immune signalling components, IFI16 and 
STING, possibly through activation of p53. It may be through ATM’s nuclear detection of 
damage, and effect on other proteins, that the immune response to DNA damage is initiated. 
In future, the involvement of DDR components could be tested more thoroughly. Here we 
have investigated ATM, PARP-1, and p53, but perhaps with other DNA damaging agents 
other DDR factors have a larger role, such as ATR or DNA-PK. 
IFI16 is also capable of detecting DNA, it binds dsDNA strongly, particularly long stretch 
(>50bp) of unchromatinised DNA (Morrone, 2014). However, upon observing nuclear 
localisation of γH2AX, a marker of DSBs, and IFI16, we found that they were not colocalised, 
therefore, IFI16 may not be directly detecting damaged DNA, but acting downstream of ATM 
signalling. We observed an increase in the levels of IFI16 in the cytoplasm after treatment 
with DNA damaging agents. This has been shown for IFI16 previously upon treatment with 
UV (Costa, 2011). This could be a mechanism by which the nuclear event of DNA damage is 
linked to cytoplasmic signalling. However, cytoplasmic IFI16 is not detected by confocal 
microscopy. It is possible that a small fraction of IFI16 is all that is required to translocate to 
promote STING complex formation. To test this further, it would be interesting to see the 
effect of using IFI16 mutants, including those that cannot bind to DNA, cannot interact with 
certain DDR components, or are restricted to the nucleus or the cytoplasm. 
PARP-1, ATM, and TRAF6 have previously been shown to be essential for the NFκB 
response to DNA damage (Hinz, 2010). The cytoplasmic translocation of ATM proved to be 
the link between the nuclear DNA damage signal and cytoplasmic signalling factor activation 
(Stilmann, 2009). However, the role of the cytoplasmic DNA sensors IFI16 and STING in this 
pathway has not previously been documented. The immediate effects of NFκB activation 
occur within minutes and are required for DNA repair. The involvement of IFI16 and STING, 
based on observation of their interactions after damage, occurs 1-2 hours after the damage 
event. This could indicate that IFI16 and STING are not required for the initiation of the NFκB 
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response but for its prolongation and its contribution to immune signalling which require 
several hours of continuous NFκB activation. 
We have reported many signalling differences between the immune responses to DNA 
damage and DNA transfection. DNA damage induces a strong NFκB response, as has been 
extensively documented (Brach, 1991; Piret, 1996). The NFκB response to transfected DNA 
has not been so extensively studied, however we observed very low NFκB induction, lower 
than some other reports (Abe, 2014). IRF-3 and TBK1 phosphorylation were not easily 
detected after Etoposide treatment, as they are after DNA transfection. However, we 
observe a small amount of IRF-3 nuclear translocation, and the importance of TBK1 function 
in the Type-I IFN response to Etoposide, indicating that even low activity of these 
components is sufficient to contribute to this response. We did not observe STING 
translocation and perinuclear clustering after Etoposide treatment as after DNA transfection. 
To explain the different modes of STING activation, we investigated which signalling factors 
were recruited to STING upon stimulation with Etoposide or with DNA transfection. We found 
that IFI16, p53, and the E3 ubiquitin ligase TRAF6 are recruited to STING upon Etoposide 
stimulation, whereas IFI16 and TBK1 are recruited to STING upon DNA transfection. 
Members of the TRAF family of proteins are conserved ubiquitin ligases that have been 
shown to be important in many signal transduction pathways (Chung, 2002). TRAF6 is an E3 
ubiquitin ligase that coordinates the addition of K63-linked polyubiquitin chains (Deng, 2000). 
Ubiquitination of STING has been shown to be important in modulating its function. TRAF6 
has not previously been shown to have a role in STING function, but it has been shown to be 
recruited to the cytoplasmic RNA sensing adaptor protein MAVS to facilitate IRF and NFκB 
activation (Liu, 2013). We have found that STING interacts with TRAF6 selectively after DNA 
damage but not after dsDNA transfection. This interaction coincided with an increase in 
STING K63-linked ubiquitination, indicating that TRAF6 ubiquitinates STING in response to 
DNA damage. We hypothesise that ATM activates the signalling complex of p53, IFI16, 
STING, and TRAF6. TRAF6 then ubiquitylates STING, facilitating its downstream activation 
of NFκB and IRF-3, which together allow the transcription of inflammatory cytokines, 
including Type-I IFNs. This process is different to that activated upon transfected DNA 
stimulation although both pathways share STING and IFI16 in common. To test this further, it 
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would be interesting to use STING mutants, known to be defective in their response to 
transfected DNA, and see their role in the Etoposide-induced immune response. K150 is a 
STING residue that has been a target for other E3 ubiquitin ligases (Tsuchida, 2010). This 
residue is also of interest because it uncouples STING activation and STING trafficking, with 
mutants unable to respond to transfected DNA but still able to traffic (Tsuchida, 2010). 
The immune response to damaged DNA may have evolved as a reaction to the persistent 
threat of nuclear DNA viruses. Cells respond to infection by initiating repair, death, and 
defensive pathways. Many viruses, with distinct life cycles, have been shown to activate the 
DNA Damage Response pathway, either through direct damage that occurs during 
integration of the viral genome, by possessing free ends resembling DNA breaks, or 
bypassing the damage event and inducing cell cycle arrest to aid their replication (Reviewed 
in Sinclair, 2006). Whether the DDR is a help or a hindrance to viral replication is still 
uncertain. On one hand, inhibiting ATM and ATR has been shown to inhibit HIV replication, 
indicating that the virus relies on these pathways for successful replication (Lau, 2005). HSV-
1 also requires the DDR to form viral replication centres (Lilley, 2005). However, other 
viruses, such as adenovirus show no change in replication with DDR inhibitors, and instead 
are known to possess virulence factors which suppress DDR signalling (Gautam, 2013). 
ICP0, an HSV-1 virulence factor, has been shown to degrade both IFI16 (Orzalli, 2012) and 
p53 (Boutell, 2003) and to be critical for HSV-1 growth. Damaged viral DNA may act as an 
alarm to activate IFI16 to foreign DNA in the nucleus through ATM. It remains to be seen if 
this activation is constitutive upon damage, requires a second signal, or relies on a threshold 
of activation of ATM. It has been recently demonstrated that viral DNA damage can activate 
a local DDR pathway, distinct from the global DDR response to cellular genome breaks, in 
which ATM activation is not amplified throughout chromatin by H2AX (Shah, 2015). This 
indicates that subtle discrimination by the DDR is possible. 
Another possible reason for the emergence of this potentially damaging response to self-
DNA, is the occurrence of cancer. It is becoming clear that the immune system can protect 
us from the emergence of tumours, and can contribute to tumour elimination by conventional 
therapies. The primary goal of classical chemotherapy has been considered to be tumour 
cell death. However, death may not be the only beneficial outcome of chemotherapy. In 
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recent years, more focus has been placed on immunotherapy to target tumours, with many 
compounds targeting immune checkpoints reaching clinical trial. Chimeric antigen receptor 
(CAR)-T cell therapy utilises the patient’s own T cells, genetically engineering them to target 
cancer-specific antigens, overcome tumour-mediated immune suppression, and penetrate 
tumours (Eshhar, 1993). Monoclonal antibodies against PDL1 have been trialled alongside 
chemotherapy to enhance anti-tumour immune responses (Koestner, 2011). Viruses 
expressing tumour antigens have been used to develop oncolytic vaccines, which could 
clear tumours but also prevent their reoccurrence by the generation of immune memory 
(Holay, 2017). Type-I IFN treatment has also been used in the treatment of melanoma 
(Kirkwood, 2001). It has been demonstrated that radiotherapy can stimulate an intratumoural 
immune response involving Type-I IFN and a range of inflammatory cytokines (Burnette, 
2011). In mouse models, both Type-I IFN receptors and STING protein have been shown to 
be required for tumour shrinkage after radiotherapy (Dunn, 2005; Burnette, 2011; Deng, 
2014), further evidence that this pathway is involved in the innate immune response to DNA 
damage. Whether this observed response to radiotherapy also requires ATM, p53, and IFI16 
similar to the Etoposide-induced immune response that I have observed remains to be seen. 
The DNA damage caused by the genotoxic agents used in chemotherapy, may be 
functioning to kill tumour cells directly, activate the DDR of the tumour cells, and to activate 
the immune response in the tumour and surrounding cells. By harnessing the power of the 
immune response alongside low dose chemotherapy, the efficacy of treatments could be 
increased while dosage and side-effects decrease.  
The function of the immune system has traditionally been the discrimination of self from non-
self (Burnet, 1976; Schlee, 2016). This idea states that immune cells develop tolerance 
towards self-antigens early in development, in a process called central tolerance. Self-
tolerance is expanded to an increasing repertoire of antigens and maintained throughout the 
life of the immune cells in the periphery. However, this paradigm does not include the innate 
immune cells that form the front line of the immune response. Keratinocytes do not undergo 
a process of central tolerance like T and B lymphocytes do. Abundance, localization, and 
characteristic molecular structures of nucleic acids contribute to the specificity of nucleic acid 
immune recognition (Roers, 2016). Self-DNA is normally contained in the nucleus, and so 
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the presence of free dsDNA in the cytosol is recognised as a pathogen or damage 
associated molecular pattern. Self-RNA in the cytosol requires specific molecular structures 
that allow the distinction between self and non-self RNA, one being the detection of blunt 
end double-stranded 5’-triphosphate RNA, detected by RIG-I (Hornung, 2006; Pichlmair, 
2006; Schlee, 2009). Damaged DNA may possess such motifs that allow it to be recognised 
by the immune system while preventing excessive autoimmune responses. 
Our finding adds to the classical immunological debate between stranger and danger 
signals. “Stranger” signals, as detected by PRRs (Janeway, 2002) have been shown to be 
essential for initiation of immune responses against a variety of pathogens. However, there 
are cases of immune responses were there is no pathogen initiating the response, yet a 
robust response is made – such is the case in transplant rejection, tumour immunity, and 
many autoimmune diseases (Matzinger, 1994; Chen, 2010). These responses may instead 
be initiated by the detection of damage, and “danger” rather than “stranger” signals. 
Similarly, viruses that evade direct detection by the immune response, would also have to 
avoid causing any cellular damage in the host cell, to completely escape immune detection. 
The detection of damage in the cell could be the difference between a microbe being 
recognised as a pathogen or a commensal (Blander, 2012).  
This immune response to DNA damage could be harnessed in many clinical situations with 
the response being enhanced or dampened depending on the desired outcome. In transplant 
patients, administration of recombinant superoxide dismutase enzyme, reduces free radical 
mediated damage and improves short-term and long-term transplant graft-survival (Land, 
1994). Inversely, in cancer treatment, toxins and the TLR4 ligand HMGB1, have been shown 
to work as adjuvants to promote tumour clearance (Coley, 1910; Apetoh, 2007). Whether the 
response that we observe is beneficial or deleterious to tumour growth within whole tissue, 
rather than cell culture, remains to be seen. However, understanding the molecular 
mechanism of this response allows the potential for more specific therapeutic targeting of it. 
These findings should ideally be followed up in an animal model of disease, or a multilayer 
keratinocyte culture, which can mimic the layers of human skin. This study provides an 
insight into sterile inflammation and a potential explanation for the immune clearance of 
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